BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 224882 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H30N4O2/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,8-9,15,17-18H,2-5,7,10-14H2,1H3,(H,23,26) NWXLNEMDCWELOX-UHFFFAOYSA-N 106412 US8586579, 1 D(2) dopamine receptor Homo sapiens 486 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106412&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768825 174008723 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224883 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.97,-2.28,;10.63,-3.05,;9.3,-2.28,;8.05,-3.19,;6.81,-2.28,;7.28,-.82,;6.51,.52,;4.97,.52,;4.2,-.82,;4.2,1.85,;2.66,1.85,;1.89,.52,;.35,.52,;-.42,1.85,;-1.96,1.85,;-2.73,.52,;-4.27,.52,;-5.04,-.82,;-6.58,-.82,;-7.35,.52,;-6.58,1.85,;-5.04,1.85,;-8.89,.52,;-9.66,1.85,;-11.2,1.85,;-11.97,.52,;-11.2,-.82,;-11.67,-2.28,;-10.43,-3.19,;-9.18,-2.28,;-9.66,-.82,;.35,3.19,;1.89,3.19,;8.82,-.82,)| InChI=1S/C27H40N4O3/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) OEQABNLZLBEHPD-UHFFFAOYSA-N 106413 US8586579, 2 D(2) dopamine receptor Homo sapiens 802 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106413&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768827 174008724 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224884 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)CC1 |r,wU:9.8,4.4,wD:12.12,1.0,(10.78,-2.82,;10.01,-1.48,;10.78,-.15,;10.01,1.18,;8.47,1.18,;7.7,2.52,;6.16,2.52,;5.39,3.85,;5.39,1.18,;3.85,1.18,;3.08,-.15,;1.54,-.15,;.77,1.18,;-.77,1.18,;-1.54,-.15,;-3.08,-.15,;-3.85,-1.48,;-5.39,-1.48,;-6.16,-.15,;-5.39,1.18,;-3.85,1.18,;-7.7,-.15,;-8.47,1.18,;-10.01,1.18,;-10.78,-.15,;-10.01,-1.48,;-10.49,-2.95,;-9.24,-3.85,;-7.99,-2.95,;-8.47,-1.48,;1.54,2.52,;3.08,2.52,;7.7,-.15,;8.47,-1.48,)| InChI=1S/C27H40N4O3/c32-23-7-3-21(4-8-23)19-26(33)29-22-5-1-20(2-6-22)10-13-30-14-16-31(17-15-30)27-24-11-18-34-25(24)9-12-28-27/h9,11-12,18,20-23,32H,1-8,10,13-17,19H2,(H,29,33) JNSGCKSGQOFGBY-UHFFFAOYSA-N 106414 US8586579, 3 D(2) dopamine receptor Homo sapiens 1538 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106414&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768826 174008725 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224885 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H32N4O2/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,9-10,16-18H,2-6,8,11-15H2,1H3,(H,24,27) CXLYWFQWNGCVEG-UHFFFAOYSA-N 106415 US8586579, 4 D(2) dopamine receptor Homo sapiens 780 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106415&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768828 174008726 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224886 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O3/c1-29-16-9-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-8-17-30-21(20)6-10-24-23/h6,8,10,17-19H,2-5,7,9,11-16H2,1H3,(H,25,28) JSEGPLRTWBZZOJ-UHFFFAOYSA-N 106416 US8586579, 5 D(2) dopamine receptor Homo sapiens 1347 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106416&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769057 174008727 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224887 OCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.54,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5.01,-.82,;-5.78,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H32N4O3/c27-15-7-21(28)24-18-3-1-17(2-4-18)6-10-25-11-13-26(14-12-25)22-19-8-16-29-20(19)5-9-23-22/h5,8-9,16-18,27H,1-4,6-7,10-15H2,(H,24,28) UOQPMMUMTSDTOB-UHFFFAOYSA-N 106417 US8586579, 6 D(2) dopamine receptor Homo sapiens 959 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106417&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769058 174008728 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224888 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H30N4O3/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,7-8,14,16-17,26H,1-4,6,9-13,15H2,(H,23,27) PNHVOOVVCPJXPA-UHFFFAOYSA-N 106418 US8586579, 7 D(2) dopamine receptor Homo sapiens 1360 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106418&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769059 174008729 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224889 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.39,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5,-.82,;-5.78,.52,;-5,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H32N4O3/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,8-9,15,17-18H,2-5,7,10-14,16H2,1H3,(H,24,27) WVCHGRAYLHEGAY-UHFFFAOYSA-N 106419 US8586579, 8 D(2) dopamine receptor Homo sapiens 1158 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106419&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769060 174008730 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224890 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-2.82,;10.01,-2.82,;9.24,-1.48,;10.01,-.15,;9.24,1.18,;7.7,1.18,;6.93,2.52,;5.39,2.52,;4.62,3.85,;4.62,1.18,;3.08,1.18,;2.31,-.15,;.77,-.15,;,1.18,;-1.54,1.18,;-2.31,-.15,;-3.85,-.15,;-4.62,-1.48,;-6.16,-1.48,;-6.93,-.15,;-6.16,1.18,;-4.62,1.18,;-8.47,-.15,;-9.24,1.18,;-10.78,1.18,;-11.55,-.15,;-10.78,-1.48,;-11.26,-2.95,;-10.01,-3.85,;-8.76,-2.95,;-9.24,-1.48,;.77,2.52,;2.31,2.52,;6.93,-.15,;7.7,-1.48,)| InChI=1S/C28H42N4O3/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,12-13,19,21-24H,2-9,11,14-18,20H2,1H3,(H,30,33) IXDPGYMHLOZKPR-UHFFFAOYSA-N 106420 US8586579, 9 D(2) dopamine receptor Homo sapiens 1463 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106420&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769061 174008731 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224891 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H38N4O3/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,9-10,18,20-22H,1-4,6-8,11-17,19H2,(H,28,31) LJEOXWDSLFLRNN-UHFFFAOYSA-N 106421 US8586579, 10 D(2) dopamine receptor Homo sapiens 683 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106421&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769062 174008732 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224892 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H36N4O3/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,9-10,18-21H,1-4,6-8,11-17H2,(H,27,30) SQLGEXQBAJPFNZ-UHFFFAOYSA-N 106422 US8586579, 11 D(2) dopamine receptor Homo sapiens 515 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106422&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769294 174008733 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224893 CCOCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O3/c1-2-29-17-22(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)23-20-9-16-30-21(20)7-10-24-23/h7,9-10,16,18-19H,2-6,8,11-15,17H2,1H3,(H,25,28) WRBKFBAHOMAFKJ-UHFFFAOYSA-N 106423 US8586579, 12 D(2) dopamine receptor Homo sapiens 996 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106423&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769295 174008734 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224894 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(6.26,-.82,;7.03,.52,;6.26,1.85,;4.72,1.85,;3.95,.52,;2.41,.52,;1.64,1.85,;.1,1.85,;-.67,.52,;-2.21,.52,;-2.98,-.82,;-4.52,-.82,;-5.29,.52,;-4.52,1.85,;-2.98,1.85,;-6.83,.52,;-7.6,1.85,;-9.14,1.85,;-9.91,.52,;-9.14,-.82,;-9.61,-2.28,;-8.37,-3.19,;-7.12,-2.28,;-7.6,-.82,;2.41,3.19,;3.95,3.19,;8.57,.52,;9.91,-.25,;9.91,1.29,)| InChI=1S/C23H32N4O2/c28-23(18-3-4-18)25-19-5-1-17(2-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,9-10,16-19H,1-6,8,11-15H2,(H,25,28) SVONVXKDHRPGFI-UHFFFAOYSA-N 106424 US8586579, 13 D(2) dopamine receptor Homo sapiens 261 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106424&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769296 174008735 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224895 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;6.47,-.25,;9.14,1.29,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H30N4O3S/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,8-9,15-17,22H,2-5,7,10-14H2,1H3 XGWUEDFPOSFGBM-UHFFFAOYSA-N 106425 US8586579, 14 D(2) dopamine receptor Homo sapiens 866 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106425&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769297 174008736 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224896 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H30N4OS/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,8-9,15,17-18H,2-5,7,10-14H2,1H3,(H,23,26) DKJHWZSZJVWAQC-UHFFFAOYSA-N 106426 US8586579, 15 D(2) dopamine receptor Homo sapiens 119 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106426&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769298 174008737 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224897 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.08,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H32N4O3S/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,9-10,16-18,23H,2-6,8,11-15H2,1H3 KNWOHCMLVYZTJW-UHFFFAOYSA-N 106427 US8586579, 16 D(2) dopamine receptor Homo sapiens 780 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106427&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770167 174008738 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224898 CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(7.31,-2.15,;8.08,-.82,;9.63,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H33N5O3S/c1-24(2)30(27,28)23-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)21-19-9-16-29-20(19)7-10-22-21/h7,9-10,16-18,23H,3-6,8,11-15H2,1-2H3 UJBLYPURSDWDKF-UHFFFAOYSA-N 106428 US8586579, 17 D(2) dopamine receptor Homo sapiens 539 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106428&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770168 174008739 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224899 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H32N4OS/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,9-10,16-18H,2-6,8,11-15H2,1H3,(H,24,27) TYZKGCIDJUPIPC-UHFFFAOYSA-N 106429 US8586579, 18 D(2) dopamine receptor Homo sapiens 163 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106429&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769299 174008740 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224900 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O2S/c1-29-16-8-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-9-17-30-21(20)6-10-24-23/h6,9-10,17-19H,2-5,7-8,11-16H2,1H3,(H,25,28) PXCHOWMQGZACON-UHFFFAOYSA-N 106430 US8586579, 19 D(2) dopamine receptor Homo sapiens 305 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106430&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769521 174008741 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224901 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-2.82,;10.01,-2.82,;9.24,-1.48,;10.01,-.15,;9.24,1.18,;7.7,1.18,;6.93,2.52,;5.39,2.52,;4.62,3.85,;4.62,1.18,;3.08,1.18,;2.31,-.15,;.77,-.15,;,1.18,;-1.54,1.18,;-2.31,-.15,;-3.85,-.15,;-4.62,-1.48,;-6.16,-1.48,;-6.93,-.15,;-6.16,1.18,;-4.62,1.18,;-8.47,-.15,;-9.24,1.18,;-10.78,1.18,;-11.55,-.15,;-10.78,-1.48,;-11.26,-2.95,;-10.01,-3.85,;-8.76,-2.95,;-9.24,-1.48,;.77,2.52,;2.31,2.52,;6.93,-.15,;7.7,-1.48,)| InChI=1S/C28H42N4O2S/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,12-13,19,21-24H,2-9,11,14-18,20H2,1H3,(H,30,33) GSZBDACNBVTFKJ-UHFFFAOYSA-N 106431 US8586579, 20 D(2) dopamine receptor Homo sapiens 302 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106431&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769522 174008742 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224902 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.69,-2.62,;10.36,-3.39,;9.02,-2.62,;7.56,-3.1,;6.65,-1.85,;7.56,-.61,;6.79,.73,;5.25,.73,;4.48,-.61,;4.48,2.06,;2.94,2.06,;2.17,.73,;.63,.73,;-.14,2.06,;-1.68,2.06,;-2.45,.73,;-3.99,.73,;-4.76,-.61,;-6.3,-.61,;-7.07,.73,;-6.3,2.06,;-4.76,2.06,;-8.61,.73,;-9.38,2.06,;-10.92,2.06,;-11.69,.73,;-10.92,-.61,;-11.4,-2.07,;-10.15,-2.98,;-8.91,-2.07,;-9.38,-.61,;.63,3.39,;2.17,3.39,;9.02,-1.08,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106432 US8586579, 21 D(2) dopamine receptor Homo sapiens 271 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106432&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769523 174008743 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224903 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.47,.52,;1.93,.52,;1.16,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.85,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.47,3.19,)| InChI=1S/C22H32N4O2S/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,8-9,15,17-18H,2-5,7,10-14,16H2,1H3,(H,24,27) CCIIACYBEVIIIN-UHFFFAOYSA-N 106433 US8586579, 22 D(2) dopamine receptor Homo sapiens 220 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106433&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769524 174008744 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224904 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H38N4O2S/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,9-10,18,20-22H,1-4,6-8,11-17,19H2,(H,28,31) OFWNLCWKTRJZBM-UHFFFAOYSA-N 106434 US8586579, 23 D(2) dopamine receptor Homo sapiens 144 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106434&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769525 174008745 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224905 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H36N4O2S/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,9-10,18-21H,1-4,6-8,11-17H2,(H,27,30) ZERNPQRYLXBKKZ-UHFFFAOYSA-N 106435 US8586579, 24 D(2) dopamine receptor Homo sapiens 992 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106435&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769526 174008746 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224906 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.88,-2.45,;10.55,-3.22,;9.22,-2.45,;7.88,-3.22,;6.74,-2.19,;7.37,-.78,;6.6,.55,;5.06,.55,;4.29,-.78,;4.29,1.89,;2.75,1.89,;1.98,.55,;.44,.55,;-.33,1.89,;-1.87,1.89,;-2.64,.55,;-4.18,.55,;-4.95,-.78,;-6.49,-.78,;-7.26,.55,;-6.49,1.89,;-4.95,1.89,;-8.8,.55,;-9.57,1.89,;-11.11,1.89,;-11.88,.55,;-11.11,-.78,;-11.59,-2.25,;-10.34,-3.15,;-9.1,-2.25,;-9.57,-.78,;.44,3.22,;1.98,3.22,;8.9,-.94,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106436 US8586579, 25 D(2) dopamine receptor Homo sapiens 234 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106436&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769523 174008747 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224907 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(11.88,-2.45,;10.55,-3.22,;9.22,-2.45,;7.88,-3.22,;6.74,-2.19,;7.37,-.78,;6.6,.55,;5.06,.55,;4.29,-.78,;4.29,1.89,;2.75,1.89,;1.98,.55,;.44,.55,;-.33,1.89,;-1.87,1.89,;-2.64,.55,;-4.18,.55,;-4.95,-.78,;-6.49,-.78,;-7.26,.55,;-6.49,1.89,;-4.95,1.89,;-8.8,.55,;-9.57,1.89,;-11.11,1.89,;-11.88,.55,;-11.11,-.78,;-11.59,-2.25,;-10.34,-3.15,;-9.1,-2.25,;-9.57,-.78,;.44,3.22,;1.98,3.22,;8.9,-.94,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106437 US8586579, 26 D(2) dopamine receptor Homo sapiens 246 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106437&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125949 174008748 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224908 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.86,.52,;7.32,.52,;6.55,-.82,;6.55,1.85,;5.01,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H30N4O2S/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,7-8,14,16-17,26H,1-4,6,9-13,15H2,(H,23,27) OYIQKTRWSDEITE-UHFFFAOYSA-N 106438 US8586579, 27 D(2) dopamine receptor Homo sapiens 218 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106438&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768043 174008749 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224909 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)CC1 |r,wU:9.8,4.4,wD:12.12,1.0,(10.78,-2.82,;10.01,-1.48,;10.78,-.15,;10.01,1.18,;8.47,1.18,;7.7,2.52,;6.16,2.52,;5.39,3.85,;5.39,1.18,;3.85,1.18,;3.08,-.15,;1.54,-.15,;.77,1.18,;-.77,1.18,;-1.54,-.15,;-3.08,-.15,;-3.85,-1.48,;-5.39,-1.48,;-6.16,-.15,;-5.39,1.18,;-3.85,1.18,;-7.7,-.15,;-8.47,1.18,;-10.01,1.18,;-10.78,-.15,;-10.01,-1.48,;-10.49,-2.95,;-9.24,-3.85,;-7.99,-2.95,;-8.47,-1.48,;1.54,2.52,;3.08,2.52,;7.7,-.15,;8.47,-1.48,)| InChI=1S/C27H40N4O2S/c32-23-7-3-21(4-8-23)19-26(33)29-22-5-1-20(2-6-22)10-13-30-14-16-31(17-15-30)27-24-11-18-34-25(24)9-12-28-27/h9,11-12,18,20-23,32H,1-8,10,13-17,19H2,(H,29,33) WKCSANGLEHNNKN-UHFFFAOYSA-N 106439 US8586579, 28 D(2) dopamine receptor Homo sapiens 392 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106439&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768824 174008750 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224910 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)c1ccnc2ccccc12 |r,wU:3.2,wD:6.6,(5.39,-.67,;6.16,.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,;7.7,.67,;8.47,2,;10.01,2,;10.78,.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;8.47,-.67,)| InChI=1S/C29H33N5O2/c35-29(24-9-13-30-26-4-2-1-3-23(24)26)32-22-7-5-21(6-8-22)11-15-33-16-18-34(19-17-33)28-25-12-20-36-27(25)10-14-31-28/h1-4,9-10,12-14,20-22H,5-8,11,15-19H2,(H,32,35) IQGWEXBXERIPCR-UHFFFAOYSA-N 106440 US8586579, 29 D(2) dopamine receptor Homo sapiens 461 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106440&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769738 174008751 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224911 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;9.14,1.29,;6.47,-.25,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H30N4O2S2/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,8-9,15-17,22H,2-5,7,10-14H2,1H3 BUNARIUEVNWERA-UHFFFAOYSA-N 106441 US8586579, 30 D(2) dopamine receptor Homo sapiens 265 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106441&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769739 174008752 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224912 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.09,-.82,;7.32,.52,;8.65,1.29,;5.98,-.25,;6.54,1.85,;5.01,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5.01,.52,;-4.23,1.85,;-2.69,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H32N4O2S2/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,9-10,16-18,23H,2-6,8,11-15H2,1H3 RRYHHCNEVZLSCS-UHFFFAOYSA-N 106442 US8586579, 31 D(2) dopamine receptor Homo sapiens 217 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106442&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769740 174008753 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224913 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H32N4O2/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,9,17-18H,2-5,7-8,10-15H2,1H3,(H,23,26) SQRMELSMCDEARL-UHFFFAOYSA-N 106443 US8586579, 32 D(2) dopamine receptor Homo sapiens 770.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106443&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769741 174008754 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224914 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H38N4O3/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,10,19-21H,1-4,6-9,11-18H2,(H,27,30) NNECCFXSSVWBTA-UHFFFAOYSA-N 106444 US8586579, 33 D(2) dopamine receptor Homo sapiens 503.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106444&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769742 174008755 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224915 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H40N4O3/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,10,20-22H,1-4,6-9,11-19H2,(H,28,31) WBVLCBQDISBZLH-UHFFFAOYSA-N 106445 US8586579, 61 D(2) dopamine receptor Homo sapiens 869 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106445&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769743 174008756 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224916 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H36N4O3/c1-29-16-9-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-8-17-30-21(20)6-10-24-23/h6,10,18-19H,2-5,7-9,11-17H2,1H3,(H,25,28) RSOWGGVCBJACCG-UHFFFAOYSA-N 106446 US8586579, 62 D(2) dopamine receptor Homo sapiens 1488 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106446&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769948 174008757 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224917 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.86,.52,;7.32,.52,;6.55,-.82,;6.55,1.85,;5.01,1.85,;4.23,.52,;2.7,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.86,1.85,;-9.62,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.7,3.19,;4.23,3.19,)| InChI=1S/C22H34N4O2/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,10,17-18H,2-6,8-9,11-16H2,1H3,(H,24,27) HHRGFYRLYOYIFM-UHFFFAOYSA-N 106447 US8586579, 36 D(2) dopamine receptor Homo sapiens 812.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106447&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769949 174008758 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224918 O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106448 US8586579, 37 D(2) dopamine receptor Homo sapiens 1471.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106448&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769951 174008759 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224919 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.92,.52,;1.16,1.85,;-.38,1.85,;-1.16,.52,;-2.7,.52,;-3.46,-.82,;-5.01,-.82,;-5.78,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.92,3.19,;3.46,3.19,)| InChI=1S/C22H34N4O3/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,9,17-18H,2-5,7-8,10-16H2,1H3,(H,24,27) PZYRQKWSXFGUED-UHFFFAOYSA-N 106449 US8586579, 38 D(2) dopamine receptor Homo sapiens 1545.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106449&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769950 174008760 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224920 CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;10.29,-.05,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C22H34N4O4S/c1-31(28,29)16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-30-20(19)6-9-23-22/h6,9,17-18H,2-5,7-8,10-16H2,1H3,(H,24,27) ZDFGDUYZGMNXLU-UHFFFAOYSA-N 106450 US8586579, 39 D(2) dopamine receptor Homo sapiens 1018.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106450&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769952 174008761 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224921 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.85,.52,;7.32,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.93,1.85,;.39,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C21H32N4O3/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,8,16-17,26H,1-4,6-7,9-15H2,(H,23,27) HUEMJHLBWFDXTF-UHFFFAOYSA-N 106451 US8586579, 40 D(2) dopamine receptor Homo sapiens 1568 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106451&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769953 174008762 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224922 OCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.85,-.82,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5.01,-.82,;-5.77,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.08,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.85,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H34N4O3/c27-15-7-21(28)24-18-3-1-17(2-4-18)6-10-25-11-13-26(14-12-25)22-19-8-16-29-20(19)5-9-23-22/h5,9,17-18,27H,1-4,6-8,10-16H2,(H,24,28) YMPBYYINMWNUQV-UHFFFAOYSA-N 106452 US8586579, 41 D(2) dopamine receptor Homo sapiens 733.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106452&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770164 174008763 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224923 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCOC1 |r,wU:3.2,wD:6.6,(5.75,-.82,;6.52,.52,;5.75,1.85,;4.21,1.85,;3.44,.52,;1.9,.52,;1.13,1.85,;-.41,1.85,;-1.18,.52,;-2.72,.52,;-3.49,-.82,;-5.03,-.82,;-5.8,.52,;-5.03,1.85,;-3.49,1.85,;-7.34,.52,;-8.12,1.85,;-9.65,1.85,;-10.43,.52,;-9.65,-.82,;-10.13,-2.28,;-8.89,-3.19,;-7.64,-2.28,;-8.12,-.82,;1.9,3.19,;3.44,3.19,;8.06,.52,;8.96,1.76,;10.43,1.29,;10.43,-.25,;8.96,-.73,)| InChI=1S/C24H36N4O3/c29-24(19-7-15-30-17-19)26-20-3-1-18(2-4-20)6-10-27-11-13-28(14-12-27)23-21-8-16-31-22(21)5-9-25-23/h5,9,18-20H,1-4,6-8,10-17H2,(H,26,29) YNWOVSGFFVVSBU-UHFFFAOYSA-N 106453 US8586579, 42 D(2) dopamine receptor Homo sapiens 609.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106453&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770165 174008764 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224924 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCCO1 |r,wU:3.2,wD:6.6,(5.75,-.82,;6.52,.52,;5.75,1.85,;4.21,1.85,;3.44,.52,;1.9,.52,;1.13,1.85,;-.41,1.85,;-1.18,.52,;-2.72,.52,;-3.49,-.82,;-5.03,-.82,;-5.8,.52,;-5.03,1.85,;-3.49,1.85,;-7.34,.52,;-8.11,1.85,;-9.65,1.85,;-10.42,.52,;-9.65,-.82,;-10.13,-2.28,;-8.88,-3.19,;-7.64,-2.28,;-8.11,-.82,;1.9,3.19,;3.44,3.19,;8.06,.52,;8.96,1.76,;10.42,1.29,;10.42,-.25,;8.96,-.73,)| InChI=1S/C24H36N4O3/c29-24(22-2-1-16-30-22)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)23-20-9-17-31-21(20)7-10-25-23/h7,10,18-19,22H,1-6,8-9,11-17H2,(H,26,29) HZQQJAKATKCPDP-UHFFFAOYSA-N 106454 US8586579, 43 D(2) dopamine receptor Homo sapiens 1044 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106454&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770166 174008765 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224925 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccccc1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C26H34N4O2/c31-26(21-4-2-1-3-5-21)28-22-8-6-20(7-9-22)11-14-29-15-17-30(18-16-29)25-23-12-19-32-24(23)10-13-27-25/h1-5,10,13,20,22H,6-9,11-12,14-19H2,(H,28,31) HAABSCYMCZRVTB-UHFFFAOYSA-N 106455 US8586579, 44 D(2) dopamine receptor Homo sapiens 481.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106455&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770169 174008766 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224926 Fc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.55,.52,;10.01,.52,;9.24,-.82,;7.7,-.82,;6.93,.52,;7.7,1.85,;9.24,1.85,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,)| InChI=1S/C26H33FN4O2/c27-21-5-3-20(4-6-21)26(32)29-22-7-1-19(2-8-22)10-13-30-14-16-31(17-15-30)25-23-11-18-33-24(23)9-12-28-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,29,32) HQAMJNKOXUQUKS-UHFFFAOYSA-N 106456 US8586579, 45 D(2) dopamine receptor Homo sapiens 341.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106456&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770380 174008767 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224927 Clc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.55,.52,;10.01,.52,;9.24,-.82,;7.7,-.82,;6.93,.52,;7.7,1.85,;9.24,1.85,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,)| InChI=1S/C26H33ClN4O2/c27-21-5-3-20(4-6-21)26(32)29-22-7-1-19(2-8-22)10-13-30-14-16-31(17-15-30)25-23-11-18-33-24(23)9-12-28-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,29,32) HMAKCCQMRGCRHO-UHFFFAOYSA-N 106457 US8586579, 73 D(2) dopamine receptor Homo sapiens 289.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106457&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770381 174008768 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224928 FC(F)(F)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.13,wD:16.17,(12.32,.52,;10.78,.52,;10.78,2.06,;10.78,-1.02,;9.24,.52,;8.47,-.82,;6.93,-.82,;6.16,.52,;6.93,1.85,;8.47,1.85,;4.62,.52,;3.85,-.82,;3.85,1.85,;2.31,1.85,;1.54,.52,;,.52,;-.77,1.85,;-2.31,1.85,;-3.08,.52,;-4.62,.52,;-5.39,-.82,;-6.93,-.82,;-7.7,.52,;-6.93,1.85,;-5.39,1.85,;-9.24,.52,;-10.01,1.85,;-11.55,1.85,;-12.32,.52,;-11.55,-.82,;-12.03,-2.28,;-10.78,-3.19,;-9.53,-2.28,;-10.01,-.82,;,3.19,;1.54,3.19,)| InChI=1S/C27H33F3N4O2/c28-27(29,30)21-5-3-20(4-6-21)26(35)32-22-7-1-19(2-8-22)10-13-33-14-16-34(17-15-33)25-23-11-18-36-24(23)9-12-31-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,32,35) JVTXPXRMOCVEDH-UHFFFAOYSA-N 106458 US8586579, 74 D(2) dopamine receptor Homo sapiens 871.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106458&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770382 174008769 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224929 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;6.47,-.25,;9.14,1.29,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H32N4O3S/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,9,16-17,22H,2-5,7-8,10-15H2,1H3 ILSVAZDAOVUDJJ-UHFFFAOYSA-N 106459 US8586579, 75 D(2) dopamine receptor Homo sapiens 1269.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106459&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770383 174008770 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224930 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.08,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.7,-.82,;-4.23,-.82,;-5.01,.52,;-4.23,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H34N4O3S/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,10,17-18,23H,2-6,8-9,11-16H2,1H3 HFJVMFBCUWJLFO-UHFFFAOYSA-N 106460 US8586579, 76 D(2) dopamine receptor Homo sapiens 1093.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106460&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770384 174008771 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224931 Fc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,wD:14.15,(10.01,-4,;9.24,-2.67,;7.7,-2.67,;6.93,-1.33,;7.7,,;9.24,,;10.01,-1.33,;6.93,1.33,;5.6,.56,;8.26,2.1,;6.16,2.67,;4.62,2.67,;3.85,1.33,;2.31,1.33,;1.54,2.67,;,2.67,;-.77,1.33,;-2.31,1.33,;-3.08,,;-4.62,,;-5.39,1.33,;-4.62,2.67,;-3.08,2.67,;-6.93,1.33,;-7.7,2.67,;-9.24,2.67,;-10.01,1.33,;-9.24,,;-9.72,-1.46,;-8.47,-2.37,;-7.22,-1.46,;-7.7,,;2.31,4,;3.85,4,)| InChI=1S/C25H33FN4O3S/c26-20-3-7-22(8-4-20)34(31,32)28-21-5-1-19(2-6-21)10-13-29-14-16-30(17-15-29)25-23-11-18-33-24(23)9-12-27-25/h3-4,7-9,12,19,21,28H,1-2,5-6,10-11,13-18H2 OXMLHENURKVGGZ-UHFFFAOYSA-N 106461 US8586579, 50 D(2) dopamine receptor Homo sapiens 240 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106461&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770385 174008772 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224932 O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.7,wD:10.11,(5.88,-.92,;6.65,.41,;8.19,.41,;8.96,1.75,;10.29,2.52,;8.96,3.29,;5.88,1.75,;4.34,1.75,;3.57,.41,;2.03,.41,;1.26,1.75,;-.28,1.75,;-1.05,.41,;-2.59,.41,;-3.36,-.92,;-4.9,-.92,;-5.67,.41,;-4.9,1.75,;-3.36,1.75,;-7.21,.41,;-7.98,1.75,;-9.52,1.75,;-10.29,.41,;-9.52,-.92,;-10,-2.38,;-8.75,-3.29,;-7.51,-2.38,;-7.98,-.92,;2.03,3.08,;3.57,3.08,)| InChI=1S/C24H36N4O2/c29-23(17-19-1-2-19)26-20-5-3-18(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,18-20H,1-6,8-9,11-17H2,(H,26,29) XPKWZBRQMHEAAX-UHFFFAOYSA-N 106462 US8586579, 51 D(2) dopamine receptor Homo sapiens 586.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106462&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125786 174008773 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224933 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCC1 |r,wU:3.2,wD:6.6,(5.83,-.82,;6.6,.52,;5.83,1.85,;4.29,1.85,;3.52,.52,;1.98,.52,;1.21,1.85,;-.33,1.85,;-1.1,.52,;-2.64,.52,;-3.41,-.82,;-4.95,-.82,;-5.72,.52,;-4.95,1.85,;-3.41,1.85,;-7.26,.52,;-8.03,1.85,;-9.57,1.85,;-10.34,.52,;-9.57,-.82,;-10.05,-2.28,;-8.8,-3.19,;-7.56,-2.28,;-8.03,-.82,;1.98,3.19,;3.52,3.19,;8.14,.52,;9.24,-.58,;10.34,.52,;9.24,1.62,)| InChI=1S/C24H36N4O2/c29-24(19-2-1-3-19)26-20-6-4-18(5-7-20)9-12-27-13-15-28(16-14-27)23-21-10-17-30-22(21)8-11-25-23/h8,11,18-20H,1-7,9-10,12-17H2,(H,26,29) IUHXMQOKDMHFCT-UHFFFAOYSA-N 106463 US8586579, 52 D(2) dopamine receptor Homo sapiens 555 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106463&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770598 174008774 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224934 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCCOC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,1.85,;10.01,1.85,;10.78,.52,;10.01,-.82,;8.47,-.82,)| InChI=1S/C25H38N4O3/c30-25(20-2-1-16-31-18-20)27-21-5-3-19(4-6-21)8-11-28-12-14-29(15-13-28)24-22-9-17-32-23(22)7-10-26-24/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) RBGONAOLWTWGIH-UHFFFAOYSA-N 106464 US8586579, 53 D(2) dopamine receptor Homo sapiens 766.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106464&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770599 174008775 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224935 C[C@]1(O)CC[C@@H](CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,1.1,wD:14.15,5.8,1.0,(11.45,1.29,;10.11,.52,;11.45,-.25,;9.34,-.82,;7.8,-.82,;7.03,.52,;7.8,1.85,;9.34,1.85,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.83,.52,;-6.06,1.85,;-4.52,1.85,;-8.37,.52,;-9.14,1.85,;-10.68,1.85,;-11.45,.52,;-10.68,-.82,;-11.15,-2.28,;-9.91,-3.19,;-8.66,-2.28,;-9.14,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C27H42N4O3/c1-27(33)11-6-21(7-12-27)26(32)29-22-4-2-20(3-5-22)9-14-30-15-17-31(18-16-30)25-23-10-19-34-24(23)8-13-28-25/h8,13,20-22,33H,2-7,9-12,14-19H2,1H3,(H,29,32) XLIXPJRYIUCZIQ-UHFFFAOYSA-N 106465 US8586579, 81 D(2) dopamine receptor Homo sapiens 506.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106465&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125777 174008776 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224936 C[C@@]1(O)CC[C@@H](CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,1.0,wD:14.15,5.8,1.1,(11.45,1.29,;10.11,.52,;11.45,-.25,;9.34,-.82,;7.8,-.82,;7.03,.52,;7.8,1.85,;9.34,1.85,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.83,.52,;-6.06,1.85,;-4.52,1.85,;-8.37,.52,;-9.14,1.85,;-10.68,1.85,;-11.45,.52,;-10.68,-.82,;-11.15,-2.28,;-9.91,-3.19,;-8.66,-2.28,;-9.14,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C27H42N4O3/c1-27(33)11-6-21(7-12-27)26(32)29-22-4-2-20(3-5-22)9-14-30-15-17-31(18-16-30)25-23-10-19-34-24(23)8-13-28-25/h8,13,20-22,33H,2-7,9-12,14-19H2,1H3,(H,29,32) XLIXPJRYIUCZIQ-UHFFFAOYSA-N 106466 US8586579, 55 D(2) dopamine receptor Homo sapiens 475 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106466&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125777 174008777 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224937 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCCCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C31H43N5O2/c37-31(25-6-10-27(11-7-25)35-16-2-1-3-17-35)33-26-8-4-24(5-9-26)13-18-34-19-21-36(22-20-34)30-28-14-23-38-29(28)12-15-32-30/h6-7,10-12,15,24,26H,1-5,8-9,13-14,16-23H2,(H,33,37) UBLOWVVYFMMWMS-UHFFFAOYSA-N 106467 US8586579, 83 D(2) dopamine receptor Homo sapiens 5340 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106467&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770600 174008778 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224938 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C30H41N5O3/c36-30(24-3-7-26(8-4-24)34-18-21-37-22-19-34)32-25-5-1-23(2-6-25)10-13-33-14-16-35(17-15-33)29-27-11-20-38-28(27)9-12-31-29/h3-4,7-9,12,23,25H,1-2,5-6,10-11,13-22H2,(H,32,36) WVPMAZJVALETCI-UHFFFAOYSA-N 106468 US8586579, 57 D(2) dopamine receptor Homo sapiens 867.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106468&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770601 174008779 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224939 OC1(CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.7,wD:10.11,(9.27,-.82,;8.5,.52,;9.98,.92,;8.89,2.01,;6.96,.52,;6.19,-.82,;6.19,1.85,;4.65,1.85,;3.88,.52,;2.34,.52,;1.57,1.85,;.03,1.85,;-.74,.52,;-2.28,.52,;-3.05,-.82,;-4.59,-.82,;-5.36,.52,;-4.59,1.85,;-3.05,1.85,;-6.9,.52,;-7.67,1.85,;-9.21,1.85,;-9.98,.52,;-9.21,-.82,;-9.69,-2.28,;-8.44,-3.19,;-7.2,-2.28,;-7.67,-.82,;2.34,3.19,;3.88,3.19,)| InChI=1S/C23H34N4O3/c28-22(23(29)8-9-23)25-18-3-1-17(2-4-18)6-11-26-12-14-27(15-13-26)21-19-7-16-30-20(19)5-10-24-21/h5,10,17-18,29H,1-4,6-9,11-16H2,(H,25,28) CKAFITNCAHORFQ-UHFFFAOYSA-N 106469 US8586579, 58 D(2) dopamine receptor Homo sapiens 592.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106469&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125810 174008780 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224940 O=C(CC#N)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(6.16,-.82,;6.93,.52,;8.47,.52,;9.24,1.85,;10.01,3.19,;6.16,1.85,;4.62,1.85,;3.85,.52,;2.31,.52,;1.54,1.85,;,1.85,;-.77,.52,;-2.31,.52,;-3.08,-.82,;-4.62,-.82,;-5.39,.52,;-4.62,1.85,;-3.08,1.85,;-6.93,.52,;-7.7,1.85,;-9.24,1.85,;-10.01,.52,;-9.24,-.82,;-9.72,-2.28,;-8.47,-3.19,;-7.22,-2.28,;-7.7,-.82,;2.31,3.19,;3.85,3.19,)| InChI=1S/C22H31N5O2/c23-9-5-21(28)25-18-3-1-17(2-4-18)7-11-26-12-14-27(15-13-26)22-19-8-16-29-20(19)6-10-24-22/h6,10,17-18H,1-5,7-8,11-16H2,(H,25,28) AZQFGKSDCVQAHH-UHFFFAOYSA-N 106470 US8586579, 59 D(2) dopamine receptor Homo sapiens 702.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106470&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770602 174008781 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224941 FC(F)(F)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;10.29,-.05,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C22H31F3N4O2/c23-22(24,25)15-20(30)27-17-3-1-16(2-4-17)6-9-28-10-12-29(13-11-28)21-18-7-14-31-19(18)5-8-26-21/h5,8,16-17H,1-4,6-7,9-15H2,(H,27,30) KAEYIPLTXHGZRS-UHFFFAOYSA-N 106471 US8586579, 60 D(2) dopamine receptor Homo sapiens 687.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106471&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770825 174008782 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224942 O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,3.2,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106472 US8586579, 61 D(2) dopamine receptor Homo sapiens 1124 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106472&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770826 174008783 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224943 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccnc2ccccc12 |r,wU:3.2,wD:6.6,(5.39,-.67,;6.16,.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,;7.7,.67,;8.47,2,;10.01,2,;10.78,.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;8.47,-.67,)| InChI=1S/C29H35N5O2/c35-29(24-9-13-30-26-4-2-1-3-23(24)26)32-22-7-5-21(6-8-22)11-15-33-16-18-34(19-17-33)28-25-12-20-36-27(25)10-14-31-28/h1-4,9-10,13-14,21-22H,5-8,11-12,15-20H2,(H,32,35) MVNMMDGTQIXAJK-UHFFFAOYSA-N 106473 US8586579, 62 D(2) dopamine receptor Homo sapiens 547.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106473&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770827 174008784 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224944 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(6.26,-.82,;7.03,.52,;6.26,1.85,;4.72,1.85,;3.95,.52,;2.41,.52,;1.64,1.85,;.1,1.85,;-.67,.52,;-2.21,.52,;-2.98,-.82,;-4.52,-.82,;-5.29,.52,;-4.52,1.85,;-2.98,1.85,;-6.83,.52,;-7.6,1.85,;-9.14,1.85,;-9.91,.52,;-9.14,-.82,;-9.61,-2.28,;-8.37,-3.19,;-7.12,-2.28,;-7.6,-.82,;2.41,3.19,;3.95,3.19,;8.57,.52,;9.91,-.25,;9.91,1.29,)| InChI=1S/C23H34N4O2/c28-23(18-3-4-18)25-19-5-1-17(2-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,10,17-19H,1-6,8-9,11-16H2,(H,25,28) OUMNETVFYOWILO-UHFFFAOYSA-N 106474 US8586579, 63 D(2) dopamine receptor Homo sapiens 485.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106474&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770828 174008785 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224945 O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106475 US8586579, 91 D(2) dopamine receptor Homo sapiens 1262.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106475&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770829 174008786 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224946 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-4,;10.01,-4,;9.24,-2.67,;10.01,-1.33,;9.24,,;7.7,,;6.93,1.33,;5.39,1.33,;4.62,,;4.62,2.67,;3.08,2.67,;2.31,1.33,;.77,1.33,;,2.67,;-1.54,2.67,;-2.31,1.33,;-3.85,1.33,;-4.62,,;-6.16,,;-6.93,1.33,;-6.16,2.67,;-4.62,2.67,;-8.47,1.33,;-9.24,2.67,;-10.78,2.67,;-11.55,1.33,;-10.78,,;-11.26,-1.46,;-10.01,-2.37,;-8.76,-1.46,;-9.24,,;.77,4,;2.31,4,;6.93,-1.33,;7.7,-2.67,)| InChI=1S/C28H44N4O3/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,13,21-24H,2-9,11-12,14-20H2,1H3,(H,30,33) JCPOEWYYYWHNCO-UHFFFAOYSA-N 106476 US8586579, 92 D(2) dopamine receptor Homo sapiens 2451.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106476&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770830 174008787 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224947 CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(9.63,-.82,;8.08,-.82,;7.31,-2.15,;7.31,.52,;8.65,1.29,;5.98,-.25,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H35N5O3S/c1-24(2)30(27,28)23-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)21-19-9-16-29-20(19)7-10-22-21/h7,10,17-18,23H,3-6,8-9,11-16H2,1-2H3 CKOUWIPOSAPIGS-UHFFFAOYSA-N 106477 US8586579, 66 D(2) dopamine receptor Homo sapiens 781.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106477&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125849 174008788 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224948 O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,3.2,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106478 US8586579, 67 D(2) dopamine receptor Homo sapiens 1461 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106478&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771057 174008789 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224949 O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,3.2,wD:12.13,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106479 US8586579, 95 D(2) dopamine receptor Homo sapiens 914.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106479&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771058 174008790 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224950 O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,3.2,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106480 US8586579, 96 D(2) dopamine receptor Homo sapiens 857.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106480&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771059 174008791 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224951 CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(8.47,2.06,;8.47,.52,;8.47,-1.02,;10.01,.52,;6.93,.52,;6.16,-.82,;6.16,1.85,;4.62,1.85,;3.85,.52,;2.31,.52,;1.54,1.85,;,1.85,;-.77,.52,;-2.31,.52,;-3.08,-.82,;-4.62,-.82,;-5.39,.52,;-4.62,1.85,;-3.08,1.85,;-6.93,.52,;-7.7,1.85,;-9.24,1.85,;-10.01,.52,;-9.24,-.82,;-9.72,-2.28,;-8.47,-3.19,;-7.22,-2.28,;-7.7,-.82,;2.31,3.19,;3.85,3.19,)| InChI=1S/C24H38N4O2/c1-24(2,3)23(29)26-19-6-4-18(5-7-19)9-12-27-13-15-28(16-14-27)22-20-10-17-30-21(20)8-11-25-22/h8,11,18-19H,4-7,9-10,12-17H2,1-3H3,(H,26,29) IHNAEAHWHZVEJK-UHFFFAOYSA-N 106481 US8586579, 70 D(2) dopamine receptor Homo sapiens 523.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106481&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771060 174008792 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224952 CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.39,-.82,;8.86,-.82,;8.08,-2.15,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C24H38N4O2/c1-18(2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,18-20H,3-6,8-9,11-17H2,1-2H3,(H,26,29) FORAQSMKEXXBJZ-UHFFFAOYSA-N 106482 US8586579, 71 D(2) dopamine receptor Homo sapiens 654.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106482&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771061 174008793 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224953 CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.29,-.05,;8.96,-.82,;9.73,-2.15,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C25H40N4O2/c1-25(2,3)18-23(30)27-20-6-4-19(5-7-20)9-12-28-13-15-29(16-14-28)24-21-10-17-31-22(21)8-11-26-24/h8,11,19-20H,4-7,9-10,12-18H2,1-3H3,(H,27,30) DQVWGUUNHWMPMS-UHFFFAOYSA-N 106483 US8586579, 99 D(2) dopamine receptor Homo sapiens 444.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106483&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771062 174008794 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224954 O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(5.8,-.82,;6.57,.52,;8.11,.52,;8.88,-.82,;8.48,-2.3,;9.97,-2.7,;10.37,-1.21,;5.8,1.85,;4.26,1.85,;3.49,.52,;1.95,.52,;1.18,1.85,;-.36,1.85,;-1.13,.52,;-2.67,.52,;-3.44,-.82,;-4.98,-.82,;-5.75,.52,;-4.98,1.85,;-3.44,1.85,;-7.29,.52,;-8.06,1.85,;-9.6,1.85,;-10.37,.52,;-9.6,-.82,;-10.07,-2.28,;-8.83,-3.19,;-7.58,-2.28,;-8.06,-.82,;1.95,3.19,;3.49,3.19,)| InChI=1S/C25H38N4O2/c30-24(18-20-2-1-3-20)27-21-6-4-19(5-7-21)9-12-28-13-15-29(16-14-28)25-22-10-17-31-23(22)8-11-26-25/h8,11,19-21H,1-7,9-10,12-18H2,(H,27,30) HRGLDIJXNKMLQF-UHFFFAOYSA-N 106484 US8586579, 73 D(2) dopamine receptor Homo sapiens 602.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106484&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771291 174008795 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224955 FC1(F)CC1C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(8.51,-1.59,;9.28,-.25,;10.53,-1,;9.28,1.29,;7.95,.52,;6.41,.52,;5.64,-.82,;5.64,1.85,;4.1,1.85,;3.33,.52,;1.79,.52,;1.02,1.85,;-.52,1.85,;-1.29,.52,;-2.83,.52,;-3.6,-.82,;-5.14,-.82,;-5.91,.52,;-5.14,1.85,;-3.6,1.85,;-7.45,.52,;-8.22,1.85,;-9.76,1.85,;-10.53,.52,;-9.76,-.82,;-10.24,-2.28,;-8.99,-3.19,;-7.75,-2.28,;-8.22,-.82,;1.79,3.19,;3.33,3.19,)| InChI=1S/C23H32F2N4O2/c24-23(25)15-19(23)22(30)27-17-3-1-16(2-4-17)6-9-28-10-12-29(13-11-28)21-18-7-14-31-20(18)5-8-26-21/h5,8,16-17,19H,1-4,6-7,9-15H2,(H,27,30) YFHWGBZGWDWNRV-UHFFFAOYSA-N 106485 US8586579, 101 D(2) dopamine receptor Homo sapiens 438.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106485&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771292 174008796 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224956 CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.62,-.82,;8.85,.52,;9.62,1.85,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C23H36N4O2/c1-17(2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) HGDNRYBOAYQHNG-UHFFFAOYSA-N 106486 US8586579, 75 D(2) dopamine receptor Homo sapiens 705.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106486&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771293 174008797 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224957 CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(8.85,3.19,;9.62,1.85,;8.85,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C24H38N4O2/c1-3-18(2)24(29)26-20-6-4-19(5-7-20)9-12-27-13-15-28(16-14-27)23-21-10-17-30-22(21)8-11-25-23/h8,11,18-20H,3-7,9-10,12-17H2,1-2H3,(H,26,29) JPVBGGFMPCPVDU-UHFFFAOYSA-N 106487 US8586579, 103 D(2) dopamine receptor Homo sapiens 709.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106487&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771294 174008798 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224958 O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(5.8,-.82,;6.57,.52,;8.11,.52,;8.88,-.82,;8.48,-2.3,;9.97,-2.7,;10.37,-1.21,;5.8,1.85,;4.26,1.85,;3.49,.52,;1.95,.52,;1.18,1.85,;-.36,1.85,;-1.13,.52,;-2.67,.52,;-3.44,-.82,;-4.98,-.82,;-5.75,.52,;-4.98,1.85,;-3.44,1.85,;-7.29,.52,;-8.06,1.85,;-9.6,1.85,;-10.37,.52,;-9.6,-.82,;-10.07,-2.28,;-8.83,-3.19,;-7.58,-2.28,;-8.06,-.82,;1.95,3.19,;3.49,3.19,)| InChI=1S/C24H36N4O3/c29-23(15-19-16-30-17-19)26-20-3-1-18(2-4-20)6-9-27-10-12-28(13-11-27)24-21-7-14-31-22(21)5-8-25-24/h5,8,18-20H,1-4,6-7,9-17H2,(H,26,29) KPWFNAZMRFBRMI-UHFFFAOYSA-N 106488 US8586579, 77 D(2) dopamine receptor Homo sapiens 754.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106488&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771295 174008799 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224959 CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.62,-.82,;8.85,.52,;9.62,1.85,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H35N5O2/c1-25(2)22(28)24-18-5-3-17(4-6-18)8-11-26-12-14-27(15-13-26)21-19-9-16-29-20(19)7-10-23-21/h7,10,17-18H,3-6,8-9,11-16H2,1-2H3,(H,24,28) UVEHFXJWIQCNDD-UHFFFAOYSA-N 106489 US8586579, 105 D(2) dopamine receptor Homo sapiens 322.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106489&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125778 174008800 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224960 FC(F)(F)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(5.6,-.05,;6.93,-.82,;8.26,-1.59,;6.16,-2.15,;7.7,.52,;9.24,.52,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H29F3N4O2/c22-21(23,24)20(29)26-16-3-1-15(2-4-16)6-9-27-10-12-28(13-11-27)19-17-7-14-30-18(17)5-8-25-19/h5,8,15-16H,1-4,6-7,9-14H2,(H,26,29) SUGHICCAJLONJR-UHFFFAOYSA-N 106490 US8586579, 106 D(2) dopamine receptor Homo sapiens 773.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106490&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 86660552 174008801 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224961 CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.39,-.82,;8.86,-.82,;8.08,-2.15,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C24H36N4O2/c1-18(2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,17,19-20H,3-6,8-9,11-16H2,1-2H3,(H,26,29) NBKJTOGTVMGTOS-UHFFFAOYSA-N 106491 US8586579, 107 D(2) dopamine receptor Homo sapiens 198.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106491&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125807 174008802 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224962 C\C=C\CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H36N4O2/c1-2-3-4-23(29)26-20-7-5-19(6-8-20)10-13-27-14-16-28(17-15-27)24-21-11-18-30-22(21)9-12-25-24/h2-3,9,12,19-20H,4-8,10-11,13-18H2,1H3,(H,26,29) KZWUXBIYAIXWII-UHFFFAOYSA-N 106492 US8586579, 108 D(2) dopamine receptor Homo sapiens 945.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106492&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125826 174008803 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224963 CC#CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.78,.52,;9.24,.52,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H32N4O2/c1-2-3-22(28)25-19-6-4-18(5-7-19)9-12-26-13-15-27(16-14-26)23-20-10-17-29-21(20)8-11-24-23/h8,11,18-19H,4-7,9-10,12-17H2,1H3,(H,25,28) XDPTVFIWUAWOLA-UHFFFAOYSA-N 106493 US8586579, 82 D(2) dopamine receptor Homo sapiens 425.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106493&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768829 174008804 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224964 O=CN[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:3.2,wD:6.6,(6.93,-.82,;7.7,.52,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C20H30N4O2/c25-15-22-17-3-1-16(2-4-17)6-9-23-10-12-24(13-11-23)20-18-7-14-26-19(18)5-8-21-20/h5,8,15-17H,1-4,6-7,9-14H2,(H,22,25) ABHVAQKOVOLZPM-UHFFFAOYSA-N 106494 US8586579, 110 D(2) dopamine receptor Homo sapiens 837.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106494&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 86660553 174008805 C06049 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224965 Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)on1 |r,wU:8.7,wD:11.11,(11.3,-3.05,;9.97,-2.28,;9.49,-.82,;7.95,-.82,;7.18,.52,;5.64,.52,;4.87,-.82,;4.87,1.85,;3.33,1.85,;2.56,.52,;1.02,.52,;.25,1.85,;-1.29,1.85,;-2.06,.52,;-3.6,.52,;-4.37,-.82,;-5.91,-.82,;-6.68,.52,;-5.91,1.85,;-4.37,1.85,;-8.22,.52,;-8.99,1.85,;-10.53,1.85,;-11.3,.52,;-10.53,-.82,;-11.01,-2.28,;-9.76,-3.19,;-8.51,-2.28,;-8.99,-.82,;1.02,3.19,;2.56,3.19,;7.47,-2.28,;8.72,-3.19,)| InChI=1S/C25H35N5O3/c1-18-16-21(33-28-18)17-24(31)27-20-4-2-19(3-5-20)7-10-29-11-13-30(14-12-29)25-22-8-15-32-23(22)6-9-26-25/h6,9,16,19-20H,2-5,7-8,10-15,17H2,1H3,(H,27,31) ZPEAQOHSKIPYKV-UHFFFAOYSA-N 106495 US8586579, 84 D(2) dopamine receptor Homo sapiens 1304.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106495&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768830 174008806 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224966 Cc1cc(on1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,(11.09,-1.02,;9.76,-.25,;8.29,-.73,;7.39,.52,;8.29,1.76,;9.76,1.29,;5.85,.52,;5.08,-.82,;5.08,1.85,;3.54,1.85,;2.77,.52,;1.23,.52,;.46,1.85,;-1.08,1.85,;-1.85,.52,;-3.39,.52,;-4.16,-.82,;-5.7,-.82,;-6.47,.52,;-5.7,1.85,;-4.16,1.85,;-8.01,.52,;-8.78,1.85,;-10.32,1.85,;-11.09,.52,;-10.32,-.82,;-10.8,-2.28,;-9.55,-3.19,;-8.31,-2.28,;-8.78,-.82,;1.23,3.19,;2.77,3.19,)| InChI=1S/C24H33N5O3/c1-17-16-22(32-27-17)24(30)26-19-4-2-18(3-5-19)7-10-28-11-13-29(14-12-28)23-20-8-15-31-21(20)6-9-25-23/h6,9,16,18-19H,2-5,7-8,10-15H2,1H3,(H,26,30) FUAJGUYRNZZDBH-UHFFFAOYSA-N 106496 US8586579, 112 D(2) dopamine receptor Homo sapiens 396.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106496&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768831 174008807 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224967 CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.9,wD:13.13,(9.24,-3.33,;10.01,-2,;11.55,-2,;9.24,-.67,;10.01,.67,;7.7,-.67,;6.93,.67,;5.39,.67,;4.62,-.67,;4.62,2,;3.08,2,;2.31,.67,;.77,.67,;,2,;-1.54,2,;-2.31,.67,;-3.85,.67,;-4.62,-.67,;-6.16,-.67,;-6.93,.67,;-6.16,2,;-4.62,2,;-8.47,.67,;-9.24,2,;-10.78,2,;-11.55,.67,;-10.78,-.67,;-11.26,-2.13,;-10.01,-3.04,;-8.76,-2.13,;-9.24,-.67,;.77,3.33,;2.31,3.33,)| InChI=1S/C25H39N5O3/c1-28(2)24(32)8-7-23(31)27-20-5-3-19(4-6-20)10-13-29-14-16-30(17-15-29)25-21-11-18-33-22(21)9-12-26-25/h9,12,19-20H,3-8,10-11,13-18H2,1-2H3,(H,27,31) GXVCWWLYAQAZCU-UHFFFAOYSA-N 106497 US8586579, 113 D(2) dopamine receptor Homo sapiens 2562.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106497&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768832 174008808 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224968 CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;7.62,-1.59,;10.29,-.05,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C24H38N4O3/c1-24(2,30)17-22(29)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)23-20-9-16-31-21(20)7-10-25-23/h7,10,18-19,30H,3-6,8-9,11-17H2,1-2H3,(H,26,29) KLTVYCHNHMTZNG-UHFFFAOYSA-N 106498 US8586579, 114 D(2) dopamine receptor Homo sapiens 999.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106498&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125781 174008809 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224969 O[C@H](CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C(F)(F)F |r,wU:6.5,wD:9.9,1.0,(7.31,-2.15,;8.08,-.82,;7.31,.52,;5.77,.52,;5,-.82,;5,1.85,;3.46,1.85,;2.69,.52,;1.15,.52,;.39,1.85,;-1.15,1.85,;-1.92,.52,;-3.46,.52,;-4.23,-.82,;-5.77,-.82,;-6.54,.52,;-5.77,1.85,;-4.23,1.85,;-8.08,.52,;-8.85,1.85,;-10.39,1.85,;-11.16,.52,;-10.39,-.82,;-10.87,-2.28,;-9.62,-3.19,;-8.38,-2.28,;-8.85,-.82,;1.15,3.19,;2.69,3.19,;9.62,-.82,;9.62,.72,;11.16,-.82,;9.62,-2.36,)| InChI=1S/C23H33F3N4O3/c24-23(25,26)20(31)15-21(32)28-17-3-1-16(2-4-17)6-9-29-10-12-30(13-11-29)22-18-7-14-33-19(18)5-8-27-22/h5,8,16-17,20,31H,1-4,6-7,9-15H2,(H,28,32) CTMBSXSNFDPMFG-UHFFFAOYSA-N 106499 US8586579, 115 D(2) dopamine receptor Homo sapiens 731.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106499&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125851 174008810 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224970 CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,2.2,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-2-20(29)17-23(30)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20,29H,2-6,8-9,11-17H2,1H3,(H,26,30) JBVSQYZVCXMFCI-UHFFFAOYSA-N 106500 US8586579, 116 D(2) dopamine receptor Homo sapiens 887.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106500&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125818 174008811 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224971 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(11.69,-2.62,;10.36,-3.39,;9.02,-2.62,;7.56,-3.1,;6.65,-1.85,;7.56,-.61,;6.79,.73,;5.25,.73,;4.48,-.61,;4.48,2.06,;2.94,2.06,;2.17,.73,;.63,.73,;-.14,2.06,;-1.68,2.06,;-2.45,.73,;-3.99,.73,;-4.76,-.61,;-6.3,-.61,;-7.07,.73,;-6.3,2.06,;-4.76,2.06,;-8.61,.73,;-9.38,2.06,;-10.92,2.06,;-11.69,.73,;-10.92,-.61,;-11.4,-2.07,;-10.15,-2.98,;-8.9,-2.07,;-9.38,-.61,;.63,3.39,;2.17,3.39,;9.02,-1.08,)| InChI=1S/C27H42N4O3/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,11,20-23H,2-7,9-10,12-19H2,1H3,(H,29,32) DQTBCNRIVXHDQE-UHFFFAOYSA-N 106501 US8586579, 117 D(2) dopamine receptor Homo sapiens 1291.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106501&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 70653201 174008812 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224972 O[C@@H]1COC(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)C1 |r,wU:9.8,wD:12.12,1.0,(11.02,-3.39,;9.69,-2.62,;8.23,-3.1,;7.32,-1.85,;8.23,-.61,;7.46,.73,;5.92,.73,;5.15,-.61,;5.15,2.06,;3.61,2.06,;2.84,.73,;1.3,.73,;.53,2.06,;-1.01,2.06,;-1.78,.73,;-3.32,.73,;-4.09,-.61,;-5.63,-.61,;-6.4,.73,;-5.63,2.06,;-4.09,2.06,;-7.94,.73,;-8.71,2.06,;-10.25,2.06,;-11.02,.73,;-10.25,-.61,;-10.73,-2.07,;-9.48,-2.98,;-8.24,-2.07,;-8.71,-.61,;1.3,3.39,;2.84,3.39,;9.69,-1.08,)| InChI=1S/C25H38N4O4/c30-20-15-21(33-17-20)16-24(31)27-19-3-1-18(2-4-19)6-9-28-10-12-29(13-11-28)25-22-7-14-32-23(22)5-8-26-25/h5,8,18-21,30H,1-4,6-7,9-17H2,(H,27,31) XIVALFSMOKTRNY-UHFFFAOYSA-N 106502 US8586579, 118 D(2) dopamine receptor Homo sapiens 926.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106502&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125839 174008813 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224973 CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.39,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5,-.82,;-5.78,.52,;-5,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C23H36N4O2/c1-2-3-22(28)25-19-6-4-18(5-7-19)9-12-26-13-15-27(16-14-26)23-20-10-17-29-21(20)8-11-24-23/h8,11,18-19H,2-7,9-10,12-17H2,1H3,(H,25,28) ABKVEMFUXMVUSG-UHFFFAOYSA-N 106503 US8586579, 119 D(2) dopamine receptor Homo sapiens 828.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106503&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125780 174008814 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224974 CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.78,.52,;10.01,-.82,;10.78,-2.15,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C25H40N4O2/c1-19(2)3-8-24(30)27-21-6-4-20(5-7-21)10-13-28-14-16-29(17-15-28)25-22-11-18-31-23(22)9-12-26-25/h9,12,19-21H,3-8,10-11,13-18H2,1-2H3,(H,27,30) VMDGNXGFFZHOON-UHFFFAOYSA-N 106504 US8586579, 120 D(2) dopamine receptor Homo sapiens 1277.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106504&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125802 174008815 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224975 CCCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O2/c1-2-3-4-23(29)26-20-7-5-19(6-8-20)10-13-27-14-16-28(17-15-27)24-21-11-18-30-22(21)9-12-25-24/h9,12,19-20H,2-8,10-11,13-18H2,1H3,(H,26,29) QVISYVCUOQJANU-UHFFFAOYSA-N 106505 US8586579, 121 D(2) dopamine receptor Homo sapiens 1143.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106505&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 70652534 174008816 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224976 FC(F)(F)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.8,wD:12.12,(9.63,.72,;9.63,-.82,;11.17,-.82,;9.63,-2.36,;8.09,-.82,;7.32,.52,;5.78,.52,;5,-.82,;5,1.85,;3.46,1.85,;2.7,.52,;1.16,.52,;.38,1.85,;-1.16,1.85,;-1.92,.52,;-3.46,.52,;-4.24,-.82,;-5.78,-.82,;-6.55,.52,;-5.78,1.85,;-4.24,1.85,;-8.09,.52,;-8.86,1.85,;-10.4,1.85,;-11.17,.52,;-10.4,-.82,;-10.87,-2.28,;-9.63,-3.19,;-8.38,-2.28,;-8.86,-.82,;1.16,3.19,;2.7,3.19,)| InChI=1S/C23H33F3N4O2/c24-23(25,26)9-5-21(31)28-18-3-1-17(2-4-18)7-11-29-12-14-30(15-13-29)22-19-8-16-32-20(19)6-10-27-22/h6,10,17-18H,1-5,7-9,11-16H2,(H,28,31) QDQDDWWAKHSCSK-UHFFFAOYSA-N 106506 US8586579, 122 D(2) dopamine receptor Homo sapiens 1253.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106506&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125799 174008817 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224977 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,3.19,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C22H32N4O2/c1-16-15-21-20(8-14-28-21)22(23-16)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h8,14-15,18-19H,3-7,9-13H2,1-2H3,(H,24,27) QGKIQQCQAJMJNK-UHFFFAOYSA-N 106507 US8586579, 96 D(2) dopamine receptor Homo sapiens 248.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106507&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125808 174008818 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224978 Cc1cc2occc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.19,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;-7.7,.52,;-8.47,1.85,;-6.16,.52,;-5.39,-.82,;-3.85,-.82,;-3.08,.52,;-1.54,.52,;-.77,1.85,;.77,1.85,;1.54,.52,;3.08,.52,;3.85,1.85,;3.08,3.19,;1.54,3.19,;5.39,1.85,;6.16,.52,;5.39,-.82,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,;-3.85,1.85,;-5.39,1.85,)| InChI=1S/C26H38N4O3/c1-19-18-24-23(9-17-33-24)25(27-19)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h9,17-18,20-22H,2-8,10-16H2,1H3,(H,28,31) GRSPAVQNQLAIED-UHFFFAOYSA-N 106508 US8586579, 124 D(2) dopamine receptor Homo sapiens 274.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106508&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125803 174008819 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224979 Cc1cc2occc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.33,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;-7.7,.67,;-8.47,2,;-6.16,.67,;-5.39,-.67,;-3.85,-.67,;-3.08,.67,;-1.54,.67,;-.77,2,;.77,2,;1.54,.67,;3.08,.67,;3.85,2,;3.08,3.33,;1.54,3.33,;5.39,2,;6.16,.67,;5.39,-.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;-3.85,2,;-5.39,2,)| InChI=1S/C27H40N4O3/c1-20-18-25-24(9-17-34-25)27(28-20)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-26(32)19-22-7-15-33-16-8-22/h9,17-18,21-23H,2-8,10-16,19H2,1H3,(H,29,32) KGHICJQDLKRYCB-UHFFFAOYSA-N 106509 US8586579, 98 D(2) dopamine receptor Homo sapiens 640.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106509&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125771 174008820 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224980 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,3.19,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H36N4O3/c1-18-17-22-21(8-16-31-22)24(25-18)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-23(29)9-15-30-2/h8,16-17,19-20H,3-7,9-15H2,1-2H3,(H,26,29) PVAIEWDYRNQJFR-UHFFFAOYSA-N 106510 US8586579, 99 D(2) dopamine receptor Homo sapiens 429.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106510&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125797 174008821 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224981 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3OCCc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,3.19,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C22H34N4O2/c1-16-15-21-20(8-14-28-21)22(23-16)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h15,18-19H,3-14H2,1-2H3,(H,24,27) VLMVFBMJXRVZOG-UHFFFAOYSA-N 106511 US8586579, 100 D(2) dopamine receptor Homo sapiens 915 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106511&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125856 174008822 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224982 Cc1cc2OCCc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.19,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;-7.7,.52,;-8.47,1.85,;-6.16,.52,;-5.39,-.82,;-3.85,-.82,;-3.08,.52,;-1.54,.52,;-.77,1.85,;.77,1.85,;1.54,.52,;3.08,.52,;3.85,1.85,;3.08,3.19,;1.54,3.19,;5.39,1.85,;6.16,.52,;5.39,-.82,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,;-3.85,1.85,;-5.39,1.85,)| InChI=1S/C26H40N4O3/c1-19-18-24-23(9-17-33-24)25(27-19)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h18,20-22H,2-17H2,1H3,(H,28,31) ITNGDGJSTGEEEQ-UHFFFAOYSA-N 106512 US8586579, 128 D(2) dopamine receptor Homo sapiens 1950 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106512&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125785 174008823 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224983 Cc1cc2OCCc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.33,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;-7.7,.67,;-8.47,2,;-6.16,.67,;-5.39,-.67,;-3.85,-.67,;-3.08,.67,;-1.54,.67,;-.77,2,;.77,2,;1.54,.67,;3.08,.67,;3.85,2,;3.08,3.33,;1.54,3.33,;5.39,2,;6.16,.67,;5.39,-.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;-3.85,2,;-5.39,2,)| InChI=1S/C27H42N4O3/c1-20-18-25-24(9-17-34-25)27(28-20)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-26(32)19-22-7-15-33-16-8-22/h18,21-23H,2-17,19H2,1H3,(H,29,32) QGUAUKGVRXXHQV-UHFFFAOYSA-N 106513 US8586579, 129 D(2) dopamine receptor Homo sapiens 1935 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106513&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768833 174008824 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224984 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,3.19,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-18-17-22-21(8-16-31-22)24(25-18)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-23(29)9-15-30-2/h17,19-20H,3-16H2,1-2H3,(H,26,29) RCSLPJAWSBFTLD-UHFFFAOYSA-N 106514 US8586579, 103 D(2) dopamine receptor Homo sapiens 1486 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106514&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125782 174008825 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224985 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3occc23)CC1 |r,wU:4.3,wD:7.7,(10.01,.52,;8.47,.52,;7.7,-.82,;7.7,1.85,;6.16,1.85,;5.39,.52,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,-.82,;-3.08,-.82,;-3.85,.52,;-3.08,1.85,;-1.54,1.85,;-5.39,.52,;-6.16,1.85,;-7.7,1.85,;-8.47,.52,;-10.01,.52,;-7.7,-.82,;-8.18,-2.28,;-6.93,-3.19,;-5.68,-2.28,;-6.16,-.82,;3.85,3.19,;5.39,3.19,)| InChI=1S/C22H32N4O2/c1-16-15-23-22(20-8-14-28-21(16)20)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h8,14-15,18-19H,3-7,9-13H2,1-2H3,(H,24,27) ALJNGMYHXPZTTG-UHFFFAOYSA-N 106515 US8586579, 131 D(2) dopamine receptor Homo sapiens 1461 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106515&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771296 174008826 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224986 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)C3CCOCC3)CC2)c2ccoc12 |r,wU:14.17,wD:11.10,(-11.55,.52,;-10.01,.52,;-9.24,1.85,;-7.7,1.85,;-6.93,.52,;-5.39,.52,;-4.62,-.82,;-3.08,-.82,;-2.31,.52,;-.77,.52,;,1.85,;1.54,1.85,;2.31,.52,;3.85,.52,;4.62,1.85,;3.85,3.19,;2.31,3.19,;6.16,1.85,;6.93,.52,;6.16,-.82,;8.47,.52,;9.24,-.82,;10.78,-.82,;11.55,.52,;10.78,1.85,;9.24,1.85,;-3.08,1.85,;-4.62,1.85,;-7.7,-.82,;-7.22,-2.28,;-8.47,-3.19,;-9.72,-2.28,;-9.24,-.82,)| InChI=1S/C26H38N4O3/c1-19-18-27-25(23-9-17-33-24(19)23)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h9,17-18,20-22H,2-8,10-16H2,1H3,(H,28,31) XZKJWFNUAUOHAC-UHFFFAOYSA-N 106516 US8586579, 105 D(2) dopamine receptor Homo sapiens 1126 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106516&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771508 174008827 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224987 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)CC3CCOCC3)CC2)c2ccoc12 |r,wU:14.17,wD:11.10,(-11.55,.67,;-10.01,.67,;-9.24,2,;-7.7,2,;-6.93,.67,;-5.39,.67,;-4.62,-.67,;-3.08,-.67,;-2.31,.67,;-.77,.67,;,2,;1.54,2,;2.31,.67,;3.85,.67,;4.62,2,;3.85,3.33,;2.31,3.33,;6.16,2,;6.93,.67,;6.16,-.67,;8.47,.67,;9.24,-.67,;8.47,-2,;9.24,-3.33,;10.78,-3.33,;11.55,-2,;10.78,-.67,;-3.08,2,;-4.62,2,;-7.7,-.67,;-7.22,-2.13,;-8.47,-3.04,;-9.72,-2.13,;-9.24,-.67,)| InChI=1S/C27H40N4O3/c1-20-19-28-27(24-9-17-34-26(20)24)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-25(32)18-22-7-15-33-16-8-22/h9,17,19,21-23H,2-8,10-16,18H2,1H3,(H,29,32) JTMYPGNBDACXLP-UHFFFAOYSA-N 106517 US8586579, 106 D(2) dopamine receptor Homo sapiens 2718 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106517&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771509 174008828 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224988 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3occc23)CC1 |r,wU:7.6,wD:10.10,(11.6,-2.32,;10.73,-.82,;9.19,-.82,;8.42,.52,;6.88,.52,;6.11,-.82,;6.11,1.85,;4.57,1.85,;3.8,.52,;2.26,.52,;1.49,1.85,;-.05,1.85,;-.82,.52,;-2.36,.52,;-3.13,-.82,;-4.67,-.82,;-5.44,.52,;-4.67,1.85,;-3.13,1.85,;-6.98,.52,;-7.75,1.85,;-9.29,1.85,;-10.06,.52,;-11.6,.52,;-9.29,-.82,;-9.77,-2.28,;-8.52,-3.19,;-7.27,-2.28,;-7.75,-.82,;2.26,3.19,;3.8,3.19,)| InChI=1S/C24H36N4O3/c1-18-17-25-24(21-8-16-31-23(18)21)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-22(29)9-15-30-2/h8,16-17,19-20H,3-7,9-15H2,1-2H3,(H,26,29) XPRRZXPFKHAHFH-UHFFFAOYSA-N 106518 US8586579, 107 D(2) dopamine receptor Homo sapiens 2471 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106518&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771510 174008829 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224989 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3OCCc23)CC1 |r,wU:4.3,wD:7.7,(10.01,.52,;8.47,.52,;7.7,-.82,;7.7,1.85,;6.16,1.85,;5.39,.52,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,-.82,;-3.08,-.82,;-3.85,.52,;-3.08,1.85,;-1.54,1.85,;-5.39,.52,;-6.16,1.85,;-7.7,1.85,;-8.47,.52,;-10.01,.52,;-7.7,-.82,;-8.18,-2.28,;-6.93,-3.19,;-5.68,-2.28,;-6.16,-.82,;3.85,3.19,;5.39,3.19,)| InChI=1S/C22H34N4O2/c1-16-15-23-22(20-8-14-28-21(16)20)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h15,18-19H,3-14H2,1-2H3,(H,24,27) ACEAZRLEPRIAMD-UHFFFAOYSA-N 106519 US8586579, 135 D(2) dopamine receptor Homo sapiens 2308 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106519&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125815 174008830 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224990 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)C3CCOCC3)CC2)c2CCOc12 |r,wU:14.17,wD:11.10,(-11.55,.52,;-10.01,.52,;-9.24,1.85,;-7.7,1.85,;-6.93,.52,;-5.39,.52,;-4.62,-.82,;-3.08,-.82,;-2.31,.52,;-.77,.52,;,1.85,;1.54,1.85,;2.31,.52,;3.85,.52,;4.62,1.85,;3.85,3.19,;2.31,3.19,;6.16,1.85,;6.93,.52,;6.16,-.82,;8.47,.52,;9.24,-.82,;10.78,-.82,;11.55,.52,;10.78,1.85,;9.24,1.85,;-3.08,1.85,;-4.62,1.85,;-7.7,-.82,;-7.22,-2.28,;-8.47,-3.19,;-9.72,-2.28,;-9.24,-.82,)| InChI=1S/C26H40N4O3/c1-19-18-27-25(23-9-17-33-24(19)23)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h18,20-22H,2-17H2,1H3,(H,28,31) KMPUTTSRRTYIRY-UHFFFAOYSA-N 106520 US8586579, 136 D(2) dopamine receptor Homo sapiens 4510 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106520&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125809 174008831 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224991 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)CC3CCOCC3)CC2)c2CCOc12 |r,wU:14.17,wD:11.10,(-11.55,.67,;-10.01,.67,;-9.24,2,;-7.7,2,;-6.93,.67,;-5.39,.67,;-4.62,-.67,;-3.08,-.67,;-2.31,.67,;-.77,.67,;,2,;1.54,2,;2.31,.67,;3.85,.67,;4.62,2,;3.85,3.33,;2.31,3.33,;6.16,2,;6.93,.67,;6.16,-.67,;8.47,.67,;9.24,-.67,;8.47,-2,;9.24,-3.33,;10.78,-3.33,;11.55,-2,;10.78,-.67,;-3.08,2,;-4.62,2,;-7.7,-.67,;-7.22,-2.13,;-8.47,-3.04,;-9.72,-2.13,;-9.24,-.67,)| InChI=1S/C27H42N4O3/c1-20-19-28-27(24-9-17-34-26(20)24)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-25(32)18-22-7-15-33-16-8-22/h19,21-23H,2-18H2,1H3,(H,29,32) ADDORVGWJJXKFK-UHFFFAOYSA-N 106521 US8586579, 137 D(2) dopamine receptor Homo sapiens 2951 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106521&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125884 174008832 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224992 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3OCCc23)CC1 |r,wU:7.6,wD:10.10,(11.6,-2.32,;10.73,-.82,;9.19,-.82,;8.42,.52,;6.88,.52,;6.11,-.82,;6.11,1.85,;4.57,1.85,;3.8,.52,;2.26,.52,;1.49,1.85,;-.05,1.85,;-.82,.52,;-2.36,.52,;-3.13,-.82,;-4.67,-.82,;-5.44,.52,;-4.67,1.85,;-3.13,1.85,;-6.98,.52,;-7.75,1.85,;-9.29,1.85,;-10.06,.52,;-11.6,.52,;-9.29,-.82,;-9.77,-2.28,;-8.52,-3.19,;-7.27,-2.28,;-7.75,-.82,;2.26,3.19,;3.8,3.19,)| InChI=1S/C24H38N4O3/c1-18-17-25-24(21-8-16-31-23(18)21)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-22(29)9-15-30-2/h17,19-20H,3-16H2,1-2H3,(H,26,29) OZUAEHNGHNUWOV-UHFFFAOYSA-N 106522 US8586579, 138 D(2) dopamine receptor Homo sapiens 3564 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106522&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771511 174008833 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224993 OC(C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C(F)(F)F |r,wU:5.4,wD:8.8,(8.96,-.82,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,;8.96,1.85,;9.73,3.19,;7.62,2.62,;10.29,1.08,)| InChI=1S/C22H31F3N4O3/c23-22(24,25)19(30)21(31)27-16-3-1-15(2-4-16)6-9-28-10-12-29(13-11-28)20-17-7-14-32-18(17)5-8-26-20/h5,8,15-16,19,30H,1-4,6-7,9-14H2,(H,27,31) PMYFBYDQSGEVHT-UHFFFAOYSA-N 106523 US8586579, 112 D(2) dopamine receptor Homo sapiens 842.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106523&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771512 174008834 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224994 COC(CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)OC |r,wU:7.6,wD:10.10,(8.48,-3.33,;7.71,-2,;8.48,-.67,;7.71,.67,;6.17,.67,;5.4,-.67,;5.4,2,;3.86,2,;3.09,.67,;1.55,.67,;.78,2,;-.76,2,;-1.53,.67,;-3.07,.67,;-3.84,-.67,;-5.38,-.67,;-6.17,.67,;-5.38,2,;-3.84,2,;-7.71,.67,;-8.48,2,;-10.02,2,;-10.79,.67,;-10.02,-.67,;-10.49,-2.13,;-9.25,-3.04,;-8,-2.13,;-8.48,-.67,;1.55,3.33,;3.09,3.33,;10.02,-.67,;10.79,.67,)| InChI=1S/C24H38N4O4/c1-30-23(31-2)17-22(29)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-20-9-16-32-21(20)7-10-25-24/h7,10,18-19,23H,3-6,8-9,11-17H2,1-2H3,(H,26,29) AVYIORKUKBQLOA-UHFFFAOYSA-N 106524 US8586579, 140 D(2) dopamine receptor Homo sapiens 1384.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106524&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125824 174008835 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224995 COC(CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)OC |r,wU:8.7,wD:11.11,(11.56,.67,;10.02,.67,;9.25,-.67,;7.71,-.67,;6.94,.67,;5.4,.67,;4.63,-.67,;4.63,2,;3.09,2,;2.32,.67,;.78,.67,;.01,2,;-1.53,2,;-2.3,.67,;-3.84,.67,;-4.61,-.67,;-6.15,-.67,;-6.94,.67,;-6.15,2,;-4.61,2,;-8.48,.67,;-9.25,2,;-10.79,2,;-11.56,.67,;-10.79,-.67,;-11.26,-2.13,;-10.02,-3.04,;-8.77,-2.13,;-9.25,-.67,;.78,3.33,;2.32,3.33,;10.02,-2,;9.25,-3.33,)| InChI=1S/C25H40N4O4/c1-31-24(32-2)8-7-23(30)27-20-5-3-19(4-6-20)10-13-28-14-16-29(17-15-28)25-21-11-18-33-22(21)9-12-26-25/h9,12,19-20,24H,3-8,10-11,13-18H2,1-2H3,(H,27,30) LIWZXUWAEHOPHY-UHFFFAOYSA-N 106525 US8586579, 141 D(2) dopamine receptor Homo sapiens 2365.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106525&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125791 174008836 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224996 CS(=O)(=O)c1ccc(s1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:12.12,wD:15.16,(11.77,-1.79,;10.43,-1.02,;9.66,-2.36,;11.2,.31,;9.1,-.25,;9.1,1.29,;7.64,1.76,;6.73,.52,;7.64,-.73,;5.19,.52,;4.42,-.82,;4.42,1.85,;2.88,1.85,;2.11,.52,;.57,.52,;-.2,1.85,;-1.74,1.85,;-2.51,.52,;-4.05,.52,;-4.82,-.82,;-6.36,-.82,;-7.15,.52,;-6.36,1.85,;-4.82,1.85,;-8.69,.52,;-9.46,1.85,;-11,1.85,;-11.77,.52,;-11,-.82,;-11.47,-2.28,;-10.23,-3.19,;-8.98,-2.28,;-9.46,-.82,;.57,3.19,;2.11,3.19,)| InChI=1S/C25H34N4O4S2/c1-35(31,32)23-7-6-22(34-23)25(30)27-19-4-2-18(3-5-19)9-12-28-13-15-29(16-14-28)24-20-10-17-33-21(20)8-11-26-24/h6-8,11,18-19H,2-5,9-10,12-17H2,1H3,(H,27,30) HWZBTMUYGJHELF-UHFFFAOYSA-N 106526 US8586579, 115 D(2) dopamine receptor Homo sapiens 516 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106526&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125814 174008837 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224997 Cc1ccc(cn1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.46,.52,;10.11,.52,;9.34,1.85,;7.8,1.85,;7.03,.52,;7.8,-.82,;9.34,-.82,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.84,.52,;-6.06,1.85,;-4.52,1.85,;-8.38,.52,;-9.15,1.85,;-10.69,1.85,;-11.46,.52,;-10.69,-.82,;-11.17,-2.28,;-9.92,-3.19,;-8.68,-2.28,;-9.15,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C26H35N5O2/c1-19-2-5-21(18-28-19)26(32)29-22-6-3-20(4-7-22)9-12-30-13-15-31(16-14-30)25-23-10-17-33-24(23)8-11-27-25/h2,5,8,11,18,20,22H,3-4,6-7,9-10,12-17H2,1H3,(H,29,32) UNPARBQWWULNRE-UHFFFAOYSA-N 106527 US8586579, 143 D(2) dopamine receptor Homo sapiens 312.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106527&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769063 174008838 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224998 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)C#N |r,wU:3.2,wD:6.6,(3.95,-.82,;4.72,.52,;3.95,1.85,;2.41,1.85,;1.64,.52,;.1,.52,;-.67,1.85,;-2.21,1.85,;-2.98,.52,;-4.52,.52,;-5.29,-.82,;-6.83,-.82,;-7.61,.52,;-6.83,1.85,;-5.29,1.85,;-9.15,.52,;-9.92,1.85,;-11.46,1.85,;-12.23,.52,;-11.46,-.82,;-11.94,-2.28,;-10.69,-3.19,;-9.45,-2.28,;-9.92,-.82,;.1,3.19,;1.64,3.19,;6.26,.52,;7.03,-.82,;8.57,-.82,;9.34,.52,;8.57,1.85,;7.03,1.85,;10.69,.52,;12.23,.52,)| InChI=1S/C27H33N5O2/c28-19-21-1-5-22(6-2-21)27(33)30-23-7-3-20(4-8-23)10-13-31-14-16-32(17-15-31)26-24-11-18-34-25(24)9-12-29-26/h1-2,5-6,9,12,20,23H,3-4,7-8,10-11,13-18H2,(H,30,33) MHYHDPMWTXPZLG-UHFFFAOYSA-N 106528 US8586579, 144 D(2) dopamine receptor Homo sapiens 381.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106528&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768834 174008839 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 224999 CN1CCN(CC1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:16.17,wD:19.21,(13.77,.52,;12.23,.52,;11.46,-.82,;9.92,-.82,;9.15,.52,;9.92,1.85,;11.46,1.85,;7.8,.52,;7.03,-.82,;5.49,-.82,;4.72,.52,;5.49,1.85,;7.03,1.85,;3.18,.52,;2.41,-.82,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,1.85,;-3.75,1.85,;-4.52,.52,;-6.06,.52,;-6.83,-.82,;-8.37,-.82,;-9.15,.52,;-8.37,1.85,;-6.83,1.85,;-10.69,.52,;-11.46,1.85,;-13,1.85,;-13.77,.52,;-13,-.82,;-13.48,-2.28,;-12.23,-3.19,;-10.99,-2.28,;-11.46,-.82,;-1.44,3.19,;.1,3.19,)| InChI=1S/C31H44N6O2/c1-34-15-19-36(20-16-34)27-8-4-25(5-9-27)31(38)33-26-6-2-24(3-7-26)11-14-35-17-21-37(22-18-35)30-28-12-23-39-29(28)10-13-32-30/h4-5,8-10,13,24,26H,2-3,6-7,11-12,14-23H2,1H3,(H,33,38) FNDLZQGZKLRGIU-UHFFFAOYSA-N 106529 US8586579, 118 D(2) dopamine receptor Homo sapiens 179.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106529&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771736 174008840 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225000 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(nc1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.18,-.82,;3.95,.52,;3.18,1.85,;1.64,1.85,;.87,.52,;-.67,.52,;-1.44,1.85,;-2.98,1.85,;-3.75,.52,;-5.29,.52,;-6.06,-.82,;-7.6,-.82,;-8.38,.52,;-7.6,1.85,;-6.06,1.85,;-9.92,.52,;-10.69,1.85,;-12.23,1.85,;-13,.52,;-12.23,-.82,;-12.71,-2.28,;-11.46,-3.19,;-10.22,-2.28,;-10.69,-.82,;-.67,3.19,;.87,3.19,;5.49,.52,;6.26,1.85,;7.8,1.85,;8.57,.52,;7.8,-.82,;6.26,-.82,;9.92,.52,;10.69,-.82,;12.23,-.82,;13,.52,;12.23,1.85,;10.69,1.85,)| InChI=1S/C29H40N6O3/c36-29(23-3-6-27(31-21-23)34-16-19-37-20-17-34)32-24-4-1-22(2-5-24)8-11-33-12-14-35(15-13-33)28-25-9-18-38-26(25)7-10-30-28/h3,6-7,10,21-22,24H,1-2,4-5,8-9,11-20H2,(H,32,36) SWYRWYLIJXJVNV-UHFFFAOYSA-N 106530 US8586579, 146 D(2) dopamine receptor Homo sapiens 998.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106530&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771737 174008841 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225001 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-c1cccnc1 |r,wU:3.2,wD:6.6,(3.18,-.82,;3.95,.52,;3.18,1.85,;1.64,1.85,;.87,.52,;-.67,.52,;-1.44,1.85,;-2.98,1.85,;-3.75,.52,;-5.29,.52,;-6.06,-.82,;-7.6,-.82,;-8.38,.52,;-7.6,1.85,;-6.06,1.85,;-9.92,.52,;-10.69,1.85,;-12.23,1.85,;-13,.52,;-12.23,-.82,;-12.71,-2.28,;-11.46,-3.19,;-10.22,-2.28,;-10.69,-.82,;-.67,3.19,;.87,3.19,;5.49,.52,;6.26,-.82,;7.8,-.82,;8.57,.52,;7.8,1.85,;6.26,1.85,;9.92,.52,;10.69,1.85,;12.23,1.85,;13,.52,;12.23,-.82,;10.69,-.82,)| InChI=1S/C31H37N5O2/c37-31(25-7-5-24(6-8-25)26-2-1-14-32-22-26)34-27-9-3-23(4-10-27)12-16-35-17-19-36(20-18-35)30-28-13-21-38-29(28)11-15-33-30/h1-2,5-8,11,14-15,22-23,27H,3-4,9-10,12-13,16-21H2,(H,34,37) SBHJIEDINHIMAF-UHFFFAOYSA-N 106531 US8586579, 120 D(2) dopamine receptor Homo sapiens 222.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106531&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125836 174008842 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225002 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc2OCOc2c1 |r,wU:3.2,wD:6.6,(4.56,-.82,;5.33,.52,;4.56,1.85,;3.02,1.85,;2.25,.52,;.71,.52,;-.06,1.85,;-1.6,1.85,;-2.37,.52,;-3.91,.52,;-4.68,-.82,;-6.22,-.82,;-7,.52,;-6.22,1.85,;-4.68,1.85,;-8.54,.52,;-9.31,1.85,;-10.85,1.85,;-11.62,.52,;-10.85,-.82,;-11.33,-2.28,;-10.08,-3.19,;-8.84,-2.28,;-9.31,-.82,;.71,3.19,;2.25,3.19,;6.87,.52,;7.64,-.82,;9.18,-.82,;9.95,.52,;11.46,.84,;11.62,2.37,;10.22,3,;9.18,1.85,;7.64,1.85,)| InChI=1S/C27H34N4O4/c32-27(20-3-6-24-25(17-20)35-18-34-24)29-21-4-1-19(2-5-21)8-11-30-12-14-31(15-13-30)26-22-9-16-33-23(22)7-10-28-26/h3,6-7,10,17,19,21H,1-2,4-5,8-9,11-16,18H2,(H,29,32) CEMWPWPBXGCHCV-UHFFFAOYSA-N 106532 US8586579, 148 D(2) dopamine receptor Homo sapiens 3372 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106532&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771738 174008843 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225003 O=C(Cc1ccc2OCOc2c1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.14,wD:16.18,(4.56,3.85,;5.33,2.52,;6.88,2.52,;7.65,1.18,;6.88,-.15,;7.65,-1.48,;9.19,-1.48,;10.22,-2.63,;11.62,-2,;11.46,-.47,;9.96,-.15,;9.19,1.18,;4.56,1.18,;3.02,1.18,;2.25,-.15,;.71,-.15,;-.06,1.18,;-1.6,1.18,;-2.37,-.15,;-3.91,-.15,;-4.68,-1.48,;-6.22,-1.48,;-7,-.15,;-6.22,1.18,;-4.68,1.18,;-8.54,-.15,;-9.31,1.18,;-10.85,1.18,;-11.62,-.15,;-10.85,-1.48,;-11.33,-2.95,;-10.08,-3.85,;-8.84,-2.95,;-9.31,-1.48,;.71,2.52,;2.25,2.52,)| InChI=1S/C28H36N4O4/c33-27(18-21-3-6-25-26(17-21)36-19-35-25)30-22-4-1-20(2-5-22)8-11-31-12-14-32(15-13-31)28-23-9-16-34-24(23)7-10-29-28/h3,6-7,10,17,20,22H,1-2,4-5,8-9,11-16,18-19H2,(H,30,33) ONAUJHKYHSJWDK-UHFFFAOYSA-N 106533 US8586579, 149 D(2) dopamine receptor Homo sapiens 3042 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106533&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771739 174008844 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225004 OC1(CCC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(8.48,-1.02,;8.48,.52,;10.02,.52,;10.02,2.06,;8.48,2.06,;6.94,.52,;6.17,-.82,;6.17,1.85,;4.63,1.85,;3.86,.52,;2.32,.52,;1.55,1.85,;.01,1.85,;-.76,.52,;-2.3,.52,;-3.07,-.82,;-4.61,-.82,;-5.4,.52,;-4.61,1.85,;-3.07,1.85,;-6.94,.52,;-7.71,1.85,;-9.25,1.85,;-10.02,.52,;-9.25,-.82,;-9.72,-2.28,;-8.48,-3.19,;-7.23,-2.28,;-7.71,-.82,;2.32,3.19,;3.86,3.19,)| InChI=1S/C24H36N4O3/c29-23(24(30)9-1-10-24)26-19-4-2-18(3-5-19)7-12-27-13-15-28(16-14-27)22-20-8-17-31-21(20)6-11-25-22/h6,11,18-19,30H,1-5,7-10,12-17H2,(H,26,29) WPDISOIHGGRFRZ-UHFFFAOYSA-N 106534 US8586579, 123 D(2) dopamine receptor Homo sapiens 958.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106534&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771740 174008845 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225005 CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.02,.52,;8.48,.52,;8.48,-1.02,;8.48,2.06,;6.94,.52,;6.17,-.82,;6.17,1.85,;4.63,1.85,;3.86,.52,;2.32,.52,;1.55,1.85,;.01,1.85,;-.76,.52,;-2.3,.52,;-3.07,-.82,;-4.61,-.82,;-5.4,.52,;-4.61,1.85,;-3.07,1.85,;-6.94,.52,;-7.71,1.85,;-9.25,1.85,;-10.02,.52,;-9.25,-.82,;-9.72,-2.28,;-8.48,-3.19,;-7.23,-2.28,;-7.71,-.82,;2.32,3.19,;3.86,3.19,)| InChI=1S/C23H36N4O3/c1-23(2,29)22(28)25-18-5-3-17(4-6-18)8-11-26-12-14-27(15-13-26)21-19-9-16-30-20(19)7-10-24-21/h7,10,17-18,29H,3-6,8-9,11-16H2,1-2H3,(H,25,28) ZATCCWHVTMAUCE-UHFFFAOYSA-N 106535 US8586579, 124 D(2) dopamine receptor Homo sapiens 1265 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106535&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125837 174008846 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225006 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCS(=O)(=O)CC1 |r,wU:3.2,wD:6.6,(2.67,-.82,;3.44,.52,;2.67,1.85,;1.13,1.85,;.36,.52,;-1.18,.52,;-1.95,1.85,;-3.49,1.85,;-4.26,.52,;-5.8,.52,;-6.57,-.82,;-8.11,-.82,;-8.89,.52,;-8.11,1.85,;-6.57,1.85,;-10.43,.52,;-11.2,1.85,;-12.74,1.85,;-13.51,.52,;-12.74,-.82,;-13.22,-2.28,;-11.97,-3.19,;-10.73,-2.28,;-11.2,-.82,;-1.18,3.19,;.36,3.19,;4.67,.52,;5.44,-.82,;6.98,-.82,;7.75,.52,;6.98,1.85,;5.44,1.85,;9.1,.52,;9.87,-.82,;11.41,-.82,;12.18,.52,;13.51,1.29,;13.51,-.25,;11.41,1.85,;9.87,1.85,)| InChI=1S/C30H41N5O4S/c36-30(24-3-7-26(8-4-24)34-18-21-40(37,38)22-19-34)32-25-5-1-23(2-6-25)10-13-33-14-16-35(17-15-33)29-27-11-20-39-28(27)9-12-31-29/h3-4,7-9,12,23,25H,1-2,5-6,10-11,13-22H2,(H,32,36) JUAVLXRBQKTSPW-UHFFFAOYSA-N 106536 US8586579, 152 D(2) dopamine receptor Homo sapiens 116.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106536&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125857 174008847 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225007 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-n1cccn1 |r,wU:3.2,wD:6.6,(3.54,-.82,;4.31,.52,;3.54,1.85,;2,1.85,;1.23,.52,;-.31,.52,;-1.08,1.85,;-2.62,1.85,;-3.39,.52,;-4.93,.52,;-5.7,-.82,;-7.24,-.82,;-8.03,.52,;-7.24,1.85,;-5.7,1.85,;-9.57,.52,;-10.34,1.85,;-11.88,1.85,;-12.65,.52,;-11.88,-.82,;-12.35,-2.28,;-11.11,-3.19,;-9.86,-2.28,;-10.34,-.82,;-.31,3.19,;1.23,3.19,;5.85,.52,;6.62,-.82,;8.16,-.82,;8.93,.52,;8.16,1.85,;6.62,1.85,;10.28,.52,;11.18,-.73,;12.65,-.25,;12.65,1.29,;11.18,1.76,)| InChI=1S/C29H36N6O2/c36-29(23-4-8-25(9-5-23)35-15-1-13-31-35)32-24-6-2-22(3-7-24)11-16-33-17-19-34(20-18-33)28-26-12-21-37-27(26)10-14-30-28/h1,4-5,8-10,13-15,22,24H,2-3,6-7,11-12,16-21H2,(H,32,36) BNGQWOSQOPVKCC-UHFFFAOYSA-N 106537 US8586579, 153 D(2) dopamine receptor Homo sapiens 478 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106537&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125848 174008848 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225008 Cc1nc(no1)-c1cccc(c1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:15.16,wD:18.20,(12.46,4.24,;11.13,3.47,;10.65,2,;9.11,2,;8.64,3.47,;9.88,4.37,;8.34,.67,;9.11,-.67,;8.34,-2,;6.8,-2,;6.03,-.67,;6.8,.67,;4.49,-.67,;3.72,-2,;3.72,.67,;2.18,.67,;1.41,-.67,;-.13,-.67,;-.9,.67,;-2.44,.67,;-3.21,-.67,;-4.75,-.67,;-5.52,-2,;-7.06,-2,;-7.84,-.67,;-7.06,.67,;-5.52,.67,;-9.38,-.67,;-10.15,.67,;-11.69,.67,;-12.46,-.67,;-11.69,-2,;-12.17,-3.47,;-10.92,-4.37,;-9.68,-3.47,;-10.15,-2,;-.13,2,;1.41,2,)| InChI=1S/C29H36N6O3/c1-20-31-27(33-38-20)22-3-2-4-23(19-22)29(36)32-24-7-5-21(6-8-24)10-13-34-14-16-35(17-15-34)28-25-11-18-37-26(25)9-12-30-28/h2-4,9,12,19,21,24H,5-8,10-11,13-18H2,1H3,(H,32,36) DZYJECJNISMMEC-UHFFFAOYSA-N 106538 US8586579, 154 D(2) dopamine receptor Homo sapiens 2147 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106538&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771971 174008849 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225009 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc2ncccc2c1 |r,wU:3.2,wD:6.6,(4.23,-.82,;5,.52,;4.23,1.85,;2.7,1.85,;1.93,.52,;.39,.52,;-.39,1.85,;-1.93,1.85,;-2.7,.52,;-4.23,.52,;-5,-.82,;-6.54,-.82,;-7.31,.52,;-6.54,1.85,;-5,1.85,;-8.85,.52,;-9.62,1.85,;-11.16,1.85,;-11.93,.52,;-11.16,-.82,;-11.64,-2.28,;-10.39,-3.19,;-9.15,-2.28,;-9.62,-.82,;.39,3.19,;1.93,3.19,;6.54,.52,;7.31,1.85,;8.85,1.85,;9.62,.52,;11.16,.52,;11.93,-.82,;11.16,-2.15,;9.62,-2.15,;8.85,-.82,;7.31,-.82,)| InChI=1S/C29H35N5O2/c35-29(23-5-8-26-22(20-23)2-1-12-30-26)32-24-6-3-21(4-7-24)10-14-33-15-17-34(18-16-33)28-25-11-19-36-27(25)9-13-31-28/h1-2,5,8-9,12-13,20-21,24H,3-4,6-7,10-11,14-19H2,(H,32,35) ATHCQCSSVYPJIN-UHFFFAOYSA-N 106539 US8586579, 155 D(2) dopamine receptor Homo sapiens 500.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106539&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771972 174008850 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225010 O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.14,wD:16.18,(4.27,-.82,;5.04,.52,;6.58,.52,;7.35,-.82,;6.87,-2.28,;8.12,-3.19,;9.36,-2.28,;10.87,-2.6,;11.9,-1.46,;11.43,.01,;9.92,.33,;8.89,-.82,;4.27,1.85,;2.73,1.85,;1.96,.52,;.42,.52,;-.35,1.85,;-1.89,1.85,;-2.66,.52,;-4.2,.52,;-4.97,-.82,;-6.51,-.82,;-7.28,.52,;-6.51,1.85,;-4.97,1.85,;-8.82,.52,;-9.59,1.85,;-11.13,1.85,;-11.9,.52,;-11.13,-.82,;-11.61,-2.28,;-10.36,-3.19,;-9.12,-2.28,;-9.59,-.82,;.42,3.19,;1.96,3.19,)| InChI=1S/C28H35N5O3/c34-27(19-24-22-3-1-2-4-26(22)36-31-24)30-21-7-5-20(6-8-21)10-13-32-14-16-33(17-15-32)28-23-11-18-35-25(23)9-12-29-28/h1-4,9,12,20-21H,5-8,10-11,13-19H2,(H,30,34) MWMCOQFLGVOAHE-UHFFFAOYSA-N 106540 US8586579, 156 D(2) dopamine receptor Homo sapiens 1308.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106540&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771973 174008851 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225011 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1cnc(cn1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,1.85,;7.7,1.85,;8.47,.52,;7.7,-.82,;6.16,-.82,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C28H39N7O3/c36-28(24-19-31-26(20-30-24)34-14-17-37-18-15-34)32-22-3-1-21(2-4-22)6-9-33-10-12-35(13-11-33)27-23-7-16-38-25(23)5-8-29-27/h5,8,19-22H,1-4,6-7,9-18H2,(H,32,36) MTJDLXLLSRKTMU-UHFFFAOYSA-N 106541 US8586579, 157 D(2) dopamine receptor Homo sapiens 506 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106541&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125784 174008852 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225012 CC(C)(C)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.13,wD:16.17,(10.78,2.06,;10.78,.52,;10.78,-1.02,;12.32,.52,;9.24,.52,;8.47,-.82,;6.93,-.82,;6.16,.52,;6.93,1.85,;8.47,1.85,;4.62,.52,;3.85,-.82,;3.85,1.85,;2.31,1.85,;1.54,.52,;,.52,;-.77,1.85,;-2.31,1.85,;-3.08,.52,;-4.62,.52,;-5.39,-.82,;-6.93,-.82,;-7.7,.52,;-6.93,1.85,;-5.39,1.85,;-9.24,.52,;-10.01,1.85,;-11.55,1.85,;-12.32,.52,;-11.55,-.82,;-12.03,-2.28,;-10.78,-3.19,;-9.53,-2.28,;-10.01,-.82,;,3.19,;1.54,3.19,)| InChI=1S/C30H42N4O2/c1-30(2,3)24-8-6-23(7-9-24)29(35)32-25-10-4-22(5-11-25)13-16-33-17-19-34(20-18-33)28-26-14-21-36-27(26)12-15-31-28/h6-9,12,15,22,25H,4-5,10-11,13-14,16-21H2,1-3H3,(H,32,35) ZZJDFRAENYUPMH-UHFFFAOYSA-N 106542 US8586579, 158 D(2) dopamine receptor Homo sapiens 1663 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106542&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771974 174008853 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225013 Clc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)c(Cl)c1 |r,wU:8.7,wD:11.11,(11.55,.52,;10.01,.52,;9.24,1.85,;7.7,1.85,;6.93,.52,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,;7.7,-.82,;6.93,-2.15,;9.24,-.82,)| InChI=1S/C26H32Cl2N4O2/c27-19-3-6-21(23(28)17-19)26(33)30-20-4-1-18(2-5-20)8-11-31-12-14-32(15-13-31)25-22-9-16-34-24(22)7-10-29-25/h3,6-7,10,17-18,20H,1-2,4-5,8-9,11-16H2,(H,30,33) KVMPVICKYUXJEP-UHFFFAOYSA-N 106543 US8586579, 159 D(2) dopamine receptor Homo sapiens 518.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106543&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771975 174008854 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225014 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-n1cccc1 |r,wU:3.2,wD:6.6,(3.44,-.82,;4.21,.52,;3.44,1.85,;1.9,1.85,;1.13,.52,;-.41,.52,;-1.18,1.85,;-2.72,1.85,;-3.49,.52,;-5.04,.52,;-5.81,-.82,;-7.35,-.82,;-8.12,.52,;-7.35,1.85,;-5.81,1.85,;-9.66,.52,;-10.43,1.85,;-11.97,1.85,;-12.74,.52,;-11.97,-.82,;-12.44,-2.28,;-11.2,-3.19,;-9.95,-2.28,;-10.43,-.82,;-.41,3.19,;1.13,3.19,;5.75,.52,;6.52,-.82,;8.06,-.82,;8.83,.52,;8.06,1.85,;6.52,1.85,;10.37,.52,;11.27,-.73,;12.74,-.25,;12.74,1.29,;11.27,1.76,)| InChI=1S/C30H37N5O2/c36-30(24-5-9-26(10-6-24)34-15-1-2-16-34)32-25-7-3-23(4-8-25)12-17-33-18-20-35(21-19-33)29-27-13-22-37-28(27)11-14-31-29/h1-2,5-6,9-11,14-16,23,25H,3-4,7-8,12-13,17-22H2,(H,32,36) HIUMOAWWYUAXFP-UHFFFAOYSA-N 106544 US8586579, 160 D(2) dopamine receptor Homo sapiens 163.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106544&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772198 174008855 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225015 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-c1ccccc1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C32H38N4O2/c37-32(27-10-8-26(9-11-27)25-4-2-1-3-5-25)34-28-12-6-24(7-13-28)15-18-35-19-21-36(22-20-35)31-29-16-23-38-30(29)14-17-33-31/h1-5,8-11,14,17,24,28H,6-7,12-13,15-16,18-23H2,(H,34,37) ZQZUTJSBLPRYPL-UHFFFAOYSA-N 106545 US8586579, 161 D(2) dopamine receptor Homo sapiens 1132 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106545&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772199 174008856 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225016 CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,2.2,(8.86,3.19,;9.63,1.85,;8.86,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C23H36N4O3/c1-17(29-2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-30-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) XHSRFVQGNJCGAD-UHFFFAOYSA-N 106546 US8586579, 135 D(2) dopamine receptor Homo sapiens 680.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106546&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125792 174008857 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225017 CC(C)(C)Oc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:14.14,wD:17.18,(12.6,-.05,;11.27,-.82,;9.93,-1.59,;12.04,-2.15,;10.5,.52,;8.96,.52,;8.19,-.82,;6.65,-.82,;5.88,.52,;6.65,1.85,;8.19,1.85,;4.34,.52,;3.57,-.82,;3.57,1.85,;2.03,1.85,;1.26,.52,;-.28,.52,;-1.05,1.85,;-2.59,1.85,;-3.36,.52,;-4.9,.52,;-5.67,-.82,;-7.21,-.82,;-7.98,.52,;-7.21,1.85,;-5.67,1.85,;-9.52,.52,;-10.29,1.85,;-11.83,1.85,;-12.6,.52,;-11.83,-.82,;-12.31,-2.28,;-11.06,-3.19,;-9.82,-2.28,;-10.29,-.82,;-.28,3.19,;1.26,3.19,)| InChI=1S/C30H42N4O3/c1-30(2,3)37-25-10-6-23(7-11-25)29(35)32-24-8-4-22(5-9-24)13-16-33-17-19-34(20-18-33)28-26-14-21-36-27(26)12-15-31-28/h6-7,10-12,15,22,24H,4-5,8-9,13-14,16-21H2,1-3H3,(H,32,35) OAIALYFMHHTONS-UHFFFAOYSA-N 106547 US8586579, 163 D(2) dopamine receptor Homo sapiens 3161 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106547&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125776 174008858 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225018 CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,2.2,wD:10.10,(8.86,3.19,;9.63,1.85,;8.86,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C23H36N4O3/c1-17(29-2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-30-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) XHSRFVQGNJCGAD-UHFFFAOYSA-N 106548 US8586579, 164 D(2) dopamine receptor Homo sapiens 788.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106548&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772200 174008859 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225019 O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccccc1 |r,wU:4.3,wD:7.7,(8.26,1.44,;6.93,.67,;5.6,-.1,;6.16,2,;4.62,2,;3.85,.67,;2.31,.67,;1.54,2,;,2,;-.77,.67,;-2.31,.67,;-3.08,-.67,;-4.62,-.67,;-5.39,.67,;-4.62,2,;-3.08,2,;-6.93,.67,;-7.7,2,;-9.24,2,;-10.01,.67,;-9.24,-.67,;-9.72,-2.13,;-8.47,-3.04,;-7.22,-2.13,;-7.7,-.67,;2.31,3.33,;3.85,3.33,;7.7,-.67,;6.93,-2,;7.7,-3.33,;9.24,-3.33,;10.01,-2,;9.24,-.67,)| InChI=1S/C25H34N4O3S/c30-33(31,22-4-2-1-3-5-22)27-21-8-6-20(7-9-21)11-14-28-15-17-29(18-16-28)25-23-12-19-32-24(23)10-13-26-25/h1-5,10,13,20-21,27H,6-9,11-12,14-19H2 LWUHTASBTHFHOH-UHFFFAOYSA-N 106549 US8586579, 165 D(2) dopamine receptor Homo sapiens 242.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106549&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772201 174008860 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225020 COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-18(30-2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20H,3-6,8-9,11-17H2,1-2H3,(H,26,29) ROGRQIGZHYODFP-UHFFFAOYSA-N 106550 US8586579, 166 D(2) dopamine receptor Homo sapiens 801.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106550&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125846 174008861 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225021 CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,2.2,wD:11.11,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-2-20(29)17-23(30)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20,29H,2-6,8-9,11-17H2,1H3,(H,26,30) JBVSQYZVCXMFCI-UHFFFAOYSA-N 106551 US8586579, 167 D(2) dopamine receptor Homo sapiens 842.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106551&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772202 174008862 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225022 OC1(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)CCC1 |r,wU:6.5,wD:9.9,(7.24,-1.59,;8.57,-.82,;7.8,.52,;6.26,.52,;5.49,-.82,;5.49,1.85,;3.95,1.85,;3.18,.52,;1.64,.52,;.87,1.85,;-.67,1.85,;-1.44,.52,;-2.98,.52,;-3.75,-.82,;-5.29,-.82,;-6.06,.52,;-5.29,1.85,;-3.75,1.85,;-7.6,.52,;-8.37,1.85,;-9.91,1.85,;-10.68,.52,;-9.91,-.82,;-10.38,-2.28,;-9.14,-3.19,;-7.89,-2.28,;-8.37,-.82,;1.64,3.19,;3.18,3.19,;9.91,-.05,;10.68,-1.38,;9.34,-2.15,)| InChI=1S/C25H38N4O3/c30-23(18-25(31)9-1-10-25)27-20-4-2-19(3-5-20)7-12-28-13-15-29(16-14-28)24-21-8-17-32-22(21)6-11-26-24/h6,11,19-20,31H,1-5,7-10,12-18H2,(H,27,30) AVJAAHWPEDARHN-UHFFFAOYSA-N 106552 US8586579, 168 D(2) dopamine receptor Homo sapiens 408.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106552&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125834 174008863 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 225023 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H30N4O2/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,8-9,15,17-18H,2-5,7,10-14H2,1H3,(H,23,26) NWXLNEMDCWELOX-UHFFFAOYSA-N 106412 US8586579, 1 D(3) dopamine receptor Homo sapiens 18.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106412&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768825 174008723 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225024 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.97,-2.28,;10.63,-3.05,;9.3,-2.28,;8.05,-3.19,;6.81,-2.28,;7.28,-.82,;6.51,.52,;4.97,.52,;4.2,-.82,;4.2,1.85,;2.66,1.85,;1.89,.52,;.35,.52,;-.42,1.85,;-1.96,1.85,;-2.73,.52,;-4.27,.52,;-5.04,-.82,;-6.58,-.82,;-7.35,.52,;-6.58,1.85,;-5.04,1.85,;-8.89,.52,;-9.66,1.85,;-11.2,1.85,;-11.97,.52,;-11.2,-.82,;-11.67,-2.28,;-10.43,-3.19,;-9.18,-2.28,;-9.66,-.82,;.35,3.19,;1.89,3.19,;8.82,-.82,)| InChI=1S/C27H40N4O3/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) OEQABNLZLBEHPD-UHFFFAOYSA-N 106413 US8586579, 2 D(3) dopamine receptor Homo sapiens 28.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106413&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768827 174008724 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225025 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)CC1 |r,wU:9.8,4.4,wD:12.12,1.0,(10.78,-2.82,;10.01,-1.48,;10.78,-.15,;10.01,1.18,;8.47,1.18,;7.7,2.52,;6.16,2.52,;5.39,3.85,;5.39,1.18,;3.85,1.18,;3.08,-.15,;1.54,-.15,;.77,1.18,;-.77,1.18,;-1.54,-.15,;-3.08,-.15,;-3.85,-1.48,;-5.39,-1.48,;-6.16,-.15,;-5.39,1.18,;-3.85,1.18,;-7.7,-.15,;-8.47,1.18,;-10.01,1.18,;-10.78,-.15,;-10.01,-1.48,;-10.49,-2.95,;-9.24,-3.85,;-7.99,-2.95,;-8.47,-1.48,;1.54,2.52,;3.08,2.52,;7.7,-.15,;8.47,-1.48,)| InChI=1S/C27H40N4O3/c32-23-7-3-21(4-8-23)19-26(33)29-22-5-1-20(2-6-22)10-13-30-14-16-31(17-15-30)27-24-11-18-34-25(24)9-12-28-27/h9,11-12,18,20-23,32H,1-8,10,13-17,19H2,(H,29,33) JNSGCKSGQOFGBY-UHFFFAOYSA-N 106414 US8586579, 3 D(3) dopamine receptor Homo sapiens 54.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106414&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768826 174008725 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225026 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H32N4O2/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,9-10,16-18H,2-6,8,11-15H2,1H3,(H,24,27) CXLYWFQWNGCVEG-UHFFFAOYSA-N 106415 US8586579, 4 D(3) dopamine receptor Homo sapiens 11.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106415&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768828 174008726 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225027 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O3/c1-29-16-9-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-8-17-30-21(20)6-10-24-23/h6,8,10,17-19H,2-5,7,9,11-16H2,1H3,(H,25,28) JSEGPLRTWBZZOJ-UHFFFAOYSA-N 106416 US8586579, 5 D(3) dopamine receptor Homo sapiens 24 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106416&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769057 174008727 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225028 OCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.54,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5.01,-.82,;-5.78,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H32N4O3/c27-15-7-21(28)24-18-3-1-17(2-4-18)6-10-25-11-13-26(14-12-25)22-19-8-16-29-20(19)5-9-23-22/h5,8-9,16-18,27H,1-4,6-7,10-15H2,(H,24,28) UOQPMMUMTSDTOB-UHFFFAOYSA-N 106417 US8586579, 6 D(3) dopamine receptor Homo sapiens 19.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106417&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769058 174008728 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225029 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H30N4O3/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,7-8,14,16-17,26H,1-4,6,9-13,15H2,(H,23,27) PNHVOOVVCPJXPA-UHFFFAOYSA-N 106418 US8586579, 7 D(3) dopamine receptor Homo sapiens 43 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106418&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769059 174008729 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225030 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.39,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5,-.82,;-5.78,.52,;-5,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H32N4O3/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,8-9,15,17-18H,2-5,7,10-14,16H2,1H3,(H,24,27) WVCHGRAYLHEGAY-UHFFFAOYSA-N 106419 US8586579, 8 D(3) dopamine receptor Homo sapiens 77.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106419&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769060 174008730 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225031 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-2.82,;10.01,-2.82,;9.24,-1.48,;10.01,-.15,;9.24,1.18,;7.7,1.18,;6.93,2.52,;5.39,2.52,;4.62,3.85,;4.62,1.18,;3.08,1.18,;2.31,-.15,;.77,-.15,;,1.18,;-1.54,1.18,;-2.31,-.15,;-3.85,-.15,;-4.62,-1.48,;-6.16,-1.48,;-6.93,-.15,;-6.16,1.18,;-4.62,1.18,;-8.47,-.15,;-9.24,1.18,;-10.78,1.18,;-11.55,-.15,;-10.78,-1.48,;-11.26,-2.95,;-10.01,-3.85,;-8.76,-2.95,;-9.24,-1.48,;.77,2.52,;2.31,2.52,;6.93,-.15,;7.7,-1.48,)| InChI=1S/C28H42N4O3/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,12-13,19,21-24H,2-9,11,14-18,20H2,1H3,(H,30,33) IXDPGYMHLOZKPR-UHFFFAOYSA-N 106420 US8586579, 9 D(3) dopamine receptor Homo sapiens 32.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106420&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769061 174008731 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225032 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H38N4O3/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,9-10,18,20-22H,1-4,6-8,11-17,19H2,(H,28,31) LJEOXWDSLFLRNN-UHFFFAOYSA-N 106421 US8586579, 10 D(3) dopamine receptor Homo sapiens 30.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106421&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769062 174008732 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225033 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H36N4O3/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,9-10,18-21H,1-4,6-8,11-17H2,(H,27,30) SQLGEXQBAJPFNZ-UHFFFAOYSA-N 106422 US8586579, 11 D(3) dopamine receptor Homo sapiens 55.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106422&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769294 174008733 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225034 CCOCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O3/c1-2-29-17-22(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)23-20-9-16-30-21(20)7-10-24-23/h7,9-10,16,18-19H,2-6,8,11-15,17H2,1H3,(H,25,28) WRBKFBAHOMAFKJ-UHFFFAOYSA-N 106423 US8586579, 12 D(3) dopamine receptor Homo sapiens 150 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106423&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769295 174008734 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225035 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(6.26,-.82,;7.03,.52,;6.26,1.85,;4.72,1.85,;3.95,.52,;2.41,.52,;1.64,1.85,;.1,1.85,;-.67,.52,;-2.21,.52,;-2.98,-.82,;-4.52,-.82,;-5.29,.52,;-4.52,1.85,;-2.98,1.85,;-6.83,.52,;-7.6,1.85,;-9.14,1.85,;-9.91,.52,;-9.14,-.82,;-9.61,-2.28,;-8.37,-3.19,;-7.12,-2.28,;-7.6,-.82,;2.41,3.19,;3.95,3.19,;8.57,.52,;9.91,-.25,;9.91,1.29,)| InChI=1S/C23H32N4O2/c28-23(18-3-4-18)25-19-5-1-17(2-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,9-10,16-19H,1-6,8,11-15H2,(H,25,28) SVONVXKDHRPGFI-UHFFFAOYSA-N 106424 US8586579, 13 D(3) dopamine receptor Homo sapiens 21.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106424&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769296 174008735 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225036 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;6.47,-.25,;9.14,1.29,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H30N4O3S/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,8-9,15-17,22H,2-5,7,10-14H2,1H3 XGWUEDFPOSFGBM-UHFFFAOYSA-N 106425 US8586579, 14 D(3) dopamine receptor Homo sapiens 34.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106425&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769297 174008736 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225037 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H30N4OS/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,8-9,15,17-18H,2-5,7,10-14H2,1H3,(H,23,26) DKJHWZSZJVWAQC-UHFFFAOYSA-N 106426 US8586579, 15 D(3) dopamine receptor Homo sapiens 1.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106426&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769298 174008737 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225038 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.08,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H32N4O3S/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,9-10,16-18,23H,2-6,8,11-15H2,1H3 KNWOHCMLVYZTJW-UHFFFAOYSA-N 106427 US8586579, 16 D(3) dopamine receptor Homo sapiens 30.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106427&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770167 174008738 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225039 CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(7.31,-2.15,;8.08,-.82,;9.63,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H33N5O3S/c1-24(2)30(27,28)23-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)21-19-9-16-29-20(19)7-10-22-21/h7,9-10,16-18,23H,3-6,8,11-15H2,1-2H3 UJBLYPURSDWDKF-UHFFFAOYSA-N 106428 US8586579, 17 D(3) dopamine receptor Homo sapiens 33 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106428&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770168 174008739 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225040 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H32N4OS/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,9-10,16-18H,2-6,8,11-15H2,1H3,(H,24,27) TYZKGCIDJUPIPC-UHFFFAOYSA-N 106429 US8586579, 18 D(3) dopamine receptor Homo sapiens 1.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106429&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769299 174008740 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225041 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O2S/c1-29-16-8-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-9-17-30-21(20)6-10-24-23/h6,9-10,17-19H,2-5,7-8,11-16H2,1H3,(H,25,28) PXCHOWMQGZACON-UHFFFAOYSA-N 106430 US8586579, 19 D(3) dopamine receptor Homo sapiens 1.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106430&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769521 174008741 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225042 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-2.82,;10.01,-2.82,;9.24,-1.48,;10.01,-.15,;9.24,1.18,;7.7,1.18,;6.93,2.52,;5.39,2.52,;4.62,3.85,;4.62,1.18,;3.08,1.18,;2.31,-.15,;.77,-.15,;,1.18,;-1.54,1.18,;-2.31,-.15,;-3.85,-.15,;-4.62,-1.48,;-6.16,-1.48,;-6.93,-.15,;-6.16,1.18,;-4.62,1.18,;-8.47,-.15,;-9.24,1.18,;-10.78,1.18,;-11.55,-.15,;-10.78,-1.48,;-11.26,-2.95,;-10.01,-3.85,;-8.76,-2.95,;-9.24,-1.48,;.77,2.52,;2.31,2.52,;6.93,-.15,;7.7,-1.48,)| InChI=1S/C28H42N4O2S/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,12-13,19,21-24H,2-9,11,14-18,20H2,1H3,(H,30,33) GSZBDACNBVTFKJ-UHFFFAOYSA-N 106431 US8586579, 20 D(3) dopamine receptor Homo sapiens 3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106431&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769522 174008742 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225043 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.69,-2.62,;10.36,-3.39,;9.02,-2.62,;7.56,-3.1,;6.65,-1.85,;7.56,-.61,;6.79,.73,;5.25,.73,;4.48,-.61,;4.48,2.06,;2.94,2.06,;2.17,.73,;.63,.73,;-.14,2.06,;-1.68,2.06,;-2.45,.73,;-3.99,.73,;-4.76,-.61,;-6.3,-.61,;-7.07,.73,;-6.3,2.06,;-4.76,2.06,;-8.61,.73,;-9.38,2.06,;-10.92,2.06,;-11.69,.73,;-10.92,-.61,;-11.4,-2.07,;-10.15,-2.98,;-8.91,-2.07,;-9.38,-.61,;.63,3.39,;2.17,3.39,;9.02,-1.08,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106432 US8586579, 21 D(3) dopamine receptor Homo sapiens 3.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106432&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769523 174008743 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225044 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.47,.52,;1.93,.52,;1.16,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.85,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.47,3.19,)| InChI=1S/C22H32N4O2S/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,8-9,15,17-18H,2-5,7,10-14,16H2,1H3,(H,24,27) CCIIACYBEVIIIN-UHFFFAOYSA-N 106433 US8586579, 22 D(3) dopamine receptor Homo sapiens 3.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106433&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769524 174008744 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225045 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H38N4O2S/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,9-10,18,20-22H,1-4,6-8,11-17,19H2,(H,28,31) OFWNLCWKTRJZBM-UHFFFAOYSA-N 106434 US8586579, 23 D(3) dopamine receptor Homo sapiens 2.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106434&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769525 174008745 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225046 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H36N4O2S/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,9-10,18-21H,1-4,6-8,11-17H2,(H,27,30) ZERNPQRYLXBKKZ-UHFFFAOYSA-N 106435 US8586579, 24 D(3) dopamine receptor Homo sapiens 3.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106435&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769526 174008746 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225047 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.88,-2.45,;10.55,-3.22,;9.22,-2.45,;7.88,-3.22,;6.74,-2.19,;7.37,-.78,;6.6,.55,;5.06,.55,;4.29,-.78,;4.29,1.89,;2.75,1.89,;1.98,.55,;.44,.55,;-.33,1.89,;-1.87,1.89,;-2.64,.55,;-4.18,.55,;-4.95,-.78,;-6.49,-.78,;-7.26,.55,;-6.49,1.89,;-4.95,1.89,;-8.8,.55,;-9.57,1.89,;-11.11,1.89,;-11.88,.55,;-11.11,-.78,;-11.59,-2.25,;-10.34,-3.15,;-9.1,-2.25,;-9.57,-.78,;.44,3.22,;1.98,3.22,;8.9,-.94,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106436 US8586579, 25 D(3) dopamine receptor Homo sapiens 2.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106436&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769523 174008747 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225048 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(11.88,-2.45,;10.55,-3.22,;9.22,-2.45,;7.88,-3.22,;6.74,-2.19,;7.37,-.78,;6.6,.55,;5.06,.55,;4.29,-.78,;4.29,1.89,;2.75,1.89,;1.98,.55,;.44,.55,;-.33,1.89,;-1.87,1.89,;-2.64,.55,;-4.18,.55,;-4.95,-.78,;-6.49,-.78,;-7.26,.55,;-6.49,1.89,;-4.95,1.89,;-8.8,.55,;-9.57,1.89,;-11.11,1.89,;-11.88,.55,;-11.11,-.78,;-11.59,-2.25,;-10.34,-3.15,;-9.1,-2.25,;-9.57,-.78,;.44,3.22,;1.98,3.22,;8.9,-.94,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106437 US8586579, 26 D(3) dopamine receptor Homo sapiens 3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106437&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125949 174008748 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225049 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.86,.52,;7.32,.52,;6.55,-.82,;6.55,1.85,;5.01,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H30N4O2S/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,7-8,14,16-17,26H,1-4,6,9-13,15H2,(H,23,27) OYIQKTRWSDEITE-UHFFFAOYSA-N 106438 US8586579, 27 D(3) dopamine receptor Homo sapiens 1.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106438&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768043 174008749 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225050 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)CC1 |r,wU:9.8,4.4,wD:12.12,1.0,(10.78,-2.82,;10.01,-1.48,;10.78,-.15,;10.01,1.18,;8.47,1.18,;7.7,2.52,;6.16,2.52,;5.39,3.85,;5.39,1.18,;3.85,1.18,;3.08,-.15,;1.54,-.15,;.77,1.18,;-.77,1.18,;-1.54,-.15,;-3.08,-.15,;-3.85,-1.48,;-5.39,-1.48,;-6.16,-.15,;-5.39,1.18,;-3.85,1.18,;-7.7,-.15,;-8.47,1.18,;-10.01,1.18,;-10.78,-.15,;-10.01,-1.48,;-10.49,-2.95,;-9.24,-3.85,;-7.99,-2.95,;-8.47,-1.48,;1.54,2.52,;3.08,2.52,;7.7,-.15,;8.47,-1.48,)| InChI=1S/C27H40N4O2S/c32-23-7-3-21(4-8-23)19-26(33)29-22-5-1-20(2-6-22)10-13-30-14-16-31(17-15-30)27-24-11-18-34-25(24)9-12-28-27/h9,11-12,18,20-23,32H,1-8,10,13-17,19H2,(H,29,33) WKCSANGLEHNNKN-UHFFFAOYSA-N 106439 US8586579, 28 D(3) dopamine receptor Homo sapiens 6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106439&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768824 174008750 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225051 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)c1ccnc2ccccc12 |r,wU:3.2,wD:6.6,(5.39,-.67,;6.16,.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,;7.7,.67,;8.47,2,;10.01,2,;10.78,.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;8.47,-.67,)| InChI=1S/C29H33N5O2/c35-29(24-9-13-30-26-4-2-1-3-23(24)26)32-22-7-5-21(6-8-22)11-15-33-16-18-34(19-17-33)28-25-12-20-36-27(25)10-14-31-28/h1-4,9-10,12-14,20-22H,5-8,11,15-19H2,(H,32,35) IQGWEXBXERIPCR-UHFFFAOYSA-N 106440 US8586579, 29 D(3) dopamine receptor Homo sapiens 23.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106440&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769738 174008751 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225052 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;9.14,1.29,;6.47,-.25,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H30N4O2S2/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,8-9,15-17,22H,2-5,7,10-14H2,1H3 BUNARIUEVNWERA-UHFFFAOYSA-N 106441 US8586579, 30 D(3) dopamine receptor Homo sapiens 4.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106441&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769739 174008752 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225053 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.09,-.82,;7.32,.52,;8.65,1.29,;5.98,-.25,;6.54,1.85,;5.01,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5.01,.52,;-4.23,1.85,;-2.69,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H32N4O2S2/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,9-10,16-18,23H,2-6,8,11-15H2,1H3 RRYHHCNEVZLSCS-UHFFFAOYSA-N 106442 US8586579, 31 D(3) dopamine receptor Homo sapiens 4.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106442&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769740 174008753 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225054 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H32N4O2/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,9,17-18H,2-5,7-8,10-15H2,1H3,(H,23,26) SQRMELSMCDEARL-UHFFFAOYSA-N 106443 US8586579, 32 D(3) dopamine receptor Homo sapiens 12.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106443&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769741 174008754 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225055 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H38N4O3/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,10,19-21H,1-4,6-9,11-18H2,(H,27,30) NNECCFXSSVWBTA-UHFFFAOYSA-N 106444 US8586579, 33 D(3) dopamine receptor Homo sapiens 38.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106444&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769742 174008755 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225056 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H40N4O3/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,10,20-22H,1-4,6-9,11-19H2,(H,28,31) WBVLCBQDISBZLH-UHFFFAOYSA-N 106445 US8586579, 61 D(3) dopamine receptor Homo sapiens 24.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106445&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769743 174008756 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225057 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H36N4O3/c1-29-16-9-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-8-17-30-21(20)6-10-24-23/h6,10,18-19H,2-5,7-9,11-17H2,1H3,(H,25,28) RSOWGGVCBJACCG-UHFFFAOYSA-N 106446 US8586579, 62 D(3) dopamine receptor Homo sapiens 17.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106446&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769948 174008757 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225058 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.86,.52,;7.32,.52,;6.55,-.82,;6.55,1.85,;5.01,1.85,;4.23,.52,;2.7,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.86,1.85,;-9.62,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.7,3.19,;4.23,3.19,)| InChI=1S/C22H34N4O2/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,10,17-18H,2-6,8-9,11-16H2,1H3,(H,24,27) HHRGFYRLYOYIFM-UHFFFAOYSA-N 106447 US8586579, 36 D(3) dopamine receptor Homo sapiens 9.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106447&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769949 174008758 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225059 O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106448 US8586579, 37 D(3) dopamine receptor Homo sapiens 19.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106448&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769951 174008759 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225060 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.92,.52,;1.16,1.85,;-.38,1.85,;-1.16,.52,;-2.7,.52,;-3.46,-.82,;-5.01,-.82,;-5.78,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.92,3.19,;3.46,3.19,)| InChI=1S/C22H34N4O3/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,9,17-18H,2-5,7-8,10-16H2,1H3,(H,24,27) PZYRQKWSXFGUED-UHFFFAOYSA-N 106449 US8586579, 38 D(3) dopamine receptor Homo sapiens 45.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106449&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769950 174008760 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225061 CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;10.29,-.05,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C22H34N4O4S/c1-31(28,29)16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-30-20(19)6-9-23-22/h6,9,17-18H,2-5,7-8,10-16H2,1H3,(H,24,27) ZDFGDUYZGMNXLU-UHFFFAOYSA-N 106450 US8586579, 39 D(3) dopamine receptor Homo sapiens 9.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106450&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769952 174008761 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225062 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.85,.52,;7.32,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.93,1.85,;.39,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C21H32N4O3/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,8,16-17,26H,1-4,6-7,9-15H2,(H,23,27) HUEMJHLBWFDXTF-UHFFFAOYSA-N 106451 US8586579, 40 D(3) dopamine receptor Homo sapiens 15.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106451&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769953 174008762 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225063 OCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.85,-.82,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5.01,-.82,;-5.77,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.08,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.85,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H34N4O3/c27-15-7-21(28)24-18-3-1-17(2-4-18)6-10-25-11-13-26(14-12-25)22-19-8-16-29-20(19)5-9-23-22/h5,9,17-18,27H,1-4,6-8,10-16H2,(H,24,28) YMPBYYINMWNUQV-UHFFFAOYSA-N 106452 US8586579, 41 D(3) dopamine receptor Homo sapiens 11.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106452&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770164 174008763 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225064 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCOC1 |r,wU:3.2,wD:6.6,(5.75,-.82,;6.52,.52,;5.75,1.85,;4.21,1.85,;3.44,.52,;1.9,.52,;1.13,1.85,;-.41,1.85,;-1.18,.52,;-2.72,.52,;-3.49,-.82,;-5.03,-.82,;-5.8,.52,;-5.03,1.85,;-3.49,1.85,;-7.34,.52,;-8.12,1.85,;-9.65,1.85,;-10.43,.52,;-9.65,-.82,;-10.13,-2.28,;-8.89,-3.19,;-7.64,-2.28,;-8.12,-.82,;1.9,3.19,;3.44,3.19,;8.06,.52,;8.96,1.76,;10.43,1.29,;10.43,-.25,;8.96,-.73,)| InChI=1S/C24H36N4O3/c29-24(19-7-15-30-17-19)26-20-3-1-18(2-4-20)6-10-27-11-13-28(14-12-27)23-21-8-16-31-22(21)5-9-25-23/h5,9,18-20H,1-4,6-8,10-17H2,(H,26,29) YNWOVSGFFVVSBU-UHFFFAOYSA-N 106453 US8586579, 42 D(3) dopamine receptor Homo sapiens 18.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106453&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770165 174008764 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225065 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCCO1 |r,wU:3.2,wD:6.6,(5.75,-.82,;6.52,.52,;5.75,1.85,;4.21,1.85,;3.44,.52,;1.9,.52,;1.13,1.85,;-.41,1.85,;-1.18,.52,;-2.72,.52,;-3.49,-.82,;-5.03,-.82,;-5.8,.52,;-5.03,1.85,;-3.49,1.85,;-7.34,.52,;-8.11,1.85,;-9.65,1.85,;-10.42,.52,;-9.65,-.82,;-10.13,-2.28,;-8.88,-3.19,;-7.64,-2.28,;-8.11,-.82,;1.9,3.19,;3.44,3.19,;8.06,.52,;8.96,1.76,;10.42,1.29,;10.42,-.25,;8.96,-.73,)| InChI=1S/C24H36N4O3/c29-24(22-2-1-16-30-22)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)23-20-9-17-31-21(20)7-10-25-23/h7,10,18-19,22H,1-6,8-9,11-17H2,(H,26,29) HZQQJAKATKCPDP-UHFFFAOYSA-N 106454 US8586579, 43 D(3) dopamine receptor Homo sapiens 120 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106454&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770166 174008765 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225066 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccccc1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C26H34N4O2/c31-26(21-4-2-1-3-5-21)28-22-8-6-20(7-9-22)11-14-29-15-17-30(18-16-29)25-23-12-19-32-24(23)10-13-27-25/h1-5,10,13,20,22H,6-9,11-12,14-19H2,(H,28,31) HAABSCYMCZRVTB-UHFFFAOYSA-N 106455 US8586579, 44 D(3) dopamine receptor Homo sapiens 7.66 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106455&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770169 174008766 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225067 Fc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.55,.52,;10.01,.52,;9.24,-.82,;7.7,-.82,;6.93,.52,;7.7,1.85,;9.24,1.85,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,)| InChI=1S/C26H33FN4O2/c27-21-5-3-20(4-6-21)26(32)29-22-7-1-19(2-8-22)10-13-30-14-16-31(17-15-30)25-23-11-18-33-24(23)9-12-28-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,29,32) HQAMJNKOXUQUKS-UHFFFAOYSA-N 106456 US8586579, 45 D(3) dopamine receptor Homo sapiens 10.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106456&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770380 174008767 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225068 Clc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.55,.52,;10.01,.52,;9.24,-.82,;7.7,-.82,;6.93,.52,;7.7,1.85,;9.24,1.85,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,)| InChI=1S/C26H33ClN4O2/c27-21-5-3-20(4-6-21)26(32)29-22-7-1-19(2-8-22)10-13-30-14-16-31(17-15-30)25-23-11-18-33-24(23)9-12-28-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,29,32) HMAKCCQMRGCRHO-UHFFFAOYSA-N 106457 US8586579, 73 D(3) dopamine receptor Homo sapiens 13.25 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106457&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770381 174008768 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225069 FC(F)(F)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.13,wD:16.17,(12.32,.52,;10.78,.52,;10.78,2.06,;10.78,-1.02,;9.24,.52,;8.47,-.82,;6.93,-.82,;6.16,.52,;6.93,1.85,;8.47,1.85,;4.62,.52,;3.85,-.82,;3.85,1.85,;2.31,1.85,;1.54,.52,;,.52,;-.77,1.85,;-2.31,1.85,;-3.08,.52,;-4.62,.52,;-5.39,-.82,;-6.93,-.82,;-7.7,.52,;-6.93,1.85,;-5.39,1.85,;-9.24,.52,;-10.01,1.85,;-11.55,1.85,;-12.32,.52,;-11.55,-.82,;-12.03,-2.28,;-10.78,-3.19,;-9.53,-2.28,;-10.01,-.82,;,3.19,;1.54,3.19,)| InChI=1S/C27H33F3N4O2/c28-27(29,30)21-5-3-20(4-6-21)26(35)32-22-7-1-19(2-8-22)10-13-33-14-16-34(17-15-33)25-23-11-18-36-24(23)9-12-31-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,32,35) JVTXPXRMOCVEDH-UHFFFAOYSA-N 106458 US8586579, 74 D(3) dopamine receptor Homo sapiens 57 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106458&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770382 174008769 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225070 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;6.47,-.25,;9.14,1.29,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H32N4O3S/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,9,16-17,22H,2-5,7-8,10-15H2,1H3 ILSVAZDAOVUDJJ-UHFFFAOYSA-N 106459 US8586579, 75 D(3) dopamine receptor Homo sapiens 31.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106459&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770383 174008770 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225071 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.08,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.7,-.82,;-4.23,-.82,;-5.01,.52,;-4.23,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H34N4O3S/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,10,17-18,23H,2-6,8-9,11-16H2,1H3 HFJVMFBCUWJLFO-UHFFFAOYSA-N 106460 US8586579, 76 D(3) dopamine receptor Homo sapiens 22 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106460&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770384 174008771 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225072 Fc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,wD:14.15,(10.01,-4,;9.24,-2.67,;7.7,-2.67,;6.93,-1.33,;7.7,,;9.24,,;10.01,-1.33,;6.93,1.33,;5.6,.56,;8.26,2.1,;6.16,2.67,;4.62,2.67,;3.85,1.33,;2.31,1.33,;1.54,2.67,;,2.67,;-.77,1.33,;-2.31,1.33,;-3.08,,;-4.62,,;-5.39,1.33,;-4.62,2.67,;-3.08,2.67,;-6.93,1.33,;-7.7,2.67,;-9.24,2.67,;-10.01,1.33,;-9.24,,;-9.72,-1.46,;-8.47,-2.37,;-7.22,-1.46,;-7.7,,;2.31,4,;3.85,4,)| InChI=1S/C25H33FN4O3S/c26-20-3-7-22(8-4-20)34(31,32)28-21-5-1-19(2-6-21)10-13-29-14-16-30(17-15-29)25-23-11-18-33-24(23)9-12-27-25/h3-4,7-9,12,19,21,28H,1-2,5-6,10-11,13-18H2 OXMLHENURKVGGZ-UHFFFAOYSA-N 106461 US8586579, 50 D(3) dopamine receptor Homo sapiens 6.72 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106461&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770385 174008772 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225073 O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.7,wD:10.11,(5.88,-.92,;6.65,.41,;8.19,.41,;8.96,1.75,;10.29,2.52,;8.96,3.29,;5.88,1.75,;4.34,1.75,;3.57,.41,;2.03,.41,;1.26,1.75,;-.28,1.75,;-1.05,.41,;-2.59,.41,;-3.36,-.92,;-4.9,-.92,;-5.67,.41,;-4.9,1.75,;-3.36,1.75,;-7.21,.41,;-7.98,1.75,;-9.52,1.75,;-10.29,.41,;-9.52,-.92,;-10,-2.38,;-8.75,-3.29,;-7.51,-2.38,;-7.98,-.92,;2.03,3.08,;3.57,3.08,)| InChI=1S/C24H36N4O2/c29-23(17-19-1-2-19)26-20-5-3-18(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,18-20H,1-6,8-9,11-17H2,(H,26,29) XPKWZBRQMHEAAX-UHFFFAOYSA-N 106462 US8586579, 51 D(3) dopamine receptor Homo sapiens 5.07 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106462&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125786 174008773 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225074 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCC1 |r,wU:3.2,wD:6.6,(5.83,-.82,;6.6,.52,;5.83,1.85,;4.29,1.85,;3.52,.52,;1.98,.52,;1.21,1.85,;-.33,1.85,;-1.1,.52,;-2.64,.52,;-3.41,-.82,;-4.95,-.82,;-5.72,.52,;-4.95,1.85,;-3.41,1.85,;-7.26,.52,;-8.03,1.85,;-9.57,1.85,;-10.34,.52,;-9.57,-.82,;-10.05,-2.28,;-8.8,-3.19,;-7.56,-2.28,;-8.03,-.82,;1.98,3.19,;3.52,3.19,;8.14,.52,;9.24,-.58,;10.34,.52,;9.24,1.62,)| InChI=1S/C24H36N4O2/c29-24(19-2-1-3-19)26-20-6-4-18(5-7-20)9-12-27-13-15-28(16-14-27)23-21-10-17-30-22(21)8-11-25-23/h8,11,18-20H,1-7,9-10,12-17H2,(H,26,29) IUHXMQOKDMHFCT-UHFFFAOYSA-N 106463 US8586579, 52 D(3) dopamine receptor Homo sapiens 15.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106463&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770598 174008774 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225075 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCCOC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,1.85,;10.01,1.85,;10.78,.52,;10.01,-.82,;8.47,-.82,)| InChI=1S/C25H38N4O3/c30-25(20-2-1-16-31-18-20)27-21-5-3-19(4-6-21)8-11-28-12-14-29(15-13-28)24-22-9-17-32-23(22)7-10-26-24/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) RBGONAOLWTWGIH-UHFFFAOYSA-N 106464 US8586579, 53 D(3) dopamine receptor Homo sapiens 28.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106464&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770599 174008775 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225076 C[C@]1(O)CC[C@@H](CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,1.1,wD:14.15,5.8,1.0,(11.45,1.29,;10.11,.52,;11.45,-.25,;9.34,-.82,;7.8,-.82,;7.03,.52,;7.8,1.85,;9.34,1.85,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.83,.52,;-6.06,1.85,;-4.52,1.85,;-8.37,.52,;-9.14,1.85,;-10.68,1.85,;-11.45,.52,;-10.68,-.82,;-11.15,-2.28,;-9.91,-3.19,;-8.66,-2.28,;-9.14,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C27H42N4O3/c1-27(33)11-6-21(7-12-27)26(32)29-22-4-2-20(3-5-22)9-14-30-15-17-31(18-16-30)25-23-10-19-34-24(23)8-13-28-25/h8,13,20-22,33H,2-7,9-12,14-19H2,1H3,(H,29,32) XLIXPJRYIUCZIQ-UHFFFAOYSA-N 106465 US8586579, 81 D(3) dopamine receptor Homo sapiens 51.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106465&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125777 174008776 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225077 C[C@@]1(O)CC[C@@H](CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,1.0,wD:14.15,5.8,1.1,(11.45,1.29,;10.11,.52,;11.45,-.25,;9.34,-.82,;7.8,-.82,;7.03,.52,;7.8,1.85,;9.34,1.85,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.83,.52,;-6.06,1.85,;-4.52,1.85,;-8.37,.52,;-9.14,1.85,;-10.68,1.85,;-11.45,.52,;-10.68,-.82,;-11.15,-2.28,;-9.91,-3.19,;-8.66,-2.28,;-9.14,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C27H42N4O3/c1-27(33)11-6-21(7-12-27)26(32)29-22-4-2-20(3-5-22)9-14-30-15-17-31(18-16-30)25-23-10-19-34-24(23)8-13-28-25/h8,13,20-22,33H,2-7,9-12,14-19H2,1H3,(H,29,32) XLIXPJRYIUCZIQ-UHFFFAOYSA-N 106466 US8586579, 55 D(3) dopamine receptor Homo sapiens 45.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106466&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125777 174008777 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225078 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCCCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C31H43N5O2/c37-31(25-6-10-27(11-7-25)35-16-2-1-3-17-35)33-26-8-4-24(5-9-26)13-18-34-19-21-36(22-20-34)30-28-14-23-38-29(28)12-15-32-30/h6-7,10-12,15,24,26H,1-5,8-9,13-14,16-23H2,(H,33,37) UBLOWVVYFMMWMS-UHFFFAOYSA-N 106467 US8586579, 83 D(3) dopamine receptor Homo sapiens 44.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106467&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770600 174008778 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225079 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C30H41N5O3/c36-30(24-3-7-26(8-4-24)34-18-21-37-22-19-34)32-25-5-1-23(2-6-25)10-13-33-14-16-35(17-15-33)29-27-11-20-38-28(27)9-12-31-29/h3-4,7-9,12,23,25H,1-2,5-6,10-11,13-22H2,(H,32,36) WVPMAZJVALETCI-UHFFFAOYSA-N 106468 US8586579, 57 D(3) dopamine receptor Homo sapiens 16.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106468&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770601 174008779 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225080 OC1(CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.7,wD:10.11,(9.27,-.82,;8.5,.52,;9.98,.92,;8.89,2.01,;6.96,.52,;6.19,-.82,;6.19,1.85,;4.65,1.85,;3.88,.52,;2.34,.52,;1.57,1.85,;.03,1.85,;-.74,.52,;-2.28,.52,;-3.05,-.82,;-4.59,-.82,;-5.36,.52,;-4.59,1.85,;-3.05,1.85,;-6.9,.52,;-7.67,1.85,;-9.21,1.85,;-9.98,.52,;-9.21,-.82,;-9.69,-2.28,;-8.44,-3.19,;-7.2,-2.28,;-7.67,-.82,;2.34,3.19,;3.88,3.19,)| InChI=1S/C23H34N4O3/c28-22(23(29)8-9-23)25-18-3-1-17(2-4-18)6-11-26-12-14-27(15-13-26)21-19-7-16-30-20(19)5-10-24-21/h5,10,17-18,29H,1-4,6-9,11-16H2,(H,25,28) CKAFITNCAHORFQ-UHFFFAOYSA-N 106469 US8586579, 58 D(3) dopamine receptor Homo sapiens 27.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106469&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125810 174008780 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225081 O=C(CC#N)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(6.16,-.82,;6.93,.52,;8.47,.52,;9.24,1.85,;10.01,3.19,;6.16,1.85,;4.62,1.85,;3.85,.52,;2.31,.52,;1.54,1.85,;,1.85,;-.77,.52,;-2.31,.52,;-3.08,-.82,;-4.62,-.82,;-5.39,.52,;-4.62,1.85,;-3.08,1.85,;-6.93,.52,;-7.7,1.85,;-9.24,1.85,;-10.01,.52,;-9.24,-.82,;-9.72,-2.28,;-8.47,-3.19,;-7.22,-2.28,;-7.7,-.82,;2.31,3.19,;3.85,3.19,)| InChI=1S/C22H31N5O2/c23-9-5-21(28)25-18-3-1-17(2-4-18)7-11-26-12-14-27(15-13-26)22-19-8-16-29-20(19)6-10-24-22/h6,10,17-18H,1-5,7-8,11-16H2,(H,25,28) AZQFGKSDCVQAHH-UHFFFAOYSA-N 106470 US8586579, 59 D(3) dopamine receptor Homo sapiens 7.74 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106470&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770602 174008781 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225082 FC(F)(F)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;10.29,-.05,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C22H31F3N4O2/c23-22(24,25)15-20(30)27-17-3-1-16(2-4-17)6-9-28-10-12-29(13-11-28)21-18-7-14-31-19(18)5-8-26-21/h5,8,16-17H,1-4,6-7,9-15H2,(H,27,30) KAEYIPLTXHGZRS-UHFFFAOYSA-N 106471 US8586579, 60 D(3) dopamine receptor Homo sapiens 6.55 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106471&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770825 174008782 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225083 O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,3.2,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106472 US8586579, 61 D(3) dopamine receptor Homo sapiens 18.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106472&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770826 174008783 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225084 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccnc2ccccc12 |r,wU:3.2,wD:6.6,(5.39,-.67,;6.16,.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,;7.7,.67,;8.47,2,;10.01,2,;10.78,.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;8.47,-.67,)| InChI=1S/C29H35N5O2/c35-29(24-9-13-30-26-4-2-1-3-23(24)26)32-22-7-5-21(6-8-22)11-15-33-16-18-34(19-17-33)28-25-12-20-36-27(25)10-14-31-28/h1-4,9-10,13-14,21-22H,5-8,11-12,15-20H2,(H,32,35) MVNMMDGTQIXAJK-UHFFFAOYSA-N 106473 US8586579, 62 D(3) dopamine receptor Homo sapiens 10.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106473&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770827 174008784 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225085 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(6.26,-.82,;7.03,.52,;6.26,1.85,;4.72,1.85,;3.95,.52,;2.41,.52,;1.64,1.85,;.1,1.85,;-.67,.52,;-2.21,.52,;-2.98,-.82,;-4.52,-.82,;-5.29,.52,;-4.52,1.85,;-2.98,1.85,;-6.83,.52,;-7.6,1.85,;-9.14,1.85,;-9.91,.52,;-9.14,-.82,;-9.61,-2.28,;-8.37,-3.19,;-7.12,-2.28,;-7.6,-.82,;2.41,3.19,;3.95,3.19,;8.57,.52,;9.91,-.25,;9.91,1.29,)| InChI=1S/C23H34N4O2/c28-23(18-3-4-18)25-19-5-1-17(2-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,10,17-19H,1-6,8-9,11-16H2,(H,25,28) OUMNETVFYOWILO-UHFFFAOYSA-N 106474 US8586579, 63 D(3) dopamine receptor Homo sapiens 18.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106474&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770828 174008785 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225086 O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106475 US8586579, 91 D(3) dopamine receptor Homo sapiens 24.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106475&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770829 174008786 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225087 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-4,;10.01,-4,;9.24,-2.67,;10.01,-1.33,;9.24,,;7.7,,;6.93,1.33,;5.39,1.33,;4.62,,;4.62,2.67,;3.08,2.67,;2.31,1.33,;.77,1.33,;,2.67,;-1.54,2.67,;-2.31,1.33,;-3.85,1.33,;-4.62,,;-6.16,,;-6.93,1.33,;-6.16,2.67,;-4.62,2.67,;-8.47,1.33,;-9.24,2.67,;-10.78,2.67,;-11.55,1.33,;-10.78,,;-11.26,-1.46,;-10.01,-2.37,;-8.76,-1.46,;-9.24,,;.77,4,;2.31,4,;6.93,-1.33,;7.7,-2.67,)| InChI=1S/C28H44N4O3/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,13,21-24H,2-9,11-12,14-20H2,1H3,(H,30,33) JCPOEWYYYWHNCO-UHFFFAOYSA-N 106476 US8586579, 92 D(3) dopamine receptor Homo sapiens 24.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106476&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54770830 174008787 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225088 CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(9.63,-.82,;8.08,-.82,;7.31,-2.15,;7.31,.52,;8.65,1.29,;5.98,-.25,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H35N5O3S/c1-24(2)30(27,28)23-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)21-19-9-16-29-20(19)7-10-22-21/h7,10,17-18,23H,3-6,8-9,11-16H2,1-2H3 CKOUWIPOSAPIGS-UHFFFAOYSA-N 106477 US8586579, 66 D(3) dopamine receptor Homo sapiens 24.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106477&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125849 174008788 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225089 O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,3.2,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106478 US8586579, 67 D(3) dopamine receptor Homo sapiens 24.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106478&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771057 174008789 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225090 O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,3.2,wD:12.13,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106479 US8586579, 95 D(3) dopamine receptor Homo sapiens 27.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106479&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771058 174008790 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225091 O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,3.2,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106480 US8586579, 96 D(3) dopamine receptor Homo sapiens 18.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106480&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771059 174008791 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225092 CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(8.47,2.06,;8.47,.52,;8.47,-1.02,;10.01,.52,;6.93,.52,;6.16,-.82,;6.16,1.85,;4.62,1.85,;3.85,.52,;2.31,.52,;1.54,1.85,;,1.85,;-.77,.52,;-2.31,.52,;-3.08,-.82,;-4.62,-.82,;-5.39,.52,;-4.62,1.85,;-3.08,1.85,;-6.93,.52,;-7.7,1.85,;-9.24,1.85,;-10.01,.52,;-9.24,-.82,;-9.72,-2.28,;-8.47,-3.19,;-7.22,-2.28,;-7.7,-.82,;2.31,3.19,;3.85,3.19,)| InChI=1S/C24H38N4O2/c1-24(2,3)23(29)26-19-6-4-18(5-7-19)9-12-27-13-15-28(16-14-27)22-20-10-17-30-21(20)8-11-25-22/h8,11,18-19H,4-7,9-10,12-17H2,1-3H3,(H,26,29) IHNAEAHWHZVEJK-UHFFFAOYSA-N 106481 US8586579, 70 D(3) dopamine receptor Homo sapiens 59.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106481&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771060 174008792 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225093 CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.39,-.82,;8.86,-.82,;8.08,-2.15,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C24H38N4O2/c1-18(2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,18-20H,3-6,8-9,11-17H2,1-2H3,(H,26,29) FORAQSMKEXXBJZ-UHFFFAOYSA-N 106482 US8586579, 71 D(3) dopamine receptor Homo sapiens 10.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106482&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771061 174008793 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225094 CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.29,-.05,;8.96,-.82,;9.73,-2.15,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C25H40N4O2/c1-25(2,3)18-23(30)27-20-6-4-19(5-7-20)9-12-28-13-15-29(16-14-28)24-21-10-17-31-22(21)8-11-26-24/h8,11,19-20H,4-7,9-10,12-18H2,1-3H3,(H,27,30) DQVWGUUNHWMPMS-UHFFFAOYSA-N 106483 US8586579, 99 D(3) dopamine receptor Homo sapiens 17 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106483&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771062 174008794 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225095 O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(5.8,-.82,;6.57,.52,;8.11,.52,;8.88,-.82,;8.48,-2.3,;9.97,-2.7,;10.37,-1.21,;5.8,1.85,;4.26,1.85,;3.49,.52,;1.95,.52,;1.18,1.85,;-.36,1.85,;-1.13,.52,;-2.67,.52,;-3.44,-.82,;-4.98,-.82,;-5.75,.52,;-4.98,1.85,;-3.44,1.85,;-7.29,.52,;-8.06,1.85,;-9.6,1.85,;-10.37,.52,;-9.6,-.82,;-10.07,-2.28,;-8.83,-3.19,;-7.58,-2.28,;-8.06,-.82,;1.95,3.19,;3.49,3.19,)| InChI=1S/C25H38N4O2/c30-24(18-20-2-1-3-20)27-21-6-4-19(5-7-21)9-12-28-13-15-29(16-14-28)25-22-10-17-31-23(22)8-11-26-25/h8,11,19-21H,1-7,9-10,12-18H2,(H,27,30) HRGLDIJXNKMLQF-UHFFFAOYSA-N 106484 US8586579, 73 D(3) dopamine receptor Homo sapiens 8.92 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106484&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771291 174008795 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225096 FC1(F)CC1C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(8.51,-1.59,;9.28,-.25,;10.53,-1,;9.28,1.29,;7.95,.52,;6.41,.52,;5.64,-.82,;5.64,1.85,;4.1,1.85,;3.33,.52,;1.79,.52,;1.02,1.85,;-.52,1.85,;-1.29,.52,;-2.83,.52,;-3.6,-.82,;-5.14,-.82,;-5.91,.52,;-5.14,1.85,;-3.6,1.85,;-7.45,.52,;-8.22,1.85,;-9.76,1.85,;-10.53,.52,;-9.76,-.82,;-10.24,-2.28,;-8.99,-3.19,;-7.75,-2.28,;-8.22,-.82,;1.79,3.19,;3.33,3.19,)| InChI=1S/C23H32F2N4O2/c24-23(25)15-19(23)22(30)27-17-3-1-16(2-4-17)6-9-28-10-12-29(13-11-28)21-18-7-14-31-20(18)5-8-26-21/h5,8,16-17,19H,1-4,6-7,9-15H2,(H,27,30) YFHWGBZGWDWNRV-UHFFFAOYSA-N 106485 US8586579, 101 D(3) dopamine receptor Homo sapiens 23.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106485&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771292 174008796 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225097 CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.62,-.82,;8.85,.52,;9.62,1.85,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C23H36N4O2/c1-17(2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) HGDNRYBOAYQHNG-UHFFFAOYSA-N 106486 US8586579, 75 D(3) dopamine receptor Homo sapiens 16.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106486&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771293 174008797 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225098 CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(8.85,3.19,;9.62,1.85,;8.85,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C24H38N4O2/c1-3-18(2)24(29)26-20-6-4-19(5-7-20)9-12-27-13-15-28(16-14-27)23-21-10-17-30-22(21)8-11-25-23/h8,11,18-20H,3-7,9-10,12-17H2,1-2H3,(H,26,29) JPVBGGFMPCPVDU-UHFFFAOYSA-N 106487 US8586579, 103 D(3) dopamine receptor Homo sapiens 25.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106487&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771294 174008798 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225099 O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(5.8,-.82,;6.57,.52,;8.11,.52,;8.88,-.82,;8.48,-2.3,;9.97,-2.7,;10.37,-1.21,;5.8,1.85,;4.26,1.85,;3.49,.52,;1.95,.52,;1.18,1.85,;-.36,1.85,;-1.13,.52,;-2.67,.52,;-3.44,-.82,;-4.98,-.82,;-5.75,.52,;-4.98,1.85,;-3.44,1.85,;-7.29,.52,;-8.06,1.85,;-9.6,1.85,;-10.37,.52,;-9.6,-.82,;-10.07,-2.28,;-8.83,-3.19,;-7.58,-2.28,;-8.06,-.82,;1.95,3.19,;3.49,3.19,)| InChI=1S/C24H36N4O3/c29-23(15-19-16-30-17-19)26-20-3-1-18(2-4-20)6-9-27-10-12-28(13-11-27)24-21-7-14-31-22(21)5-8-25-24/h5,8,18-20H,1-4,6-7,9-17H2,(H,26,29) KPWFNAZMRFBRMI-UHFFFAOYSA-N 106488 US8586579, 77 D(3) dopamine receptor Homo sapiens 12.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106488&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771295 174008799 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225100 CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.62,-.82,;8.85,.52,;9.62,1.85,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H35N5O2/c1-25(2)22(28)24-18-5-3-17(4-6-18)8-11-26-12-14-27(15-13-26)21-19-9-16-29-20(19)7-10-23-21/h7,10,17-18H,3-6,8-9,11-16H2,1-2H3,(H,24,28) UVEHFXJWIQCNDD-UHFFFAOYSA-N 106489 US8586579, 105 D(3) dopamine receptor Homo sapiens 92.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106489&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125778 174008800 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225101 FC(F)(F)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(5.6,-.05,;6.93,-.82,;8.26,-1.59,;6.16,-2.15,;7.7,.52,;9.24,.52,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H29F3N4O2/c22-21(23,24)20(29)26-16-3-1-15(2-4-16)6-9-27-10-12-28(13-11-27)19-17-7-14-30-18(17)5-8-25-19/h5,8,15-16H,1-4,6-7,9-14H2,(H,26,29) SUGHICCAJLONJR-UHFFFAOYSA-N 106490 US8586579, 106 D(3) dopamine receptor Homo sapiens 47.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106490&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 86660552 174008801 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225102 CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.39,-.82,;8.86,-.82,;8.08,-2.15,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C24H36N4O2/c1-18(2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,17,19-20H,3-6,8-9,11-16H2,1-2H3,(H,26,29) NBKJTOGTVMGTOS-UHFFFAOYSA-N 106491 US8586579, 107 D(3) dopamine receptor Homo sapiens 15.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106491&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125807 174008802 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225103 C\C=C\CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H36N4O2/c1-2-3-4-23(29)26-20-7-5-19(6-8-20)10-13-27-14-16-28(17-15-27)24-21-11-18-30-22(21)9-12-25-24/h2-3,9,12,19-20H,4-8,10-11,13-18H2,1H3,(H,26,29) KZWUXBIYAIXWII-UHFFFAOYSA-N 106492 US8586579, 108 D(3) dopamine receptor Homo sapiens 12.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106492&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125826 174008803 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225104 CC#CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.78,.52,;9.24,.52,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H32N4O2/c1-2-3-22(28)25-19-6-4-18(5-7-19)9-12-26-13-15-27(16-14-26)23-20-10-17-29-21(20)8-11-24-23/h8,11,18-19H,4-7,9-10,12-17H2,1H3,(H,25,28) XDPTVFIWUAWOLA-UHFFFAOYSA-N 106493 US8586579, 82 D(3) dopamine receptor Homo sapiens 17.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106493&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768829 174008804 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225105 O=CN[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:3.2,wD:6.6,(6.93,-.82,;7.7,.52,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C20H30N4O2/c25-15-22-17-3-1-16(2-4-17)6-9-23-10-12-24(13-11-23)20-18-7-14-26-19(18)5-8-21-20/h5,8,15-17H,1-4,6-7,9-14H2,(H,22,25) ABHVAQKOVOLZPM-UHFFFAOYSA-N 106494 US8586579, 110 D(3) dopamine receptor Homo sapiens 28 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106494&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 86660553 174008805 C06049 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225106 Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)on1 |r,wU:8.7,wD:11.11,(11.3,-3.05,;9.97,-2.28,;9.49,-.82,;7.95,-.82,;7.18,.52,;5.64,.52,;4.87,-.82,;4.87,1.85,;3.33,1.85,;2.56,.52,;1.02,.52,;.25,1.85,;-1.29,1.85,;-2.06,.52,;-3.6,.52,;-4.37,-.82,;-5.91,-.82,;-6.68,.52,;-5.91,1.85,;-4.37,1.85,;-8.22,.52,;-8.99,1.85,;-10.53,1.85,;-11.3,.52,;-10.53,-.82,;-11.01,-2.28,;-9.76,-3.19,;-8.51,-2.28,;-8.99,-.82,;1.02,3.19,;2.56,3.19,;7.47,-2.28,;8.72,-3.19,)| InChI=1S/C25H35N5O3/c1-18-16-21(33-28-18)17-24(31)27-20-4-2-19(3-5-20)7-10-29-11-13-30(14-12-29)25-22-8-15-32-23(22)6-9-26-25/h6,9,16,19-20H,2-5,7-8,10-15,17H2,1H3,(H,27,31) ZPEAQOHSKIPYKV-UHFFFAOYSA-N 106495 US8586579, 84 D(3) dopamine receptor Homo sapiens 4.01 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106495&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768830 174008806 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225107 Cc1cc(on1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,(11.09,-1.02,;9.76,-.25,;8.29,-.73,;7.39,.52,;8.29,1.76,;9.76,1.29,;5.85,.52,;5.08,-.82,;5.08,1.85,;3.54,1.85,;2.77,.52,;1.23,.52,;.46,1.85,;-1.08,1.85,;-1.85,.52,;-3.39,.52,;-4.16,-.82,;-5.7,-.82,;-6.47,.52,;-5.7,1.85,;-4.16,1.85,;-8.01,.52,;-8.78,1.85,;-10.32,1.85,;-11.09,.52,;-10.32,-.82,;-10.8,-2.28,;-9.55,-3.19,;-8.31,-2.28,;-8.78,-.82,;1.23,3.19,;2.77,3.19,)| InChI=1S/C24H33N5O3/c1-17-16-22(32-27-17)24(30)26-19-4-2-18(3-5-19)7-10-28-11-13-29(14-12-28)23-20-8-15-31-21(20)6-9-25-23/h6,9,16,18-19H,2-5,7-8,10-15H2,1H3,(H,26,30) FUAJGUYRNZZDBH-UHFFFAOYSA-N 106496 US8586579, 112 D(3) dopamine receptor Homo sapiens 31.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106496&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768831 174008807 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225108 CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.9,wD:13.13,(9.24,-3.33,;10.01,-2,;11.55,-2,;9.24,-.67,;10.01,.67,;7.7,-.67,;6.93,.67,;5.39,.67,;4.62,-.67,;4.62,2,;3.08,2,;2.31,.67,;.77,.67,;,2,;-1.54,2,;-2.31,.67,;-3.85,.67,;-4.62,-.67,;-6.16,-.67,;-6.93,.67,;-6.16,2,;-4.62,2,;-8.47,.67,;-9.24,2,;-10.78,2,;-11.55,.67,;-10.78,-.67,;-11.26,-2.13,;-10.01,-3.04,;-8.76,-2.13,;-9.24,-.67,;.77,3.33,;2.31,3.33,)| InChI=1S/C25H39N5O3/c1-28(2)24(32)8-7-23(31)27-20-5-3-19(4-6-20)10-13-29-14-16-30(17-15-29)25-21-11-18-33-22(21)9-12-26-25/h9,12,19-20H,3-8,10-11,13-18H2,1-2H3,(H,27,31) GXVCWWLYAQAZCU-UHFFFAOYSA-N 106497 US8586579, 113 D(3) dopamine receptor Homo sapiens 37.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106497&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768832 174008808 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225109 CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;7.62,-1.59,;10.29,-.05,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C24H38N4O3/c1-24(2,30)17-22(29)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)23-20-9-16-31-21(20)7-10-25-23/h7,10,18-19,30H,3-6,8-9,11-17H2,1-2H3,(H,26,29) KLTVYCHNHMTZNG-UHFFFAOYSA-N 106498 US8586579, 114 D(3) dopamine receptor Homo sapiens 21.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106498&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125781 174008809 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225110 O[C@H](CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C(F)(F)F |r,wU:6.5,wD:9.9,1.0,(7.31,-2.15,;8.08,-.82,;7.31,.52,;5.77,.52,;5,-.82,;5,1.85,;3.46,1.85,;2.69,.52,;1.15,.52,;.39,1.85,;-1.15,1.85,;-1.92,.52,;-3.46,.52,;-4.23,-.82,;-5.77,-.82,;-6.54,.52,;-5.77,1.85,;-4.23,1.85,;-8.08,.52,;-8.85,1.85,;-10.39,1.85,;-11.16,.52,;-10.39,-.82,;-10.87,-2.28,;-9.62,-3.19,;-8.38,-2.28,;-8.85,-.82,;1.15,3.19,;2.69,3.19,;9.62,-.82,;9.62,.72,;11.16,-.82,;9.62,-2.36,)| InChI=1S/C23H33F3N4O3/c24-23(25,26)20(31)15-21(32)28-17-3-1-16(2-4-17)6-9-29-10-12-30(13-11-29)22-18-7-14-33-19(18)5-8-27-22/h5,8,16-17,20,31H,1-4,6-7,9-15H2,(H,28,32) CTMBSXSNFDPMFG-UHFFFAOYSA-N 106499 US8586579, 115 D(3) dopamine receptor Homo sapiens 19.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106499&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125851 174008810 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225111 CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,2.2,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-2-20(29)17-23(30)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20,29H,2-6,8-9,11-17H2,1H3,(H,26,30) JBVSQYZVCXMFCI-UHFFFAOYSA-N 106500 US8586579, 116 D(3) dopamine receptor Homo sapiens 20 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106500&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125818 174008811 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225112 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(11.69,-2.62,;10.36,-3.39,;9.02,-2.62,;7.56,-3.1,;6.65,-1.85,;7.56,-.61,;6.79,.73,;5.25,.73,;4.48,-.61,;4.48,2.06,;2.94,2.06,;2.17,.73,;.63,.73,;-.14,2.06,;-1.68,2.06,;-2.45,.73,;-3.99,.73,;-4.76,-.61,;-6.3,-.61,;-7.07,.73,;-6.3,2.06,;-4.76,2.06,;-8.61,.73,;-9.38,2.06,;-10.92,2.06,;-11.69,.73,;-10.92,-.61,;-11.4,-2.07,;-10.15,-2.98,;-8.9,-2.07,;-9.38,-.61,;.63,3.39,;2.17,3.39,;9.02,-1.08,)| InChI=1S/C27H42N4O3/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,11,20-23H,2-7,9-10,12-19H2,1H3,(H,29,32) DQTBCNRIVXHDQE-UHFFFAOYSA-N 106501 US8586579, 117 D(3) dopamine receptor Homo sapiens 19.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106501&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 70653201 174008812 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225113 O[C@@H]1COC(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)C1 |r,wU:9.8,wD:12.12,1.0,(11.02,-3.39,;9.69,-2.62,;8.23,-3.1,;7.32,-1.85,;8.23,-.61,;7.46,.73,;5.92,.73,;5.15,-.61,;5.15,2.06,;3.61,2.06,;2.84,.73,;1.3,.73,;.53,2.06,;-1.01,2.06,;-1.78,.73,;-3.32,.73,;-4.09,-.61,;-5.63,-.61,;-6.4,.73,;-5.63,2.06,;-4.09,2.06,;-7.94,.73,;-8.71,2.06,;-10.25,2.06,;-11.02,.73,;-10.25,-.61,;-10.73,-2.07,;-9.48,-2.98,;-8.24,-2.07,;-8.71,-.61,;1.3,3.39,;2.84,3.39,;9.69,-1.08,)| InChI=1S/C25H38N4O4/c30-20-15-21(33-17-20)16-24(31)27-19-3-1-18(2-4-19)6-9-28-10-12-29(13-11-28)25-22-7-14-32-23(22)5-8-26-25/h5,8,18-21,30H,1-4,6-7,9-17H2,(H,27,31) XIVALFSMOKTRNY-UHFFFAOYSA-N 106502 US8586579, 118 D(3) dopamine receptor Homo sapiens 14.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106502&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125839 174008813 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225114 CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.39,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5,-.82,;-5.78,.52,;-5,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C23H36N4O2/c1-2-3-22(28)25-19-6-4-18(5-7-19)9-12-26-13-15-27(16-14-26)23-20-10-17-29-21(20)8-11-24-23/h8,11,18-19H,2-7,9-10,12-17H2,1H3,(H,25,28) ABKVEMFUXMVUSG-UHFFFAOYSA-N 106503 US8586579, 119 D(3) dopamine receptor Homo sapiens 15.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106503&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125780 174008814 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225115 CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.78,.52,;10.01,-.82,;10.78,-2.15,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C25H40N4O2/c1-19(2)3-8-24(30)27-21-6-4-20(5-7-21)10-13-28-14-16-29(17-15-28)25-22-11-18-31-23(22)9-12-26-25/h9,12,19-21H,3-8,10-11,13-18H2,1-2H3,(H,27,30) VMDGNXGFFZHOON-UHFFFAOYSA-N 106504 US8586579, 120 D(3) dopamine receptor Homo sapiens 22.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106504&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125802 174008815 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225116 CCCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O2/c1-2-3-4-23(29)26-20-7-5-19(6-8-20)10-13-27-14-16-28(17-15-27)24-21-11-18-30-22(21)9-12-25-24/h9,12,19-20H,2-8,10-11,13-18H2,1H3,(H,26,29) QVISYVCUOQJANU-UHFFFAOYSA-N 106505 US8586579, 121 D(3) dopamine receptor Homo sapiens 19.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106505&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 70652534 174008816 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225117 FC(F)(F)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.8,wD:12.12,(9.63,.72,;9.63,-.82,;11.17,-.82,;9.63,-2.36,;8.09,-.82,;7.32,.52,;5.78,.52,;5,-.82,;5,1.85,;3.46,1.85,;2.7,.52,;1.16,.52,;.38,1.85,;-1.16,1.85,;-1.92,.52,;-3.46,.52,;-4.24,-.82,;-5.78,-.82,;-6.55,.52,;-5.78,1.85,;-4.24,1.85,;-8.09,.52,;-8.86,1.85,;-10.4,1.85,;-11.17,.52,;-10.4,-.82,;-10.87,-2.28,;-9.63,-3.19,;-8.38,-2.28,;-8.86,-.82,;1.16,3.19,;2.7,3.19,)| InChI=1S/C23H33F3N4O2/c24-23(25,26)9-5-21(31)28-18-3-1-17(2-4-18)7-11-29-12-14-30(15-13-29)22-19-8-16-32-20(19)6-10-27-22/h6,10,17-18H,1-5,7-9,11-16H2,(H,28,31) QDQDDWWAKHSCSK-UHFFFAOYSA-N 106506 US8586579, 122 D(3) dopamine receptor Homo sapiens 20 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106506&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125799 174008817 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225118 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,3.19,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C22H32N4O2/c1-16-15-21-20(8-14-28-21)22(23-16)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h8,14-15,18-19H,3-7,9-13H2,1-2H3,(H,24,27) QGKIQQCQAJMJNK-UHFFFAOYSA-N 106507 US8586579, 96 D(3) dopamine receptor Homo sapiens 4.64 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106507&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125808 174008818 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225119 Cc1cc2occc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.19,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;-7.7,.52,;-8.47,1.85,;-6.16,.52,;-5.39,-.82,;-3.85,-.82,;-3.08,.52,;-1.54,.52,;-.77,1.85,;.77,1.85,;1.54,.52,;3.08,.52,;3.85,1.85,;3.08,3.19,;1.54,3.19,;5.39,1.85,;6.16,.52,;5.39,-.82,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,;-3.85,1.85,;-5.39,1.85,)| InChI=1S/C26H38N4O3/c1-19-18-24-23(9-17-33-24)25(27-19)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h9,17-18,20-22H,2-8,10-16H2,1H3,(H,28,31) GRSPAVQNQLAIED-UHFFFAOYSA-N 106508 US8586579, 124 D(3) dopamine receptor Homo sapiens 14.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106508&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125803 174008819 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225120 Cc1cc2occc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.33,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;-7.7,.67,;-8.47,2,;-6.16,.67,;-5.39,-.67,;-3.85,-.67,;-3.08,.67,;-1.54,.67,;-.77,2,;.77,2,;1.54,.67,;3.08,.67,;3.85,2,;3.08,3.33,;1.54,3.33,;5.39,2,;6.16,.67,;5.39,-.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;-3.85,2,;-5.39,2,)| InChI=1S/C27H40N4O3/c1-20-18-25-24(9-17-34-25)27(28-20)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-26(32)19-22-7-15-33-16-8-22/h9,17-18,21-23H,2-8,10-16,19H2,1H3,(H,29,32) KGHICJQDLKRYCB-UHFFFAOYSA-N 106509 US8586579, 98 D(3) dopamine receptor Homo sapiens 9.45 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106509&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125771 174008820 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225121 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,3.19,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H36N4O3/c1-18-17-22-21(8-16-31-22)24(25-18)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-23(29)9-15-30-2/h8,16-17,19-20H,3-7,9-15H2,1-2H3,(H,26,29) PVAIEWDYRNQJFR-UHFFFAOYSA-N 106510 US8586579, 99 D(3) dopamine receptor Homo sapiens 4.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106510&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125797 174008821 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225122 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3OCCc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,3.19,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C22H34N4O2/c1-16-15-21-20(8-14-28-21)22(23-16)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h15,18-19H,3-14H2,1-2H3,(H,24,27) VLMVFBMJXRVZOG-UHFFFAOYSA-N 106511 US8586579, 100 D(3) dopamine receptor Homo sapiens 7.58 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106511&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125856 174008822 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225123 Cc1cc2OCCc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.19,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;-7.7,.52,;-8.47,1.85,;-6.16,.52,;-5.39,-.82,;-3.85,-.82,;-3.08,.52,;-1.54,.52,;-.77,1.85,;.77,1.85,;1.54,.52,;3.08,.52,;3.85,1.85,;3.08,3.19,;1.54,3.19,;5.39,1.85,;6.16,.52,;5.39,-.82,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,;-3.85,1.85,;-5.39,1.85,)| InChI=1S/C26H40N4O3/c1-19-18-24-23(9-17-33-24)25(27-19)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h18,20-22H,2-17H2,1H3,(H,28,31) ITNGDGJSTGEEEQ-UHFFFAOYSA-N 106512 US8586579, 128 D(3) dopamine receptor Homo sapiens 34.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106512&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125785 174008823 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225124 Cc1cc2OCCc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.33,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;-7.7,.67,;-8.47,2,;-6.16,.67,;-5.39,-.67,;-3.85,-.67,;-3.08,.67,;-1.54,.67,;-.77,2,;.77,2,;1.54,.67,;3.08,.67,;3.85,2,;3.08,3.33,;1.54,3.33,;5.39,2,;6.16,.67,;5.39,-.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;-3.85,2,;-5.39,2,)| InChI=1S/C27H42N4O3/c1-20-18-25-24(9-17-34-25)27(28-20)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-26(32)19-22-7-15-33-16-8-22/h18,21-23H,2-17,19H2,1H3,(H,29,32) QGUAUKGVRXXHQV-UHFFFAOYSA-N 106513 US8586579, 129 D(3) dopamine receptor Homo sapiens 18.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106513&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768833 174008824 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225125 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,3.19,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-18-17-22-21(8-16-31-22)24(25-18)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-23(29)9-15-30-2/h17,19-20H,3-16H2,1-2H3,(H,26,29) RCSLPJAWSBFTLD-UHFFFAOYSA-N 106514 US8586579, 103 D(3) dopamine receptor Homo sapiens 11.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106514&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125782 174008825 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225126 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3occc23)CC1 |r,wU:4.3,wD:7.7,(10.01,.52,;8.47,.52,;7.7,-.82,;7.7,1.85,;6.16,1.85,;5.39,.52,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,-.82,;-3.08,-.82,;-3.85,.52,;-3.08,1.85,;-1.54,1.85,;-5.39,.52,;-6.16,1.85,;-7.7,1.85,;-8.47,.52,;-10.01,.52,;-7.7,-.82,;-8.18,-2.28,;-6.93,-3.19,;-5.68,-2.28,;-6.16,-.82,;3.85,3.19,;5.39,3.19,)| InChI=1S/C22H32N4O2/c1-16-15-23-22(20-8-14-28-21(16)20)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h8,14-15,18-19H,3-7,9-13H2,1-2H3,(H,24,27) ALJNGMYHXPZTTG-UHFFFAOYSA-N 106515 US8586579, 131 D(3) dopamine receptor Homo sapiens 21.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106515&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771296 174008826 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225127 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)C3CCOCC3)CC2)c2ccoc12 |r,wU:14.17,wD:11.10,(-11.55,.52,;-10.01,.52,;-9.24,1.85,;-7.7,1.85,;-6.93,.52,;-5.39,.52,;-4.62,-.82,;-3.08,-.82,;-2.31,.52,;-.77,.52,;,1.85,;1.54,1.85,;2.31,.52,;3.85,.52,;4.62,1.85,;3.85,3.19,;2.31,3.19,;6.16,1.85,;6.93,.52,;6.16,-.82,;8.47,.52,;9.24,-.82,;10.78,-.82,;11.55,.52,;10.78,1.85,;9.24,1.85,;-3.08,1.85,;-4.62,1.85,;-7.7,-.82,;-7.22,-2.28,;-8.47,-3.19,;-9.72,-2.28,;-9.24,-.82,)| InChI=1S/C26H38N4O3/c1-19-18-27-25(23-9-17-33-24(19)23)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h9,17-18,20-22H,2-8,10-16H2,1H3,(H,28,31) XZKJWFNUAUOHAC-UHFFFAOYSA-N 106516 US8586579, 105 D(3) dopamine receptor Homo sapiens 72.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106516&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771508 174008827 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225128 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)CC3CCOCC3)CC2)c2ccoc12 |r,wU:14.17,wD:11.10,(-11.55,.67,;-10.01,.67,;-9.24,2,;-7.7,2,;-6.93,.67,;-5.39,.67,;-4.62,-.67,;-3.08,-.67,;-2.31,.67,;-.77,.67,;,2,;1.54,2,;2.31,.67,;3.85,.67,;4.62,2,;3.85,3.33,;2.31,3.33,;6.16,2,;6.93,.67,;6.16,-.67,;8.47,.67,;9.24,-.67,;8.47,-2,;9.24,-3.33,;10.78,-3.33,;11.55,-2,;10.78,-.67,;-3.08,2,;-4.62,2,;-7.7,-.67,;-7.22,-2.13,;-8.47,-3.04,;-9.72,-2.13,;-9.24,-.67,)| InChI=1S/C27H40N4O3/c1-20-19-28-27(24-9-17-34-26(20)24)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-25(32)18-22-7-15-33-16-8-22/h9,17,19,21-23H,2-8,10-16,18H2,1H3,(H,29,32) JTMYPGNBDACXLP-UHFFFAOYSA-N 106517 US8586579, 106 D(3) dopamine receptor Homo sapiens 38 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106517&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771509 174008828 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225129 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3occc23)CC1 |r,wU:7.6,wD:10.10,(11.6,-2.32,;10.73,-.82,;9.19,-.82,;8.42,.52,;6.88,.52,;6.11,-.82,;6.11,1.85,;4.57,1.85,;3.8,.52,;2.26,.52,;1.49,1.85,;-.05,1.85,;-.82,.52,;-2.36,.52,;-3.13,-.82,;-4.67,-.82,;-5.44,.52,;-4.67,1.85,;-3.13,1.85,;-6.98,.52,;-7.75,1.85,;-9.29,1.85,;-10.06,.52,;-11.6,.52,;-9.29,-.82,;-9.77,-2.28,;-8.52,-3.19,;-7.27,-2.28,;-7.75,-.82,;2.26,3.19,;3.8,3.19,)| InChI=1S/C24H36N4O3/c1-18-17-25-24(21-8-16-31-23(18)21)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-22(29)9-15-30-2/h8,16-17,19-20H,3-7,9-15H2,1-2H3,(H,26,29) XPRRZXPFKHAHFH-UHFFFAOYSA-N 106518 US8586579, 107 D(3) dopamine receptor Homo sapiens 30 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106518&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771510 174008829 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225130 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3OCCc23)CC1 |r,wU:4.3,wD:7.7,(10.01,.52,;8.47,.52,;7.7,-.82,;7.7,1.85,;6.16,1.85,;5.39,.52,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,-.82,;-3.08,-.82,;-3.85,.52,;-3.08,1.85,;-1.54,1.85,;-5.39,.52,;-6.16,1.85,;-7.7,1.85,;-8.47,.52,;-10.01,.52,;-7.7,-.82,;-8.18,-2.28,;-6.93,-3.19,;-5.68,-2.28,;-6.16,-.82,;3.85,3.19,;5.39,3.19,)| InChI=1S/C22H34N4O2/c1-16-15-23-22(20-8-14-28-21(16)20)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h15,18-19H,3-14H2,1-2H3,(H,24,27) ACEAZRLEPRIAMD-UHFFFAOYSA-N 106519 US8586579, 135 D(3) dopamine receptor Homo sapiens 48.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106519&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125815 174008830 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225131 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)C3CCOCC3)CC2)c2CCOc12 |r,wU:14.17,wD:11.10,(-11.55,.52,;-10.01,.52,;-9.24,1.85,;-7.7,1.85,;-6.93,.52,;-5.39,.52,;-4.62,-.82,;-3.08,-.82,;-2.31,.52,;-.77,.52,;,1.85,;1.54,1.85,;2.31,.52,;3.85,.52,;4.62,1.85,;3.85,3.19,;2.31,3.19,;6.16,1.85,;6.93,.52,;6.16,-.82,;8.47,.52,;9.24,-.82,;10.78,-.82,;11.55,.52,;10.78,1.85,;9.24,1.85,;-3.08,1.85,;-4.62,1.85,;-7.7,-.82,;-7.22,-2.28,;-8.47,-3.19,;-9.72,-2.28,;-9.24,-.82,)| InChI=1S/C26H40N4O3/c1-19-18-27-25(23-9-17-33-24(19)23)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h18,20-22H,2-17H2,1H3,(H,28,31) KMPUTTSRRTYIRY-UHFFFAOYSA-N 106520 US8586579, 136 D(3) dopamine receptor Homo sapiens 98.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106520&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125809 174008831 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225132 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)CC3CCOCC3)CC2)c2CCOc12 |r,wU:14.17,wD:11.10,(-11.55,.67,;-10.01,.67,;-9.24,2,;-7.7,2,;-6.93,.67,;-5.39,.67,;-4.62,-.67,;-3.08,-.67,;-2.31,.67,;-.77,.67,;,2,;1.54,2,;2.31,.67,;3.85,.67,;4.62,2,;3.85,3.33,;2.31,3.33,;6.16,2,;6.93,.67,;6.16,-.67,;8.47,.67,;9.24,-.67,;8.47,-2,;9.24,-3.33,;10.78,-3.33,;11.55,-2,;10.78,-.67,;-3.08,2,;-4.62,2,;-7.7,-.67,;-7.22,-2.13,;-8.47,-3.04,;-9.72,-2.13,;-9.24,-.67,)| InChI=1S/C27H42N4O3/c1-20-19-28-27(24-9-17-34-26(20)24)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-25(32)18-22-7-15-33-16-8-22/h19,21-23H,2-18H2,1H3,(H,29,32) ADDORVGWJJXKFK-UHFFFAOYSA-N 106521 US8586579, 137 D(3) dopamine receptor Homo sapiens 69.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106521&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125884 174008832 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225133 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3OCCc23)CC1 |r,wU:7.6,wD:10.10,(11.6,-2.32,;10.73,-.82,;9.19,-.82,;8.42,.52,;6.88,.52,;6.11,-.82,;6.11,1.85,;4.57,1.85,;3.8,.52,;2.26,.52,;1.49,1.85,;-.05,1.85,;-.82,.52,;-2.36,.52,;-3.13,-.82,;-4.67,-.82,;-5.44,.52,;-4.67,1.85,;-3.13,1.85,;-6.98,.52,;-7.75,1.85,;-9.29,1.85,;-10.06,.52,;-11.6,.52,;-9.29,-.82,;-9.77,-2.28,;-8.52,-3.19,;-7.27,-2.28,;-7.75,-.82,;2.26,3.19,;3.8,3.19,)| InChI=1S/C24H38N4O3/c1-18-17-25-24(21-8-16-31-23(18)21)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-22(29)9-15-30-2/h17,19-20H,3-16H2,1-2H3,(H,26,29) OZUAEHNGHNUWOV-UHFFFAOYSA-N 106522 US8586579, 138 D(3) dopamine receptor Homo sapiens 46.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106522&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771511 174008833 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225134 OC(C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C(F)(F)F |r,wU:5.4,wD:8.8,(8.96,-.82,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,;8.96,1.85,;9.73,3.19,;7.62,2.62,;10.29,1.08,)| InChI=1S/C22H31F3N4O3/c23-22(24,25)19(30)21(31)27-16-3-1-15(2-4-16)6-9-28-10-12-29(13-11-28)20-17-7-14-32-18(17)5-8-26-20/h5,8,15-16,19,30H,1-4,6-7,9-14H2,(H,27,31) PMYFBYDQSGEVHT-UHFFFAOYSA-N 106523 US8586579, 112 D(3) dopamine receptor Homo sapiens 37.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106523&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771512 174008834 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225135 COC(CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)OC |r,wU:7.6,wD:10.10,(8.48,-3.33,;7.71,-2,;8.48,-.67,;7.71,.67,;6.17,.67,;5.4,-.67,;5.4,2,;3.86,2,;3.09,.67,;1.55,.67,;.78,2,;-.76,2,;-1.53,.67,;-3.07,.67,;-3.84,-.67,;-5.38,-.67,;-6.17,.67,;-5.38,2,;-3.84,2,;-7.71,.67,;-8.48,2,;-10.02,2,;-10.79,.67,;-10.02,-.67,;-10.49,-2.13,;-9.25,-3.04,;-8,-2.13,;-8.48,-.67,;1.55,3.33,;3.09,3.33,;10.02,-.67,;10.79,.67,)| InChI=1S/C24H38N4O4/c1-30-23(31-2)17-22(29)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-20-9-16-32-21(20)7-10-25-24/h7,10,18-19,23H,3-6,8-9,11-17H2,1-2H3,(H,26,29) AVYIORKUKBQLOA-UHFFFAOYSA-N 106524 US8586579, 140 D(3) dopamine receptor Homo sapiens 19.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106524&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125824 174008835 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225136 COC(CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)OC |r,wU:8.7,wD:11.11,(11.56,.67,;10.02,.67,;9.25,-.67,;7.71,-.67,;6.94,.67,;5.4,.67,;4.63,-.67,;4.63,2,;3.09,2,;2.32,.67,;.78,.67,;.01,2,;-1.53,2,;-2.3,.67,;-3.84,.67,;-4.61,-.67,;-6.15,-.67,;-6.94,.67,;-6.15,2,;-4.61,2,;-8.48,.67,;-9.25,2,;-10.79,2,;-11.56,.67,;-10.79,-.67,;-11.26,-2.13,;-10.02,-3.04,;-8.77,-2.13,;-9.25,-.67,;.78,3.33,;2.32,3.33,;10.02,-2,;9.25,-3.33,)| InChI=1S/C25H40N4O4/c1-31-24(32-2)8-7-23(30)27-20-5-3-19(4-6-20)10-13-28-14-16-29(17-15-28)25-21-11-18-33-22(21)9-12-26-25/h9,12,19-20,24H,3-8,10-11,13-18H2,1-2H3,(H,27,30) LIWZXUWAEHOPHY-UHFFFAOYSA-N 106525 US8586579, 141 D(3) dopamine receptor Homo sapiens 68 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106525&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125791 174008836 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225137 CS(=O)(=O)c1ccc(s1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:12.12,wD:15.16,(11.77,-1.79,;10.43,-1.02,;9.66,-2.36,;11.2,.31,;9.1,-.25,;9.1,1.29,;7.64,1.76,;6.73,.52,;7.64,-.73,;5.19,.52,;4.42,-.82,;4.42,1.85,;2.88,1.85,;2.11,.52,;.57,.52,;-.2,1.85,;-1.74,1.85,;-2.51,.52,;-4.05,.52,;-4.82,-.82,;-6.36,-.82,;-7.15,.52,;-6.36,1.85,;-4.82,1.85,;-8.69,.52,;-9.46,1.85,;-11,1.85,;-11.77,.52,;-11,-.82,;-11.47,-2.28,;-10.23,-3.19,;-8.98,-2.28,;-9.46,-.82,;.57,3.19,;2.11,3.19,)| InChI=1S/C25H34N4O4S2/c1-35(31,32)23-7-6-22(34-23)25(30)27-19-4-2-18(3-5-19)9-12-28-13-15-29(16-14-28)24-20-10-17-33-21(20)8-11-26-24/h6-8,11,18-19H,2-5,9-10,12-17H2,1H3,(H,27,30) HWZBTMUYGJHELF-UHFFFAOYSA-N 106526 US8586579, 115 D(3) dopamine receptor Homo sapiens 33.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106526&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125814 174008837 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225138 Cc1ccc(cn1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.46,.52,;10.11,.52,;9.34,1.85,;7.8,1.85,;7.03,.52,;7.8,-.82,;9.34,-.82,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.84,.52,;-6.06,1.85,;-4.52,1.85,;-8.38,.52,;-9.15,1.85,;-10.69,1.85,;-11.46,.52,;-10.69,-.82,;-11.17,-2.28,;-9.92,-3.19,;-8.68,-2.28,;-9.15,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C26H35N5O2/c1-19-2-5-21(18-28-19)26(32)29-22-6-3-20(4-7-22)9-12-30-13-15-31(16-14-30)25-23-10-17-33-24(23)8-11-27-25/h2,5,8,11,18,20,22H,3-4,6-7,9-10,12-17H2,1H3,(H,29,32) UNPARBQWWULNRE-UHFFFAOYSA-N 106527 US8586579, 143 D(3) dopamine receptor Homo sapiens 52.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106527&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54769063 174008838 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225139 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)C#N |r,wU:3.2,wD:6.6,(3.95,-.82,;4.72,.52,;3.95,1.85,;2.41,1.85,;1.64,.52,;.1,.52,;-.67,1.85,;-2.21,1.85,;-2.98,.52,;-4.52,.52,;-5.29,-.82,;-6.83,-.82,;-7.61,.52,;-6.83,1.85,;-5.29,1.85,;-9.15,.52,;-9.92,1.85,;-11.46,1.85,;-12.23,.52,;-11.46,-.82,;-11.94,-2.28,;-10.69,-3.19,;-9.45,-2.28,;-9.92,-.82,;.1,3.19,;1.64,3.19,;6.26,.52,;7.03,-.82,;8.57,-.82,;9.34,.52,;8.57,1.85,;7.03,1.85,;10.69,.52,;12.23,.52,)| InChI=1S/C27H33N5O2/c28-19-21-1-5-22(6-2-21)27(33)30-23-7-3-20(4-8-23)10-13-31-14-16-32(17-15-31)26-24-11-18-34-25(24)9-12-29-26/h1-2,5-6,9,12,20,23H,3-4,7-8,10-11,13-18H2,(H,30,33) MHYHDPMWTXPZLG-UHFFFAOYSA-N 106528 US8586579, 144 D(3) dopamine receptor Homo sapiens 28 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106528&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54768834 174008839 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225140 CN1CCN(CC1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:16.17,wD:19.21,(13.77,.52,;12.23,.52,;11.46,-.82,;9.92,-.82,;9.15,.52,;9.92,1.85,;11.46,1.85,;7.8,.52,;7.03,-.82,;5.49,-.82,;4.72,.52,;5.49,1.85,;7.03,1.85,;3.18,.52,;2.41,-.82,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,1.85,;-3.75,1.85,;-4.52,.52,;-6.06,.52,;-6.83,-.82,;-8.37,-.82,;-9.15,.52,;-8.37,1.85,;-6.83,1.85,;-10.69,.52,;-11.46,1.85,;-13,1.85,;-13.77,.52,;-13,-.82,;-13.48,-2.28,;-12.23,-3.19,;-10.99,-2.28,;-11.46,-.82,;-1.44,3.19,;.1,3.19,)| InChI=1S/C31H44N6O2/c1-34-15-19-36(20-16-34)27-8-4-25(5-9-27)31(38)33-26-6-2-24(3-7-26)11-14-35-17-21-37(22-18-35)30-28-12-23-39-29(28)10-13-32-30/h4-5,8-10,13,24,26H,2-3,6-7,11-12,14-23H2,1H3,(H,33,38) FNDLZQGZKLRGIU-UHFFFAOYSA-N 106529 US8586579, 118 D(3) dopamine receptor Homo sapiens 14.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106529&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771736 174008840 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225141 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(nc1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.18,-.82,;3.95,.52,;3.18,1.85,;1.64,1.85,;.87,.52,;-.67,.52,;-1.44,1.85,;-2.98,1.85,;-3.75,.52,;-5.29,.52,;-6.06,-.82,;-7.6,-.82,;-8.38,.52,;-7.6,1.85,;-6.06,1.85,;-9.92,.52,;-10.69,1.85,;-12.23,1.85,;-13,.52,;-12.23,-.82,;-12.71,-2.28,;-11.46,-3.19,;-10.22,-2.28,;-10.69,-.82,;-.67,3.19,;.87,3.19,;5.49,.52,;6.26,1.85,;7.8,1.85,;8.57,.52,;7.8,-.82,;6.26,-.82,;9.92,.52,;10.69,-.82,;12.23,-.82,;13,.52,;12.23,1.85,;10.69,1.85,)| InChI=1S/C29H40N6O3/c36-29(23-3-6-27(31-21-23)34-16-19-37-20-17-34)32-24-4-1-22(2-5-24)8-11-33-12-14-35(15-13-33)28-25-9-18-38-26(25)7-10-30-28/h3,6-7,10,21-22,24H,1-2,4-5,8-9,11-20H2,(H,32,36) SWYRWYLIJXJVNV-UHFFFAOYSA-N 106530 US8586579, 146 D(3) dopamine receptor Homo sapiens 44.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106530&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771737 174008841 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225142 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-c1cccnc1 |r,wU:3.2,wD:6.6,(3.18,-.82,;3.95,.52,;3.18,1.85,;1.64,1.85,;.87,.52,;-.67,.52,;-1.44,1.85,;-2.98,1.85,;-3.75,.52,;-5.29,.52,;-6.06,-.82,;-7.6,-.82,;-8.38,.52,;-7.6,1.85,;-6.06,1.85,;-9.92,.52,;-10.69,1.85,;-12.23,1.85,;-13,.52,;-12.23,-.82,;-12.71,-2.28,;-11.46,-3.19,;-10.22,-2.28,;-10.69,-.82,;-.67,3.19,;.87,3.19,;5.49,.52,;6.26,-.82,;7.8,-.82,;8.57,.52,;7.8,1.85,;6.26,1.85,;9.92,.52,;10.69,1.85,;12.23,1.85,;13,.52,;12.23,-.82,;10.69,-.82,)| InChI=1S/C31H37N5O2/c37-31(25-7-5-24(6-8-25)26-2-1-14-32-22-26)34-27-9-3-23(4-10-27)12-16-35-17-19-36(20-18-35)30-28-13-21-38-29(28)11-15-33-30/h1-2,5-8,11,14-15,22-23,27H,3-4,9-10,12-13,16-21H2,(H,34,37) SBHJIEDINHIMAF-UHFFFAOYSA-N 106531 US8586579, 120 D(3) dopamine receptor Homo sapiens 16.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106531&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125836 174008842 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225143 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc2OCOc2c1 |r,wU:3.2,wD:6.6,(4.56,-.82,;5.33,.52,;4.56,1.85,;3.02,1.85,;2.25,.52,;.71,.52,;-.06,1.85,;-1.6,1.85,;-2.37,.52,;-3.91,.52,;-4.68,-.82,;-6.22,-.82,;-7,.52,;-6.22,1.85,;-4.68,1.85,;-8.54,.52,;-9.31,1.85,;-10.85,1.85,;-11.62,.52,;-10.85,-.82,;-11.33,-2.28,;-10.08,-3.19,;-8.84,-2.28,;-9.31,-.82,;.71,3.19,;2.25,3.19,;6.87,.52,;7.64,-.82,;9.18,-.82,;9.95,.52,;11.46,.84,;11.62,2.37,;10.22,3,;9.18,1.85,;7.64,1.85,)| InChI=1S/C27H34N4O4/c32-27(20-3-6-24-25(17-20)35-18-34-24)29-21-4-1-19(2-5-21)8-11-30-12-14-31(15-13-30)26-22-9-16-33-23(22)7-10-28-26/h3,6-7,10,17,19,21H,1-2,4-5,8-9,11-16,18H2,(H,29,32) CEMWPWPBXGCHCV-UHFFFAOYSA-N 106532 US8586579, 148 D(3) dopamine receptor Homo sapiens 21.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106532&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771738 174008843 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225144 O=C(Cc1ccc2OCOc2c1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.14,wD:16.18,(4.56,3.85,;5.33,2.52,;6.88,2.52,;7.65,1.18,;6.88,-.15,;7.65,-1.48,;9.19,-1.48,;10.22,-2.63,;11.62,-2,;11.46,-.47,;9.96,-.15,;9.19,1.18,;4.56,1.18,;3.02,1.18,;2.25,-.15,;.71,-.15,;-.06,1.18,;-1.6,1.18,;-2.37,-.15,;-3.91,-.15,;-4.68,-1.48,;-6.22,-1.48,;-7,-.15,;-6.22,1.18,;-4.68,1.18,;-8.54,-.15,;-9.31,1.18,;-10.85,1.18,;-11.62,-.15,;-10.85,-1.48,;-11.33,-2.95,;-10.08,-3.85,;-8.84,-2.95,;-9.31,-1.48,;.71,2.52,;2.25,2.52,)| InChI=1S/C28H36N4O4/c33-27(18-21-3-6-25-26(17-21)36-19-35-25)30-22-4-1-20(2-5-22)8-11-31-12-14-32(15-13-31)28-23-9-16-34-24(23)7-10-29-28/h3,6-7,10,17,20,22H,1-2,4-5,8-9,11-16,18-19H2,(H,30,33) ONAUJHKYHSJWDK-UHFFFAOYSA-N 106533 US8586579, 149 D(3) dopamine receptor Homo sapiens 18.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106533&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771739 174008844 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225145 OC1(CCC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(8.48,-1.02,;8.48,.52,;10.02,.52,;10.02,2.06,;8.48,2.06,;6.94,.52,;6.17,-.82,;6.17,1.85,;4.63,1.85,;3.86,.52,;2.32,.52,;1.55,1.85,;.01,1.85,;-.76,.52,;-2.3,.52,;-3.07,-.82,;-4.61,-.82,;-5.4,.52,;-4.61,1.85,;-3.07,1.85,;-6.94,.52,;-7.71,1.85,;-9.25,1.85,;-10.02,.52,;-9.25,-.82,;-9.72,-2.28,;-8.48,-3.19,;-7.23,-2.28,;-7.71,-.82,;2.32,3.19,;3.86,3.19,)| InChI=1S/C24H36N4O3/c29-23(24(30)9-1-10-24)26-19-4-2-18(3-5-19)7-12-27-13-15-28(16-14-27)22-20-8-17-31-21(20)6-11-25-22/h6,11,18-19,30H,1-5,7-10,12-17H2,(H,26,29) WPDISOIHGGRFRZ-UHFFFAOYSA-N 106534 US8586579, 123 D(3) dopamine receptor Homo sapiens 131.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106534&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771740 174008845 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225146 CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.02,.52,;8.48,.52,;8.48,-1.02,;8.48,2.06,;6.94,.52,;6.17,-.82,;6.17,1.85,;4.63,1.85,;3.86,.52,;2.32,.52,;1.55,1.85,;.01,1.85,;-.76,.52,;-2.3,.52,;-3.07,-.82,;-4.61,-.82,;-5.4,.52,;-4.61,1.85,;-3.07,1.85,;-6.94,.52,;-7.71,1.85,;-9.25,1.85,;-10.02,.52,;-9.25,-.82,;-9.72,-2.28,;-8.48,-3.19,;-7.23,-2.28,;-7.71,-.82,;2.32,3.19,;3.86,3.19,)| InChI=1S/C23H36N4O3/c1-23(2,29)22(28)25-18-5-3-17(4-6-18)8-11-26-12-14-27(15-13-26)21-19-9-16-30-20(19)7-10-24-21/h7,10,17-18,29H,3-6,8-9,11-16H2,1-2H3,(H,25,28) ZATCCWHVTMAUCE-UHFFFAOYSA-N 106535 US8586579, 124 D(3) dopamine receptor Homo sapiens 194.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106535&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125837 174008846 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225147 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCS(=O)(=O)CC1 |r,wU:3.2,wD:6.6,(2.67,-.82,;3.44,.52,;2.67,1.85,;1.13,1.85,;.36,.52,;-1.18,.52,;-1.95,1.85,;-3.49,1.85,;-4.26,.52,;-5.8,.52,;-6.57,-.82,;-8.11,-.82,;-8.89,.52,;-8.11,1.85,;-6.57,1.85,;-10.43,.52,;-11.2,1.85,;-12.74,1.85,;-13.51,.52,;-12.74,-.82,;-13.22,-2.28,;-11.97,-3.19,;-10.73,-2.28,;-11.2,-.82,;-1.18,3.19,;.36,3.19,;4.67,.52,;5.44,-.82,;6.98,-.82,;7.75,.52,;6.98,1.85,;5.44,1.85,;9.1,.52,;9.87,-.82,;11.41,-.82,;12.18,.52,;13.51,1.29,;13.51,-.25,;11.41,1.85,;9.87,1.85,)| InChI=1S/C30H41N5O4S/c36-30(24-3-7-26(8-4-24)34-18-21-40(37,38)22-19-34)32-25-5-1-23(2-6-25)10-13-33-14-16-35(17-15-33)29-27-11-20-39-28(27)9-12-31-29/h3-4,7-9,12,23,25H,1-2,5-6,10-11,13-22H2,(H,32,36) JUAVLXRBQKTSPW-UHFFFAOYSA-N 106536 US8586579, 152 D(3) dopamine receptor Homo sapiens 14.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106536&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125857 174008847 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225148 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-n1cccn1 |r,wU:3.2,wD:6.6,(3.54,-.82,;4.31,.52,;3.54,1.85,;2,1.85,;1.23,.52,;-.31,.52,;-1.08,1.85,;-2.62,1.85,;-3.39,.52,;-4.93,.52,;-5.7,-.82,;-7.24,-.82,;-8.03,.52,;-7.24,1.85,;-5.7,1.85,;-9.57,.52,;-10.34,1.85,;-11.88,1.85,;-12.65,.52,;-11.88,-.82,;-12.35,-2.28,;-11.11,-3.19,;-9.86,-2.28,;-10.34,-.82,;-.31,3.19,;1.23,3.19,;5.85,.52,;6.62,-.82,;8.16,-.82,;8.93,.52,;8.16,1.85,;6.62,1.85,;10.28,.52,;11.18,-.73,;12.65,-.25,;12.65,1.29,;11.18,1.76,)| InChI=1S/C29H36N6O2/c36-29(23-4-8-25(9-5-23)35-15-1-13-31-35)32-24-6-2-22(3-7-24)11-16-33-17-19-34(20-18-33)28-26-12-21-37-27(26)10-14-30-28/h1,4-5,8-10,13-15,22,24H,2-3,6-7,11-12,16-21H2,(H,32,36) BNGQWOSQOPVKCC-UHFFFAOYSA-N 106537 US8586579, 153 D(3) dopamine receptor Homo sapiens 44.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106537&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125848 174008848 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225149 Cc1nc(no1)-c1cccc(c1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:15.16,wD:18.20,(12.46,4.24,;11.13,3.47,;10.65,2,;9.11,2,;8.64,3.47,;9.88,4.37,;8.34,.67,;9.11,-.67,;8.34,-2,;6.8,-2,;6.03,-.67,;6.8,.67,;4.49,-.67,;3.72,-2,;3.72,.67,;2.18,.67,;1.41,-.67,;-.13,-.67,;-.9,.67,;-2.44,.67,;-3.21,-.67,;-4.75,-.67,;-5.52,-2,;-7.06,-2,;-7.84,-.67,;-7.06,.67,;-5.52,.67,;-9.38,-.67,;-10.15,.67,;-11.69,.67,;-12.46,-.67,;-11.69,-2,;-12.17,-3.47,;-10.92,-4.37,;-9.68,-3.47,;-10.15,-2,;-.13,2,;1.41,2,)| InChI=1S/C29H36N6O3/c1-20-31-27(33-38-20)22-3-2-4-23(19-22)29(36)32-24-7-5-21(6-8-24)10-13-34-14-16-35(17-15-34)28-25-11-18-37-26(25)9-12-30-28/h2-4,9,12,19,21,24H,5-8,10-11,13-18H2,1H3,(H,32,36) DZYJECJNISMMEC-UHFFFAOYSA-N 106538 US8586579, 154 D(3) dopamine receptor Homo sapiens 19.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106538&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771971 174008849 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225150 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc2ncccc2c1 |r,wU:3.2,wD:6.6,(4.23,-.82,;5,.52,;4.23,1.85,;2.7,1.85,;1.93,.52,;.39,.52,;-.39,1.85,;-1.93,1.85,;-2.7,.52,;-4.23,.52,;-5,-.82,;-6.54,-.82,;-7.31,.52,;-6.54,1.85,;-5,1.85,;-8.85,.52,;-9.62,1.85,;-11.16,1.85,;-11.93,.52,;-11.16,-.82,;-11.64,-2.28,;-10.39,-3.19,;-9.15,-2.28,;-9.62,-.82,;.39,3.19,;1.93,3.19,;6.54,.52,;7.31,1.85,;8.85,1.85,;9.62,.52,;11.16,.52,;11.93,-.82,;11.16,-2.15,;9.62,-2.15,;8.85,-.82,;7.31,-.82,)| InChI=1S/C29H35N5O2/c35-29(23-5-8-26-22(20-23)2-1-12-30-26)32-24-6-3-21(4-7-24)10-14-33-15-17-34(18-16-33)28-25-11-19-36-27(25)9-13-31-28/h1-2,5,8-9,12-13,20-21,24H,3-4,6-7,10-11,14-19H2,(H,32,35) ATHCQCSSVYPJIN-UHFFFAOYSA-N 106539 US8586579, 155 D(3) dopamine receptor Homo sapiens 20.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106539&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771972 174008850 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225151 O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.14,wD:16.18,(4.27,-.82,;5.04,.52,;6.58,.52,;7.35,-.82,;6.87,-2.28,;8.12,-3.19,;9.36,-2.28,;10.87,-2.6,;11.9,-1.46,;11.43,.01,;9.92,.33,;8.89,-.82,;4.27,1.85,;2.73,1.85,;1.96,.52,;.42,.52,;-.35,1.85,;-1.89,1.85,;-2.66,.52,;-4.2,.52,;-4.97,-.82,;-6.51,-.82,;-7.28,.52,;-6.51,1.85,;-4.97,1.85,;-8.82,.52,;-9.59,1.85,;-11.13,1.85,;-11.9,.52,;-11.13,-.82,;-11.61,-2.28,;-10.36,-3.19,;-9.12,-2.28,;-9.59,-.82,;.42,3.19,;1.96,3.19,)| InChI=1S/C28H35N5O3/c34-27(19-24-22-3-1-2-4-26(22)36-31-24)30-21-7-5-20(6-8-21)10-13-32-14-16-33(17-15-32)28-23-11-18-35-25(23)9-12-29-28/h1-4,9,12,20-21H,5-8,10-11,13-19H2,(H,30,34) MWMCOQFLGVOAHE-UHFFFAOYSA-N 106540 US8586579, 156 D(3) dopamine receptor Homo sapiens 14.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106540&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771973 174008851 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225152 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1cnc(cn1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,1.85,;7.7,1.85,;8.47,.52,;7.7,-.82,;6.16,-.82,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C28H39N7O3/c36-28(24-19-31-26(20-30-24)34-14-17-37-18-15-34)32-22-3-1-21(2-4-22)6-9-33-10-12-35(13-11-33)27-23-7-16-38-25(23)5-8-29-27/h5,8,19-22H,1-4,6-7,9-18H2,(H,32,36) MTJDLXLLSRKTMU-UHFFFAOYSA-N 106541 US8586579, 157 D(3) dopamine receptor Homo sapiens 119.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106541&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125784 174008852 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225153 CC(C)(C)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.13,wD:16.17,(10.78,2.06,;10.78,.52,;10.78,-1.02,;12.32,.52,;9.24,.52,;8.47,-.82,;6.93,-.82,;6.16,.52,;6.93,1.85,;8.47,1.85,;4.62,.52,;3.85,-.82,;3.85,1.85,;2.31,1.85,;1.54,.52,;,.52,;-.77,1.85,;-2.31,1.85,;-3.08,.52,;-4.62,.52,;-5.39,-.82,;-6.93,-.82,;-7.7,.52,;-6.93,1.85,;-5.39,1.85,;-9.24,.52,;-10.01,1.85,;-11.55,1.85,;-12.32,.52,;-11.55,-.82,;-12.03,-2.28,;-10.78,-3.19,;-9.53,-2.28,;-10.01,-.82,;,3.19,;1.54,3.19,)| InChI=1S/C30H42N4O2/c1-30(2,3)24-8-6-23(7-9-24)29(35)32-25-10-4-22(5-11-25)13-16-33-17-19-34(20-18-33)28-26-14-21-36-27(26)12-15-31-28/h6-9,12,15,22,25H,4-5,10-11,13-14,16-21H2,1-3H3,(H,32,35) ZZJDFRAENYUPMH-UHFFFAOYSA-N 106542 US8586579, 158 D(3) dopamine receptor Homo sapiens 146.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106542&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771974 174008853 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225154 Clc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)c(Cl)c1 |r,wU:8.7,wD:11.11,(11.55,.52,;10.01,.52,;9.24,1.85,;7.7,1.85,;6.93,.52,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,;7.7,-.82,;6.93,-2.15,;9.24,-.82,)| InChI=1S/C26H32Cl2N4O2/c27-19-3-6-21(23(28)17-19)26(33)30-20-4-1-18(2-5-20)8-11-31-12-14-32(15-13-31)25-22-9-16-34-24(22)7-10-29-25/h3,6-7,10,17-18,20H,1-2,4-5,8-9,11-16H2,(H,30,33) KVMPVICKYUXJEP-UHFFFAOYSA-N 106543 US8586579, 159 D(3) dopamine receptor Homo sapiens 26.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106543&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54771975 174008854 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225155 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-n1cccc1 |r,wU:3.2,wD:6.6,(3.44,-.82,;4.21,.52,;3.44,1.85,;1.9,1.85,;1.13,.52,;-.41,.52,;-1.18,1.85,;-2.72,1.85,;-3.49,.52,;-5.04,.52,;-5.81,-.82,;-7.35,-.82,;-8.12,.52,;-7.35,1.85,;-5.81,1.85,;-9.66,.52,;-10.43,1.85,;-11.97,1.85,;-12.74,.52,;-11.97,-.82,;-12.44,-2.28,;-11.2,-3.19,;-9.95,-2.28,;-10.43,-.82,;-.41,3.19,;1.13,3.19,;5.75,.52,;6.52,-.82,;8.06,-.82,;8.83,.52,;8.06,1.85,;6.52,1.85,;10.37,.52,;11.27,-.73,;12.74,-.25,;12.74,1.29,;11.27,1.76,)| InChI=1S/C30H37N5O2/c36-30(24-5-9-26(10-6-24)34-15-1-2-16-34)32-25-7-3-23(4-8-25)12-17-33-18-20-35(21-19-33)29-27-13-22-37-28(27)11-14-31-29/h1-2,5-6,9-11,14-16,23,25H,3-4,7-8,12-13,17-22H2,(H,32,36) HIUMOAWWYUAXFP-UHFFFAOYSA-N 106544 US8586579, 160 D(3) dopamine receptor Homo sapiens 24.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106544&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772198 174008855 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225156 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-c1ccccc1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C32H38N4O2/c37-32(27-10-8-26(9-11-27)25-4-2-1-3-5-25)34-28-12-6-24(7-13-28)15-18-35-19-21-36(22-20-35)31-29-16-23-38-30(29)14-17-33-31/h1-5,8-11,14,17,24,28H,6-7,12-13,15-16,18-23H2,(H,34,37) ZQZUTJSBLPRYPL-UHFFFAOYSA-N 106545 US8586579, 161 D(3) dopamine receptor Homo sapiens 18.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106545&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772199 174008856 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225157 CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,2.2,(8.86,3.19,;9.63,1.85,;8.86,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C23H36N4O3/c1-17(29-2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-30-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) XHSRFVQGNJCGAD-UHFFFAOYSA-N 106546 US8586579, 135 D(3) dopamine receptor Homo sapiens 109.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106546&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125792 174008857 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225158 CC(C)(C)Oc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:14.14,wD:17.18,(12.6,-.05,;11.27,-.82,;9.93,-1.59,;12.04,-2.15,;10.5,.52,;8.96,.52,;8.19,-.82,;6.65,-.82,;5.88,.52,;6.65,1.85,;8.19,1.85,;4.34,.52,;3.57,-.82,;3.57,1.85,;2.03,1.85,;1.26,.52,;-.28,.52,;-1.05,1.85,;-2.59,1.85,;-3.36,.52,;-4.9,.52,;-5.67,-.82,;-7.21,-.82,;-7.98,.52,;-7.21,1.85,;-5.67,1.85,;-9.52,.52,;-10.29,1.85,;-11.83,1.85,;-12.6,.52,;-11.83,-.82,;-12.31,-2.28,;-11.06,-3.19,;-9.82,-2.28,;-10.29,-.82,;-.28,3.19,;1.26,3.19,)| InChI=1S/C30H42N4O3/c1-30(2,3)37-25-10-6-23(7-11-25)29(35)32-24-8-4-22(5-9-24)13-16-33-17-19-34(20-18-33)28-26-14-21-36-27(26)12-15-31-28/h6-7,10-12,15,22,24H,4-5,8-9,13-14,16-21H2,1-3H3,(H,32,35) OAIALYFMHHTONS-UHFFFAOYSA-N 106547 US8586579, 163 D(3) dopamine receptor Homo sapiens 69.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106547&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125776 174008858 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225159 CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,2.2,wD:10.10,(8.86,3.19,;9.63,1.85,;8.86,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C23H36N4O3/c1-17(29-2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-30-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) XHSRFVQGNJCGAD-UHFFFAOYSA-N 106548 US8586579, 164 D(3) dopamine receptor Homo sapiens 252.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106548&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772200 174008859 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225160 O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccccc1 |r,wU:4.3,wD:7.7,(8.26,1.44,;6.93,.67,;5.6,-.1,;6.16,2,;4.62,2,;3.85,.67,;2.31,.67,;1.54,2,;,2,;-.77,.67,;-2.31,.67,;-3.08,-.67,;-4.62,-.67,;-5.39,.67,;-4.62,2,;-3.08,2,;-6.93,.67,;-7.7,2,;-9.24,2,;-10.01,.67,;-9.24,-.67,;-9.72,-2.13,;-8.47,-3.04,;-7.22,-2.13,;-7.7,-.67,;2.31,3.33,;3.85,3.33,;7.7,-.67,;6.93,-2,;7.7,-3.33,;9.24,-3.33,;10.01,-2,;9.24,-.67,)| InChI=1S/C25H34N4O3S/c30-33(31,22-4-2-1-3-5-22)27-21-8-6-20(7-9-21)11-14-28-15-17-29(18-16-28)25-23-12-19-32-24(23)10-13-26-25/h1-5,10,13,20-21,27H,6-9,11-12,14-19H2 LWUHTASBTHFHOH-UHFFFAOYSA-N 106549 US8586579, 165 D(3) dopamine receptor Homo sapiens 15.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106549&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772201 174008860 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225161 COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-18(30-2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20H,3-6,8-9,11-17H2,1-2H3,(H,26,29) ROGRQIGZHYODFP-UHFFFAOYSA-N 106550 US8586579, 166 D(3) dopamine receptor Homo sapiens 40.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106550&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125846 174008861 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225162 CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,2.2,wD:11.11,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-2-20(29)17-23(30)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20,29H,2-6,8-9,11-17H2,1H3,(H,26,30) JBVSQYZVCXMFCI-UHFFFAOYSA-N 106551 US8586579, 167 D(3) dopamine receptor Homo sapiens 44.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106551&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 54772202 174008862 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225163 OC1(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)CCC1 |r,wU:6.5,wD:9.9,(7.24,-1.59,;8.57,-.82,;7.8,.52,;6.26,.52,;5.49,-.82,;5.49,1.85,;3.95,1.85,;3.18,.52,;1.64,.52,;.87,1.85,;-.67,1.85,;-1.44,.52,;-2.98,.52,;-3.75,-.82,;-5.29,-.82,;-6.06,.52,;-5.29,1.85,;-3.75,1.85,;-7.6,.52,;-8.37,1.85,;-9.91,1.85,;-10.68,.52,;-9.91,-.82,;-10.38,-2.28,;-9.14,-3.19,;-7.89,-2.28,;-8.37,-.82,;1.64,3.19,;3.18,3.19,;9.91,-.05,;10.68,-1.38,;9.34,-2.15,)| InChI=1S/C25H38N4O3/c30-23(18-25(31)9-1-10-25)27-20-4-2-19(3-5-20)7-12-28-13-15-29(16-14-28)24-21-8-17-32-22(21)6-11-26-24/h6,11,19-20,31H,1-5,7-10,12-18H2,(H,27,30) AVJAAHWPEDARHN-UHFFFAOYSA-N 106552 US8586579, 168 D(3) dopamine receptor Homo sapiens 25.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106552&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 67125834 174008863 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 225164 CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,2.2,(8.86,3.19,;9.63,1.85,;8.86,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C23H36N4O3/c1-17(29-2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-30-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) XHSRFVQGNJCGAD-UHFFFAOYSA-N 106546 US8586579, 135 5-hydroxytryptamine receptor 2A Homo sapiens 7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106546&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125792 174008857 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225165 CC(C)(C)Oc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:14.14,wD:17.18,(12.6,-.05,;11.27,-.82,;9.93,-1.59,;12.04,-2.15,;10.5,.52,;8.96,.52,;8.19,-.82,;6.65,-.82,;5.88,.52,;6.65,1.85,;8.19,1.85,;4.34,.52,;3.57,-.82,;3.57,1.85,;2.03,1.85,;1.26,.52,;-.28,.52,;-1.05,1.85,;-2.59,1.85,;-3.36,.52,;-4.9,.52,;-5.67,-.82,;-7.21,-.82,;-7.98,.52,;-7.21,1.85,;-5.67,1.85,;-9.52,.52,;-10.29,1.85,;-11.83,1.85,;-12.6,.52,;-11.83,-.82,;-12.31,-2.28,;-11.06,-3.19,;-9.82,-2.28,;-10.29,-.82,;-.28,3.19,;1.26,3.19,)| InChI=1S/C30H42N4O3/c1-30(2,3)37-25-10-6-23(7-11-25)29(35)32-24-8-4-22(5-9-24)13-16-33-17-19-34(20-18-33)28-26-14-21-36-27(26)12-15-31-28/h6-7,10-12,15,22,24H,4-5,8-9,13-14,16-21H2,1-3H3,(H,32,35) OAIALYFMHHTONS-UHFFFAOYSA-N 106547 US8586579, 163 5-hydroxytryptamine receptor 2A Homo sapiens 41.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106547&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125776 174008858 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225166 CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,2.2,wD:10.10,(8.86,3.19,;9.63,1.85,;8.86,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C23H36N4O3/c1-17(29-2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-30-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) XHSRFVQGNJCGAD-UHFFFAOYSA-N 106548 US8586579, 164 5-hydroxytryptamine receptor 2A Homo sapiens 20.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106548&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54772200 174008859 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225167 O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccccc1 |r,wU:4.3,wD:7.7,(8.26,1.44,;6.93,.67,;5.6,-.1,;6.16,2,;4.62,2,;3.85,.67,;2.31,.67,;1.54,2,;,2,;-.77,.67,;-2.31,.67,;-3.08,-.67,;-4.62,-.67,;-5.39,.67,;-4.62,2,;-3.08,2,;-6.93,.67,;-7.7,2,;-9.24,2,;-10.01,.67,;-9.24,-.67,;-9.72,-2.13,;-8.47,-3.04,;-7.22,-2.13,;-7.7,-.67,;2.31,3.33,;3.85,3.33,;7.7,-.67,;6.93,-2,;7.7,-3.33,;9.24,-3.33,;10.01,-2,;9.24,-.67,)| InChI=1S/C25H34N4O3S/c30-33(31,22-4-2-1-3-5-22)27-21-8-6-20(7-9-21)11-14-28-15-17-29(18-16-28)25-23-12-19-32-24(23)10-13-26-25/h1-5,10,13,20-21,27H,6-9,11-12,14-19H2 LWUHTASBTHFHOH-UHFFFAOYSA-N 106549 US8586579, 165 5-hydroxytryptamine receptor 2A Homo sapiens 70.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106549&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54772201 174008860 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225168 COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-18(30-2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20H,3-6,8-9,11-17H2,1-2H3,(H,26,29) ROGRQIGZHYODFP-UHFFFAOYSA-N 106550 US8586579, 166 5-hydroxytryptamine receptor 2A Homo sapiens 30.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106550&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125846 174008861 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225169 CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,2.2,wD:11.11,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-2-20(29)17-23(30)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20,29H,2-6,8-9,11-17H2,1H3,(H,26,30) JBVSQYZVCXMFCI-UHFFFAOYSA-N 106551 US8586579, 167 5-hydroxytryptamine receptor 2A Homo sapiens 42 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106551&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54772202 174008862 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225170 OC1(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)CCC1 |r,wU:6.5,wD:9.9,(7.24,-1.59,;8.57,-.82,;7.8,.52,;6.26,.52,;5.49,-.82,;5.49,1.85,;3.95,1.85,;3.18,.52,;1.64,.52,;.87,1.85,;-.67,1.85,;-1.44,.52,;-2.98,.52,;-3.75,-.82,;-5.29,-.82,;-6.06,.52,;-5.29,1.85,;-3.75,1.85,;-7.6,.52,;-8.37,1.85,;-9.91,1.85,;-10.68,.52,;-9.91,-.82,;-10.38,-2.28,;-9.14,-3.19,;-7.89,-2.28,;-8.37,-.82,;1.64,3.19,;3.18,3.19,;9.91,-.05,;10.68,-1.38,;9.34,-2.15,)| InChI=1S/C25H38N4O3/c30-23(18-25(31)9-1-10-25)27-20-4-2-19(3-5-20)7-12-28-13-15-29(16-14-28)24-21-8-17-32-22(21)6-11-26-24/h6,11,19-20,31H,1-5,7-10,12-18H2,(H,27,30) AVJAAHWPEDARHN-UHFFFAOYSA-N 106552 US8586579, 168 5-hydroxytryptamine receptor 2A Homo sapiens 22.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106552&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125834 174008863 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225171 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H30N4O2/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,8-9,15,17-18H,2-5,7,10-14H2,1H3,(H,23,26) NWXLNEMDCWELOX-UHFFFAOYSA-N 106412 US8586579, 1 5-hydroxytryptamine receptor 2A Homo sapiens 9.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106412&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768825 174008723 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225172 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.97,-2.28,;10.63,-3.05,;9.3,-2.28,;8.05,-3.19,;6.81,-2.28,;7.28,-.82,;6.51,.52,;4.97,.52,;4.2,-.82,;4.2,1.85,;2.66,1.85,;1.89,.52,;.35,.52,;-.42,1.85,;-1.96,1.85,;-2.73,.52,;-4.27,.52,;-5.04,-.82,;-6.58,-.82,;-7.35,.52,;-6.58,1.85,;-5.04,1.85,;-8.89,.52,;-9.66,1.85,;-11.2,1.85,;-11.97,.52,;-11.2,-.82,;-11.67,-2.28,;-10.43,-3.19,;-9.18,-2.28,;-9.66,-.82,;.35,3.19,;1.89,3.19,;8.82,-.82,)| InChI=1S/C27H40N4O3/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) OEQABNLZLBEHPD-UHFFFAOYSA-N 106413 US8586579, 2 5-hydroxytryptamine receptor 2A Homo sapiens 6.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106413&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768827 174008724 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225173 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)CC1 |r,wU:9.8,4.4,wD:12.12,1.0,(10.78,-2.82,;10.01,-1.48,;10.78,-.15,;10.01,1.18,;8.47,1.18,;7.7,2.52,;6.16,2.52,;5.39,3.85,;5.39,1.18,;3.85,1.18,;3.08,-.15,;1.54,-.15,;.77,1.18,;-.77,1.18,;-1.54,-.15,;-3.08,-.15,;-3.85,-1.48,;-5.39,-1.48,;-6.16,-.15,;-5.39,1.18,;-3.85,1.18,;-7.7,-.15,;-8.47,1.18,;-10.01,1.18,;-10.78,-.15,;-10.01,-1.48,;-10.49,-2.95,;-9.24,-3.85,;-7.99,-2.95,;-8.47,-1.48,;1.54,2.52,;3.08,2.52,;7.7,-.15,;8.47,-1.48,)| InChI=1S/C27H40N4O3/c32-23-7-3-21(4-8-23)19-26(33)29-22-5-1-20(2-6-22)10-13-30-14-16-31(17-15-30)27-24-11-18-34-25(24)9-12-28-27/h9,11-12,18,20-23,32H,1-8,10,13-17,19H2,(H,29,33) JNSGCKSGQOFGBY-UHFFFAOYSA-N 106414 US8586579, 3 5-hydroxytryptamine receptor 2A Homo sapiens 8.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106414&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768826 174008725 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225174 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H32N4O2/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,9-10,16-18H,2-6,8,11-15H2,1H3,(H,24,27) CXLYWFQWNGCVEG-UHFFFAOYSA-N 106415 US8586579, 4 5-hydroxytryptamine receptor 2A Homo sapiens 6.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106415&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768828 174008726 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225175 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O3/c1-29-16-9-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-8-17-30-21(20)6-10-24-23/h6,8,10,17-19H,2-5,7,9,11-16H2,1H3,(H,25,28) JSEGPLRTWBZZOJ-UHFFFAOYSA-N 106416 US8586579, 5 5-hydroxytryptamine receptor 2A Homo sapiens 8.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106416&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769057 174008727 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225176 OCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.54,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5.01,-.82,;-5.78,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H32N4O3/c27-15-7-21(28)24-18-3-1-17(2-4-18)6-10-25-11-13-26(14-12-25)22-19-8-16-29-20(19)5-9-23-22/h5,8-9,16-18,27H,1-4,6-7,10-15H2,(H,24,28) UOQPMMUMTSDTOB-UHFFFAOYSA-N 106417 US8586579, 6 5-hydroxytryptamine receptor 2A Homo sapiens 10.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106417&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769058 174008728 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225177 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H30N4O3/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,7-8,14,16-17,26H,1-4,6,9-13,15H2,(H,23,27) PNHVOOVVCPJXPA-UHFFFAOYSA-N 106418 US8586579, 7 5-hydroxytryptamine receptor 2A Homo sapiens 5.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106418&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769059 174008729 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225178 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.39,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5,-.82,;-5.78,.52,;-5,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H32N4O3/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,8-9,15,17-18H,2-5,7,10-14,16H2,1H3,(H,24,27) WVCHGRAYLHEGAY-UHFFFAOYSA-N 106419 US8586579, 8 5-hydroxytryptamine receptor 2A Homo sapiens 4.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106419&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769060 174008730 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225179 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4occc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-2.82,;10.01,-2.82,;9.24,-1.48,;10.01,-.15,;9.24,1.18,;7.7,1.18,;6.93,2.52,;5.39,2.52,;4.62,3.85,;4.62,1.18,;3.08,1.18,;2.31,-.15,;.77,-.15,;,1.18,;-1.54,1.18,;-2.31,-.15,;-3.85,-.15,;-4.62,-1.48,;-6.16,-1.48,;-6.93,-.15,;-6.16,1.18,;-4.62,1.18,;-8.47,-.15,;-9.24,1.18,;-10.78,1.18,;-11.55,-.15,;-10.78,-1.48,;-11.26,-2.95,;-10.01,-3.85,;-8.76,-2.95,;-9.24,-1.48,;.77,2.52,;2.31,2.52,;6.93,-.15,;7.7,-1.48,)| InChI=1S/C28H42N4O3/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,12-13,19,21-24H,2-9,11,14-18,20H2,1H3,(H,30,33) IXDPGYMHLOZKPR-UHFFFAOYSA-N 106420 US8586579, 9 5-hydroxytryptamine receptor 2A Homo sapiens 5.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106420&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769061 174008731 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225180 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H38N4O3/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,9-10,18,20-22H,1-4,6-8,11-17,19H2,(H,28,31) LJEOXWDSLFLRNN-UHFFFAOYSA-N 106421 US8586579, 10 5-hydroxytryptamine receptor 2A Homo sapiens 6.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106421&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769062 174008732 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225181 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H36N4O3/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,9-10,18-21H,1-4,6-8,11-17H2,(H,27,30) SQLGEXQBAJPFNZ-UHFFFAOYSA-N 106422 US8586579, 11 5-hydroxytryptamine receptor 2A Homo sapiens 2.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106422&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769294 174008733 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225182 CCOCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O3/c1-2-29-17-22(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)23-20-9-16-30-21(20)7-10-24-23/h7,9-10,16,18-19H,2-6,8,11-15,17H2,1H3,(H,25,28) WRBKFBAHOMAFKJ-UHFFFAOYSA-N 106423 US8586579, 12 5-hydroxytryptamine receptor 2A Homo sapiens 7.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106423&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769295 174008734 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225183 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(6.26,-.82,;7.03,.52,;6.26,1.85,;4.72,1.85,;3.95,.52,;2.41,.52,;1.64,1.85,;.1,1.85,;-.67,.52,;-2.21,.52,;-2.98,-.82,;-4.52,-.82,;-5.29,.52,;-4.52,1.85,;-2.98,1.85,;-6.83,.52,;-7.6,1.85,;-9.14,1.85,;-9.91,.52,;-9.14,-.82,;-9.61,-2.28,;-8.37,-3.19,;-7.12,-2.28,;-7.6,-.82,;2.41,3.19,;3.95,3.19,;8.57,.52,;9.91,-.25,;9.91,1.29,)| InChI=1S/C23H32N4O2/c28-23(18-3-4-18)25-19-5-1-17(2-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,9-10,16-19H,1-6,8,11-15H2,(H,25,28) SVONVXKDHRPGFI-UHFFFAOYSA-N 106424 US8586579, 13 5-hydroxytryptamine receptor 2A Homo sapiens 4.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106424&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769296 174008735 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225184 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;6.47,-.25,;9.14,1.29,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H30N4O3S/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,8-9,15-17,22H,2-5,7,10-14H2,1H3 XGWUEDFPOSFGBM-UHFFFAOYSA-N 106425 US8586579, 14 5-hydroxytryptamine receptor 2A Homo sapiens 6.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106425&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769297 174008736 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225185 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H30N4OS/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,8-9,15,17-18H,2-5,7,10-14H2,1H3,(H,23,26) DKJHWZSZJVWAQC-UHFFFAOYSA-N 106426 US8586579, 15 5-hydroxytryptamine receptor 2A Homo sapiens 3.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106426&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769298 174008737 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225186 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.08,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H32N4O3S/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,9-10,16-18,23H,2-6,8,11-15H2,1H3 KNWOHCMLVYZTJW-UHFFFAOYSA-N 106427 US8586579, 16 5-hydroxytryptamine receptor 2A Homo sapiens 8.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106427&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770167 174008738 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225187 CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1 |r,wU:7.6,wD:10.10,(7.31,-2.15,;8.08,-.82,;9.63,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H33N5O3S/c1-24(2)30(27,28)23-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)21-19-9-16-29-20(19)7-10-22-21/h7,9-10,16-18,23H,3-6,8,11-15H2,1-2H3 UJBLYPURSDWDKF-UHFFFAOYSA-N 106428 US8586579, 17 5-hydroxytryptamine receptor 2A Homo sapiens 5.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106428&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770168 174008739 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225188 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.85,.52,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H32N4OS/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,9-10,16-18H,2-6,8,11-15H2,1H3,(H,24,27) TYZKGCIDJUPIPC-UHFFFAOYSA-N 106429 US8586579, 18 5-hydroxytryptamine receptor 2A Homo sapiens 2.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106429&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769299 174008740 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225189 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H34N4O2S/c1-29-16-8-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-9-17-30-21(20)6-10-24-23/h6,9-10,17-19H,2-5,7-8,11-16H2,1H3,(H,25,28) PXCHOWMQGZACON-UHFFFAOYSA-N 106430 US8586579, 19 5-hydroxytryptamine receptor 2A Homo sapiens 3.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106430&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769521 174008741 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225190 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-2.82,;10.01,-2.82,;9.24,-1.48,;10.01,-.15,;9.24,1.18,;7.7,1.18,;6.93,2.52,;5.39,2.52,;4.62,3.85,;4.62,1.18,;3.08,1.18,;2.31,-.15,;.77,-.15,;,1.18,;-1.54,1.18,;-2.31,-.15,;-3.85,-.15,;-4.62,-1.48,;-6.16,-1.48,;-6.93,-.15,;-6.16,1.18,;-4.62,1.18,;-8.47,-.15,;-9.24,1.18,;-10.78,1.18,;-11.55,-.15,;-10.78,-1.48,;-11.26,-2.95,;-10.01,-3.85,;-8.76,-2.95,;-9.24,-1.48,;.77,2.52,;2.31,2.52,;6.93,-.15,;7.7,-1.48,)| InChI=1S/C28H42N4O2S/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,12-13,19,21-24H,2-9,11,14-18,20H2,1H3,(H,30,33) GSZBDACNBVTFKJ-UHFFFAOYSA-N 106431 US8586579, 20 5-hydroxytryptamine receptor 2A Homo sapiens 2.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106431&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769522 174008742 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225191 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.69,-2.62,;10.36,-3.39,;9.02,-2.62,;7.56,-3.1,;6.65,-1.85,;7.56,-.61,;6.79,.73,;5.25,.73,;4.48,-.61,;4.48,2.06,;2.94,2.06,;2.17,.73,;.63,.73,;-.14,2.06,;-1.68,2.06,;-2.45,.73,;-3.99,.73,;-4.76,-.61,;-6.3,-.61,;-7.07,.73,;-6.3,2.06,;-4.76,2.06,;-8.61,.73,;-9.38,2.06,;-10.92,2.06,;-11.69,.73,;-10.92,-.61,;-11.4,-2.07,;-10.15,-2.98,;-8.91,-2.07,;-9.38,-.61,;.63,3.39,;2.17,3.39,;9.02,-1.08,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106432 US8586579, 21 5-hydroxytryptamine receptor 2A Homo sapiens 3.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106432&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769523 174008743 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225192 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.47,.52,;1.93,.52,;1.16,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.85,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.47,3.19,)| InChI=1S/C22H32N4O2S/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,8-9,15,17-18H,2-5,7,10-14,16H2,1H3,(H,24,27) CCIIACYBEVIIIN-UHFFFAOYSA-N 106433 US8586579, 22 5-hydroxytryptamine receptor 2A Homo sapiens 2.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106433&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769524 174008744 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225193 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H38N4O2S/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,9-10,18,20-22H,1-4,6-8,11-17,19H2,(H,28,31) OFWNLCWKTRJZBM-UHFFFAOYSA-N 106434 US8586579, 23 5-hydroxytryptamine receptor 2A Homo sapiens 3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106434&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769525 174008745 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225194 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H36N4O2S/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,9-10,18-21H,1-4,6-8,11-17H2,(H,27,30) ZERNPQRYLXBKKZ-UHFFFAOYSA-N 106435 US8586579, 24 5-hydroxytryptamine receptor 2A Homo sapiens 1.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106435&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769526 174008746 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225195 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.88,-2.45,;10.55,-3.22,;9.22,-2.45,;7.88,-3.22,;6.74,-2.19,;7.37,-.78,;6.6,.55,;5.06,.55,;4.29,-.78,;4.29,1.89,;2.75,1.89,;1.98,.55,;.44,.55,;-.33,1.89,;-1.87,1.89,;-2.64,.55,;-4.18,.55,;-4.95,-.78,;-6.49,-.78,;-7.26,.55,;-6.49,1.89,;-4.95,1.89,;-8.8,.55,;-9.57,1.89,;-11.11,1.89,;-11.88,.55,;-11.11,-.78,;-11.59,-2.25,;-10.34,-3.15,;-9.1,-2.25,;-9.57,-.78,;.44,3.22,;1.98,3.22,;8.9,-.94,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106436 US8586579, 25 5-hydroxytryptamine receptor 2A Homo sapiens 4.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106436&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769523 174008747 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225196 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(11.88,-2.45,;10.55,-3.22,;9.22,-2.45,;7.88,-3.22,;6.74,-2.19,;7.37,-.78,;6.6,.55,;5.06,.55,;4.29,-.78,;4.29,1.89,;2.75,1.89,;1.98,.55,;.44,.55,;-.33,1.89,;-1.87,1.89,;-2.64,.55,;-4.18,.55,;-4.95,-.78,;-6.49,-.78,;-7.26,.55,;-6.49,1.89,;-4.95,1.89,;-8.8,.55,;-9.57,1.89,;-11.11,1.89,;-11.88,.55,;-11.11,-.78,;-11.59,-2.25,;-10.34,-3.15,;-9.1,-2.25,;-9.57,-.78,;.44,3.22,;1.98,3.22,;8.9,-.94,)| InChI=1S/C27H40N4O2S/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,10-11,17,20-23H,2-7,9,12-16,18-19H2,1H3,(H,29,32) ZJADORDBVJWZKV-UHFFFAOYSA-N 106437 US8586579, 26 5-hydroxytryptamine receptor 2A Homo sapiens 4.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106437&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125949 174008748 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225197 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.86,.52,;7.32,.52,;6.55,-.82,;6.55,1.85,;5.01,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.39,.52,;-1.93,.52,;-2.7,-.82,;-4.24,-.82,;-5.01,.52,;-4.24,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.09,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H30N4O2S/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,7-8,14,16-17,26H,1-4,6,9-13,15H2,(H,23,27) OYIQKTRWSDEITE-UHFFFAOYSA-N 106438 US8586579, 27 5-hydroxytryptamine receptor 2A Homo sapiens 1.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106438&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768043 174008749 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225198 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4sccc34)CC2)CC1 |r,wU:9.8,4.4,wD:12.12,1.0,(10.78,-2.82,;10.01,-1.48,;10.78,-.15,;10.01,1.18,;8.47,1.18,;7.7,2.52,;6.16,2.52,;5.39,3.85,;5.39,1.18,;3.85,1.18,;3.08,-.15,;1.54,-.15,;.77,1.18,;-.77,1.18,;-1.54,-.15,;-3.08,-.15,;-3.85,-1.48,;-5.39,-1.48,;-6.16,-.15,;-5.39,1.18,;-3.85,1.18,;-7.7,-.15,;-8.47,1.18,;-10.01,1.18,;-10.78,-.15,;-10.01,-1.48,;-10.49,-2.95,;-9.24,-3.85,;-7.99,-2.95,;-8.47,-1.48,;1.54,2.52,;3.08,2.52,;7.7,-.15,;8.47,-1.48,)| InChI=1S/C27H40N4O2S/c32-23-7-3-21(4-8-23)19-26(33)29-22-5-1-20(2-6-22)10-13-30-14-16-31(17-15-30)27-24-11-18-34-25(24)9-12-28-27/h9,11-12,18,20-23,32H,1-8,10,13-17,19H2,(H,29,33) WKCSANGLEHNNKN-UHFFFAOYSA-N 106439 US8586579, 28 5-hydroxytryptamine receptor 2A Homo sapiens 4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106439&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768824 174008750 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225199 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3occc23)CC1)c1ccnc2ccccc12 |r,wU:3.2,wD:6.6,(5.39,-.67,;6.16,.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,;7.7,.67,;8.47,2,;10.01,2,;10.78,.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;8.47,-.67,)| InChI=1S/C29H33N5O2/c35-29(24-9-13-30-26-4-2-1-3-23(24)26)32-22-7-5-21(6-8-22)11-15-33-16-18-34(19-17-33)28-25-12-20-36-27(25)10-14-31-28/h1-4,9-10,12-14,20-22H,5-8,11,15-19H2,(H,32,35) IQGWEXBXERIPCR-UHFFFAOYSA-N 106440 US8586579, 29 5-hydroxytryptamine receptor 2A Homo sapiens 5.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106440&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769738 174008751 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225200 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;9.14,1.29,;6.47,-.25,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H30N4O2S2/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,8-9,15-17,22H,2-5,7,10-14H2,1H3 BUNARIUEVNWERA-UHFFFAOYSA-N 106441 US8586579, 30 5-hydroxytryptamine receptor 2A Homo sapiens 2.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106441&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769739 174008752 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225201 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3sccc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.09,-.82,;7.32,.52,;8.65,1.29,;5.98,-.25,;6.54,1.85,;5.01,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5.01,.52,;-4.23,1.85,;-2.69,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H32N4O2S2/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,9-10,16-18,23H,2-6,8,11-15H2,1H3 RRYHHCNEVZLSCS-UHFFFAOYSA-N 106442 US8586579, 31 5-hydroxytryptamine receptor 2A Homo sapiens 2.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106442&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769740 174008753 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225202 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H32N4O2/c1-16(26)23-18-4-2-17(3-5-18)7-10-24-11-13-25(14-12-24)21-19-8-15-27-20(19)6-9-22-21/h6,9,17-18H,2-5,7-8,10-15H2,1H3,(H,23,26) SQRMELSMCDEARL-UHFFFAOYSA-N 106443 US8586579, 32 5-hydroxytryptamine receptor 2A Homo sapiens 22.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106443&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769741 174008754 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225203 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCOCC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C25H38N4O3/c30-25(20-7-16-31-17-8-20)27-21-3-1-19(2-4-21)6-11-28-12-14-29(15-13-28)24-22-9-18-32-23(22)5-10-26-24/h5,10,19-21H,1-4,6-9,11-18H2,(H,27,30) NNECCFXSSVWBTA-UHFFFAOYSA-N 106444 US8586579, 33 5-hydroxytryptamine receptor 2A Homo sapiens 5.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106444&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769742 174008755 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225204 O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C26H40N4O3/c31-25(19-21-7-16-32-17-8-21)28-22-3-1-20(2-4-22)6-11-29-12-14-30(15-13-29)26-23-9-18-33-24(23)5-10-27-26/h5,10,20-22H,1-4,6-9,11-19H2,(H,28,31) WBVLCBQDISBZLH-UHFFFAOYSA-N 106445 US8586579, 61 5-hydroxytryptamine receptor 2A Homo sapiens 20.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106445&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769743 174008756 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225205 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H36N4O3/c1-29-16-9-22(28)25-19-4-2-18(3-5-19)7-11-26-12-14-27(15-13-26)23-20-8-17-30-21(20)6-10-24-23/h6,10,18-19H,2-5,7-9,11-17H2,1H3,(H,25,28) RSOWGGVCBJACCG-UHFFFAOYSA-N 106446 US8586579, 62 5-hydroxytryptamine receptor 2A Homo sapiens 24.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106446&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769948 174008757 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225206 CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(9.62,1.85,;8.86,.52,;7.32,.52,;6.55,-.82,;6.55,1.85,;5.01,1.85,;4.23,.52,;2.7,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.86,1.85,;-9.62,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.7,3.19,;4.23,3.19,)| InChI=1S/C22H34N4O2/c1-2-21(27)24-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)22-19-9-16-28-20(19)7-10-23-22/h7,10,17-18H,2-6,8-9,11-16H2,1H3,(H,24,27) HHRGFYRLYOYIFM-UHFFFAOYSA-N 106447 US8586579, 36 5-hydroxytryptamine receptor 2A Homo sapiens 13.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106447&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769949 174008758 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225207 O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106448 US8586579, 37 5-hydroxytryptamine receptor 2A Homo sapiens 9.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106448&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769951 174008759 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225208 COCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.92,.52,;1.16,1.85,;-.38,1.85,;-1.16,.52,;-2.7,.52,;-3.46,-.82,;-5.01,-.82,;-5.78,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.92,3.19,;3.46,3.19,)| InChI=1S/C22H34N4O3/c1-28-16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-29-20(19)6-9-23-22/h6,9,17-18H,2-5,7-8,10-16H2,1H3,(H,24,27) PZYRQKWSXFGUED-UHFFFAOYSA-N 106449 US8586579, 38 5-hydroxytryptamine receptor 2A Homo sapiens 11 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106449&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769950 174008760 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225209 CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;10.29,-.05,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C22H34N4O4S/c1-31(28,29)16-21(27)24-18-4-2-17(3-5-18)7-10-25-11-13-26(14-12-25)22-19-8-15-30-20(19)6-9-23-22/h6,9,17-18H,2-5,7-8,10-16H2,1H3,(H,24,27) ZDFGDUYZGMNXLU-UHFFFAOYSA-N 106450 US8586579, 39 5-hydroxytryptamine receptor 2A Homo sapiens 16.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106450&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769952 174008761 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225210 OCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(9.63,1.85,;8.85,.52,;7.32,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.24,.52,;2.69,.52,;1.93,1.85,;.39,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.24,3.19,)| InChI=1S/C21H32N4O3/c26-15-20(27)23-17-3-1-16(2-4-17)6-9-24-10-12-25(13-11-24)21-18-7-14-28-19(18)5-8-22-21/h5,8,16-17,26H,1-4,6-7,9-15H2,(H,23,27) HUEMJHLBWFDXTF-UHFFFAOYSA-N 106451 US8586579, 40 5-hydroxytryptamine receptor 2A Homo sapiens 12.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106451&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769953 174008762 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225211 OCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.85,-.82,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5.01,-.82,;-5.77,.52,;-5.01,1.85,;-3.46,1.85,;-7.32,.52,;-8.08,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.85,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C22H34N4O3/c27-15-7-21(28)24-18-3-1-17(2-4-18)6-10-25-11-13-26(14-12-25)22-19-8-16-29-20(19)5-9-23-22/h5,9,17-18,27H,1-4,6-8,10-16H2,(H,24,28) YMPBYYINMWNUQV-UHFFFAOYSA-N 106452 US8586579, 41 5-hydroxytryptamine receptor 2A Homo sapiens 35.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106452&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770164 174008763 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225212 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCOC1 |r,wU:3.2,wD:6.6,(5.75,-.82,;6.52,.52,;5.75,1.85,;4.21,1.85,;3.44,.52,;1.9,.52,;1.13,1.85,;-.41,1.85,;-1.18,.52,;-2.72,.52,;-3.49,-.82,;-5.03,-.82,;-5.8,.52,;-5.03,1.85,;-3.49,1.85,;-7.34,.52,;-8.12,1.85,;-9.65,1.85,;-10.43,.52,;-9.65,-.82,;-10.13,-2.28,;-8.89,-3.19,;-7.64,-2.28,;-8.12,-.82,;1.9,3.19,;3.44,3.19,;8.06,.52,;8.96,1.76,;10.43,1.29,;10.43,-.25,;8.96,-.73,)| InChI=1S/C24H36N4O3/c29-24(19-7-15-30-17-19)26-20-3-1-18(2-4-20)6-10-27-11-13-28(14-12-27)23-21-8-16-31-22(21)5-9-25-23/h5,9,18-20H,1-4,6-8,10-17H2,(H,26,29) YNWOVSGFFVVSBU-UHFFFAOYSA-N 106453 US8586579, 42 5-hydroxytryptamine receptor 2A Homo sapiens 9.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106453&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770165 174008764 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225213 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCCO1 |r,wU:3.2,wD:6.6,(5.75,-.82,;6.52,.52,;5.75,1.85,;4.21,1.85,;3.44,.52,;1.9,.52,;1.13,1.85,;-.41,1.85,;-1.18,.52,;-2.72,.52,;-3.49,-.82,;-5.03,-.82,;-5.8,.52,;-5.03,1.85,;-3.49,1.85,;-7.34,.52,;-8.11,1.85,;-9.65,1.85,;-10.42,.52,;-9.65,-.82,;-10.13,-2.28,;-8.88,-3.19,;-7.64,-2.28,;-8.11,-.82,;1.9,3.19,;3.44,3.19,;8.06,.52,;8.96,1.76,;10.42,1.29,;10.42,-.25,;8.96,-.73,)| InChI=1S/C24H36N4O3/c29-24(22-2-1-16-30-22)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)23-20-9-17-31-21(20)7-10-25-23/h7,10,18-19,22H,1-6,8-9,11-17H2,(H,26,29) HZQQJAKATKCPDP-UHFFFAOYSA-N 106454 US8586579, 43 5-hydroxytryptamine receptor 2A Homo sapiens 6.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106454&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770166 174008765 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225214 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccccc1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,)| InChI=1S/C26H34N4O2/c31-26(21-4-2-1-3-5-21)28-22-8-6-20(7-9-22)11-14-29-15-17-30(18-16-29)25-23-12-19-32-24(23)10-13-27-25/h1-5,10,13,20,22H,6-9,11-12,14-19H2,(H,28,31) HAABSCYMCZRVTB-UHFFFAOYSA-N 106455 US8586579, 44 5-hydroxytryptamine receptor 2A Homo sapiens 7.63 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106455&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770169 174008766 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225215 Fc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.55,.52,;10.01,.52,;9.24,-.82,;7.7,-.82,;6.93,.52,;7.7,1.85,;9.24,1.85,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,)| InChI=1S/C26H33FN4O2/c27-21-5-3-20(4-6-21)26(32)29-22-7-1-19(2-8-22)10-13-30-14-16-31(17-15-30)25-23-11-18-33-24(23)9-12-28-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,29,32) HQAMJNKOXUQUKS-UHFFFAOYSA-N 106456 US8586579, 45 5-hydroxytryptamine receptor 2A Homo sapiens 11.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106456&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770380 174008767 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225216 Clc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.55,.52,;10.01,.52,;9.24,-.82,;7.7,-.82,;6.93,.52,;7.7,1.85,;9.24,1.85,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,)| InChI=1S/C26H33ClN4O2/c27-21-5-3-20(4-6-21)26(32)29-22-7-1-19(2-8-22)10-13-30-14-16-31(17-15-30)25-23-11-18-33-24(23)9-12-28-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,29,32) HMAKCCQMRGCRHO-UHFFFAOYSA-N 106457 US8586579, 73 5-hydroxytryptamine receptor 2A Homo sapiens 14.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106457&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770381 174008768 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225217 FC(F)(F)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.13,wD:16.17,(12.32,.52,;10.78,.52,;10.78,2.06,;10.78,-1.02,;9.24,.52,;8.47,-.82,;6.93,-.82,;6.16,.52,;6.93,1.85,;8.47,1.85,;4.62,.52,;3.85,-.82,;3.85,1.85,;2.31,1.85,;1.54,.52,;,.52,;-.77,1.85,;-2.31,1.85,;-3.08,.52,;-4.62,.52,;-5.39,-.82,;-6.93,-.82,;-7.7,.52,;-6.93,1.85,;-5.39,1.85,;-9.24,.52,;-10.01,1.85,;-11.55,1.85,;-12.32,.52,;-11.55,-.82,;-12.03,-2.28,;-10.78,-3.19,;-9.53,-2.28,;-10.01,-.82,;,3.19,;1.54,3.19,)| InChI=1S/C27H33F3N4O2/c28-27(29,30)21-5-3-20(4-6-21)26(35)32-22-7-1-19(2-8-22)10-13-33-14-16-34(17-15-33)25-23-11-18-36-24(23)9-12-31-25/h3-6,9,12,19,22H,1-2,7-8,10-11,13-18H2,(H,32,35) JVTXPXRMOCVEDH-UHFFFAOYSA-N 106458 US8586579, 74 5-hydroxytryptamine receptor 2A Homo sapiens 18.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106458&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770382 174008769 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225218 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:5.4,wD:8.8,(8.57,-.82,;7.8,.52,;6.47,-.25,;9.14,1.29,;7.03,1.85,;5.49,1.85,;4.72,.52,;3.18,.52,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,-.82,;-3.75,-.82,;-4.52,.52,;-3.75,1.85,;-2.21,1.85,;-6.06,.52,;-6.83,1.85,;-8.37,1.85,;-9.14,.52,;-8.37,-.82,;-8.84,-2.28,;-7.6,-3.19,;-6.35,-2.28,;-6.83,-.82,;3.18,3.19,;4.72,3.19,)| InChI=1S/C20H32N4O3S/c1-28(25,26)22-17-4-2-16(3-5-17)7-10-23-11-13-24(14-12-23)20-18-8-15-27-19(18)6-9-21-20/h6,9,16-17,22H,2-5,7-8,10-15H2,1H3 ILSVAZDAOVUDJJ-UHFFFAOYSA-N 106459 US8586579, 75 5-hydroxytryptamine receptor 2A Homo sapiens 21.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106459&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770383 174008770 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225219 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.63,-.82,;8.08,-.82,;7.31,.52,;5.98,-.25,;8.65,1.29,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.7,-.82,;-4.23,-.82,;-5.01,.52,;-4.23,1.85,;-2.7,1.85,;-6.55,.52,;-7.32,1.85,;-8.86,1.85,;-9.63,.52,;-8.86,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.32,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H34N4O3S/c1-2-29(26,27)23-18-5-3-17(4-6-18)8-11-24-12-14-25(15-13-24)21-19-9-16-28-20(19)7-10-22-21/h7,10,17-18,23H,2-6,8-9,11-16H2,1H3 HFJVMFBCUWJLFO-UHFFFAOYSA-N 106460 US8586579, 76 5-hydroxytryptamine receptor 2A Homo sapiens 17.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106460 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106460&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770384 174008771 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225220 Fc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,wD:14.15,(10.01,-4,;9.24,-2.67,;7.7,-2.67,;6.93,-1.33,;7.7,,;9.24,,;10.01,-1.33,;6.93,1.33,;5.6,.56,;8.26,2.1,;6.16,2.67,;4.62,2.67,;3.85,1.33,;2.31,1.33,;1.54,2.67,;,2.67,;-.77,1.33,;-2.31,1.33,;-3.08,,;-4.62,,;-5.39,1.33,;-4.62,2.67,;-3.08,2.67,;-6.93,1.33,;-7.7,2.67,;-9.24,2.67,;-10.01,1.33,;-9.24,,;-9.72,-1.46,;-8.47,-2.37,;-7.22,-1.46,;-7.7,,;2.31,4,;3.85,4,)| InChI=1S/C25H33FN4O3S/c26-20-3-7-22(8-4-20)34(31,32)28-21-5-1-19(2-6-21)10-13-29-14-16-30(17-15-29)25-23-11-18-33-24(23)9-12-27-25/h3-4,7-9,12,19,21,28H,1-2,5-6,10-11,13-18H2 OXMLHENURKVGGZ-UHFFFAOYSA-N 106461 US8586579, 50 5-hydroxytryptamine receptor 2A Homo sapiens 39.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106461&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770385 174008772 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225221 O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.7,wD:10.11,(5.88,-.92,;6.65,.41,;8.19,.41,;8.96,1.75,;10.29,2.52,;8.96,3.29,;5.88,1.75,;4.34,1.75,;3.57,.41,;2.03,.41,;1.26,1.75,;-.28,1.75,;-1.05,.41,;-2.59,.41,;-3.36,-.92,;-4.9,-.92,;-5.67,.41,;-4.9,1.75,;-3.36,1.75,;-7.21,.41,;-7.98,1.75,;-9.52,1.75,;-10.29,.41,;-9.52,-.92,;-10,-2.38,;-8.75,-3.29,;-7.51,-2.38,;-7.98,-.92,;2.03,3.08,;3.57,3.08,)| InChI=1S/C24H36N4O2/c29-23(17-19-1-2-19)26-20-5-3-18(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,18-20H,1-6,8-9,11-17H2,(H,26,29) XPKWZBRQMHEAAX-UHFFFAOYSA-N 106462 US8586579, 51 5-hydroxytryptamine receptor 2A Homo sapiens 13.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106462&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125786 174008773 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225222 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCC1 |r,wU:3.2,wD:6.6,(5.83,-.82,;6.6,.52,;5.83,1.85,;4.29,1.85,;3.52,.52,;1.98,.52,;1.21,1.85,;-.33,1.85,;-1.1,.52,;-2.64,.52,;-3.41,-.82,;-4.95,-.82,;-5.72,.52,;-4.95,1.85,;-3.41,1.85,;-7.26,.52,;-8.03,1.85,;-9.57,1.85,;-10.34,.52,;-9.57,-.82,;-10.05,-2.28,;-8.8,-3.19,;-7.56,-2.28,;-8.03,-.82,;1.98,3.19,;3.52,3.19,;8.14,.52,;9.24,-.58,;10.34,.52,;9.24,1.62,)| InChI=1S/C24H36N4O2/c29-24(19-2-1-3-19)26-20-6-4-18(5-7-20)9-12-27-13-15-28(16-14-27)23-21-10-17-30-22(21)8-11-25-23/h8,11,18-20H,1-7,9-10,12-17H2,(H,26,29) IUHXMQOKDMHFCT-UHFFFAOYSA-N 106463 US8586579, 52 5-hydroxytryptamine receptor 2A Homo sapiens 10.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106463&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770598 174008774 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225223 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CCCOC1 |r,wU:3.2,wD:6.6,(5.39,-.82,;6.16,.52,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,;7.7,.52,;8.47,1.85,;10.01,1.85,;10.78,.52,;10.01,-.82,;8.47,-.82,)| InChI=1S/C25H38N4O3/c30-25(20-2-1-16-31-18-20)27-21-5-3-19(4-6-21)8-11-28-12-14-29(15-13-28)24-22-9-17-32-23(22)7-10-26-24/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) RBGONAOLWTWGIH-UHFFFAOYSA-N 106464 US8586579, 53 5-hydroxytryptamine receptor 2A Homo sapiens 6.37 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106464&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770599 174008775 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225224 C[C@]1(O)CC[C@@H](CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,1.1,wD:14.15,5.8,1.0,(11.45,1.29,;10.11,.52,;11.45,-.25,;9.34,-.82,;7.8,-.82,;7.03,.52,;7.8,1.85,;9.34,1.85,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.83,.52,;-6.06,1.85,;-4.52,1.85,;-8.37,.52,;-9.14,1.85,;-10.68,1.85,;-11.45,.52,;-10.68,-.82,;-11.15,-2.28,;-9.91,-3.19,;-8.66,-2.28,;-9.14,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C27H42N4O3/c1-27(33)11-6-21(7-12-27)26(32)29-22-4-2-20(3-5-22)9-14-30-15-17-31(18-16-30)25-23-10-19-34-24(23)8-13-28-25/h8,13,20-22,33H,2-7,9-12,14-19H2,1H3,(H,29,32) XLIXPJRYIUCZIQ-UHFFFAOYSA-N 106465 US8586579, 81 5-hydroxytryptamine receptor 2A Homo sapiens 12.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106465&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125777 174008776 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225225 C[C@@]1(O)CC[C@@H](CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:11.11,1.0,wD:14.15,5.8,1.1,(11.45,1.29,;10.11,.52,;11.45,-.25,;9.34,-.82,;7.8,-.82,;7.03,.52,;7.8,1.85,;9.34,1.85,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.83,.52,;-6.06,1.85,;-4.52,1.85,;-8.37,.52,;-9.14,1.85,;-10.68,1.85,;-11.45,.52,;-10.68,-.82,;-11.15,-2.28,;-9.91,-3.19,;-8.66,-2.28,;-9.14,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C27H42N4O3/c1-27(33)11-6-21(7-12-27)26(32)29-22-4-2-20(3-5-22)9-14-30-15-17-31(18-16-30)25-23-10-19-34-24(23)8-13-28-25/h8,13,20-22,33H,2-7,9-12,14-19H2,1H3,(H,29,32) XLIXPJRYIUCZIQ-UHFFFAOYSA-N 106466 US8586579, 55 5-hydroxytryptamine receptor 2A Homo sapiens 6.14 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106466&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125777 174008777 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225226 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCCCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C31H43N5O2/c37-31(25-6-10-27(11-7-25)35-16-2-1-3-17-35)33-26-8-4-24(5-9-26)13-18-34-19-21-36(22-20-34)30-28-14-23-38-29(28)12-15-32-30/h6-7,10-12,15,24,26H,1-5,8-9,13-14,16-23H2,(H,33,37) UBLOWVVYFMMWMS-UHFFFAOYSA-N 106467 US8586579, 83 5-hydroxytryptamine receptor 2A Homo sapiens 19.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106467&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770600 174008778 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225227 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C30H41N5O3/c36-30(24-3-7-26(8-4-24)34-18-21-37-22-19-34)32-25-5-1-23(2-6-25)10-13-33-14-16-35(17-15-33)29-27-11-20-38-28(27)9-12-31-29/h3-4,7-9,12,23,25H,1-2,5-6,10-11,13-22H2,(H,32,36) WVPMAZJVALETCI-UHFFFAOYSA-N 106468 US8586579, 57 5-hydroxytryptamine receptor 2A Homo sapiens 4.52 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106468&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770601 174008779 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225228 OC1(CC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.7,wD:10.11,(9.27,-.82,;8.5,.52,;9.98,.92,;8.89,2.01,;6.96,.52,;6.19,-.82,;6.19,1.85,;4.65,1.85,;3.88,.52,;2.34,.52,;1.57,1.85,;.03,1.85,;-.74,.52,;-2.28,.52,;-3.05,-.82,;-4.59,-.82,;-5.36,.52,;-4.59,1.85,;-3.05,1.85,;-6.9,.52,;-7.67,1.85,;-9.21,1.85,;-9.98,.52,;-9.21,-.82,;-9.69,-2.28,;-8.44,-3.19,;-7.2,-2.28,;-7.67,-.82,;2.34,3.19,;3.88,3.19,)| InChI=1S/C23H34N4O3/c28-22(23(29)8-9-23)25-18-3-1-17(2-4-18)6-11-26-12-14-27(15-13-26)21-19-7-16-30-20(19)5-10-24-21/h5,10,17-18,29H,1-4,6-9,11-16H2,(H,25,28) CKAFITNCAHORFQ-UHFFFAOYSA-N 106469 US8586579, 58 5-hydroxytryptamine receptor 2A Homo sapiens 5.92 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106469&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125810 174008780 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225229 O=C(CC#N)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(6.16,-.82,;6.93,.52,;8.47,.52,;9.24,1.85,;10.01,3.19,;6.16,1.85,;4.62,1.85,;3.85,.52,;2.31,.52,;1.54,1.85,;,1.85,;-.77,.52,;-2.31,.52,;-3.08,-.82,;-4.62,-.82,;-5.39,.52,;-4.62,1.85,;-3.08,1.85,;-6.93,.52,;-7.7,1.85,;-9.24,1.85,;-10.01,.52,;-9.24,-.82,;-9.72,-2.28,;-8.47,-3.19,;-7.22,-2.28,;-7.7,-.82,;2.31,3.19,;3.85,3.19,)| InChI=1S/C22H31N5O2/c23-9-5-21(28)25-18-3-1-17(2-4-18)7-11-26-12-14-27(15-13-26)22-19-8-16-29-20(19)6-10-24-22/h6,10,17-18H,1-5,7-8,11-16H2,(H,25,28) AZQFGKSDCVQAHH-UHFFFAOYSA-N 106470 US8586579, 59 5-hydroxytryptamine receptor 2A Homo sapiens 15.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106470&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770602 174008781 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225230 FC(F)(F)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;10.29,-.05,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C22H31F3N4O2/c23-22(24,25)15-20(30)27-17-3-1-16(2-4-17)6-9-28-10-12-29(13-11-28)21-18-7-14-31-19(18)5-8-26-21/h5,8,16-17H,1-4,6-7,9-15H2,(H,27,30) KAEYIPLTXHGZRS-UHFFFAOYSA-N 106471 US8586579, 60 5-hydroxytryptamine receptor 2A Homo sapiens 11 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106471&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770825 174008782 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225231 O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,3.2,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106472 US8586579, 61 5-hydroxytryptamine receptor 2A Homo sapiens 11.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106472&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770826 174008783 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225232 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccnc2ccccc12 |r,wU:3.2,wD:6.6,(5.39,-.67,;6.16,.67,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,;7.7,.67,;8.47,2,;10.01,2,;10.78,.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;8.47,-.67,)| InChI=1S/C29H35N5O2/c35-29(24-9-13-30-26-4-2-1-3-23(24)26)32-22-7-5-21(6-8-22)11-15-33-16-18-34(19-17-33)28-25-12-20-36-27(25)10-14-31-28/h1-4,9-10,13-14,21-22H,5-8,11-12,15-20H2,(H,32,35) MVNMMDGTQIXAJK-UHFFFAOYSA-N 106473 US8586579, 62 5-hydroxytryptamine receptor 2A Homo sapiens 3.62 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106473&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770827 174008784 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225233 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C1CC1 |r,wU:3.2,wD:6.6,(6.26,-.82,;7.03,.52,;6.26,1.85,;4.72,1.85,;3.95,.52,;2.41,.52,;1.64,1.85,;.1,1.85,;-.67,.52,;-2.21,.52,;-2.98,-.82,;-4.52,-.82,;-5.29,.52,;-4.52,1.85,;-2.98,1.85,;-6.83,.52,;-7.6,1.85,;-9.14,1.85,;-9.91,.52,;-9.14,-.82,;-9.61,-2.28,;-8.37,-3.19,;-7.12,-2.28,;-7.6,-.82,;2.41,3.19,;3.95,3.19,;8.57,.52,;9.91,-.25,;9.91,1.29,)| InChI=1S/C23H34N4O2/c28-23(18-3-4-18)25-19-5-1-17(2-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,10,17-19H,1-6,8-9,11-16H2,(H,25,28) OUMNETVFYOWILO-UHFFFAOYSA-N 106474 US8586579, 63 5-hydroxytryptamine receptor 2A Homo sapiens 11.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106474&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770828 174008785 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225234 O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106475 US8586579, 91 5-hydroxytryptamine receptor 2A Homo sapiens 16.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106475&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770829 174008786 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225235 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)CC1 |r,wU:10.9,5.5,wD:13.13,2.1,(11.55,-4,;10.01,-4,;9.24,-2.67,;10.01,-1.33,;9.24,,;7.7,,;6.93,1.33,;5.39,1.33,;4.62,,;4.62,2.67,;3.08,2.67,;2.31,1.33,;.77,1.33,;,2.67,;-1.54,2.67,;-2.31,1.33,;-3.85,1.33,;-4.62,,;-6.16,,;-6.93,1.33,;-6.16,2.67,;-4.62,2.67,;-8.47,1.33,;-9.24,2.67,;-10.78,2.67,;-11.55,1.33,;-10.78,,;-11.26,-1.46,;-10.01,-2.37,;-8.76,-1.46,;-9.24,,;.77,4,;2.31,4,;6.93,-1.33,;7.7,-2.67,)| InChI=1S/C28H44N4O3/c1-34-24-8-4-22(5-9-24)20-27(33)30-23-6-2-21(3-7-23)11-14-31-15-17-32(18-16-31)28-25-12-19-35-26(25)10-13-29-28/h10,13,21-24H,2-9,11-12,14-20H2,1H3,(H,30,33) JCPOEWYYYWHNCO-UHFFFAOYSA-N 106476 US8586579, 92 5-hydroxytryptamine receptor 2A Homo sapiens 14.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106476&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54770830 174008787 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225236 CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(9.63,-.82,;8.08,-.82,;7.31,-2.15,;7.31,.52,;8.65,1.29,;5.98,-.25,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.93,1.85,;.38,1.85,;-.38,.52,;-1.93,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.63,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C21H35N5O3S/c1-24(2)30(27,28)23-18-5-3-17(4-6-18)8-11-25-12-14-26(15-13-25)21-19-9-16-29-20(19)7-10-22-21/h7,10,17-18,23H,3-6,8-9,11-16H2,1-2H3 CKOUWIPOSAPIGS-UHFFFAOYSA-N 106477 US8586579, 66 5-hydroxytryptamine receptor 2A Homo sapiens 11.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106477&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125849 174008788 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225237 O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,3.2,wD:13.14,(5.39,-.67,;6.16,.67,;7.7,.67,;8.47,-.67,;10.01,-.67,;10.78,-2,;10.01,-3.33,;8.47,-3.33,;7.7,-2,;5.39,2,;3.85,2,;3.08,.67,;1.54,.67,;.77,2,;-.77,2,;-1.54,.67,;-3.08,.67,;-3.85,-.67,;-5.39,-.67,;-6.16,.67,;-5.39,2,;-3.85,2,;-7.7,.67,;-8.47,2,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;1.54,3.33,;3.08,3.33,)| InChI=1S/C25H38N4O4/c30-24(17-21-18-31-15-16-32-21)27-20-3-1-19(2-4-20)6-9-28-10-12-29(13-11-28)25-22-7-14-33-23(22)5-8-26-25/h5,8,19-21H,1-4,6-7,9-18H2,(H,27,30) YGCYKAKZEZYUMC-UHFFFAOYSA-N 106478 US8586579, 67 5-hydroxytryptamine receptor 2A Homo sapiens 8.15 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106478&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771057 174008789 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225238 O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,3.2,wD:12.13,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106479 US8586579, 95 5-hydroxytryptamine receptor 2A Homo sapiens 14.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106479&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771058 174008790 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225239 O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,3.2,(5.54,-.82,;6.31,.52,;7.85,.52,;8.62,-.82,;10.16,-.82,;10.63,-2.28,;9.39,-3.19,;8.14,-2.28,;5.54,1.85,;4,1.85,;3.23,.52,;1.69,.52,;.92,1.85,;-.62,1.85,;-1.39,.52,;-2.93,.52,;-3.7,-.82,;-5.24,-.82,;-6.01,.52,;-5.24,1.85,;-3.7,1.85,;-7.55,.52,;-8.32,1.85,;-9.86,1.85,;-10.63,.52,;-9.86,-.82,;-10.34,-2.28,;-9.09,-3.19,;-7.85,-2.28,;-8.32,-.82,;1.69,3.19,;3.23,3.19,)| InChI=1S/C25H38N4O3/c30-24(18-21-2-1-16-31-21)27-20-5-3-19(4-6-20)8-11-28-12-14-29(15-13-28)25-22-9-17-32-23(22)7-10-26-25/h7,10,19-21H,1-6,8-9,11-18H2,(H,27,30) SAWRNBNIFPXPCC-UHFFFAOYSA-N 106480 US8586579, 96 5-hydroxytryptamine receptor 2A Homo sapiens 24.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106480&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771059 174008791 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225240 CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(8.47,2.06,;8.47,.52,;8.47,-1.02,;10.01,.52,;6.93,.52,;6.16,-.82,;6.16,1.85,;4.62,1.85,;3.85,.52,;2.31,.52,;1.54,1.85,;,1.85,;-.77,.52,;-2.31,.52,;-3.08,-.82,;-4.62,-.82,;-5.39,.52,;-4.62,1.85,;-3.08,1.85,;-6.93,.52,;-7.7,1.85,;-9.24,1.85,;-10.01,.52,;-9.24,-.82,;-9.72,-2.28,;-8.47,-3.19,;-7.22,-2.28,;-7.7,-.82,;2.31,3.19,;3.85,3.19,)| InChI=1S/C24H38N4O2/c1-24(2,3)23(29)26-19-6-4-18(5-7-19)9-12-27-13-15-28(16-14-27)22-20-10-17-30-21(20)8-11-25-22/h8,11,18-19H,4-7,9-10,12-17H2,1-3H3,(H,26,29) IHNAEAHWHZVEJK-UHFFFAOYSA-N 106481 US8586579, 70 5-hydroxytryptamine receptor 2A Homo sapiens 9.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106481&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771060 174008792 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225241 CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.39,-.82,;8.86,-.82,;8.08,-2.15,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C24H38N4O2/c1-18(2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,18-20H,3-6,8-9,11-17H2,1-2H3,(H,26,29) FORAQSMKEXXBJZ-UHFFFAOYSA-N 106482 US8586579, 71 5-hydroxytryptamine receptor 2A Homo sapiens 15.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106482&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771061 174008793 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225242 CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.29,-.05,;8.96,-.82,;9.73,-2.15,;7.62,-1.59,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C25H40N4O2/c1-25(2,3)18-23(30)27-20-6-4-19(5-7-20)9-12-28-13-15-29(16-14-28)24-21-10-17-31-22(21)8-11-26-24/h8,11,19-20H,4-7,9-10,12-18H2,1-3H3,(H,27,30) DQVWGUUNHWMPMS-UHFFFAOYSA-N 106483 US8586579, 99 5-hydroxytryptamine receptor 2A Homo sapiens 16.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106483&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771062 174008794 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225243 O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(5.8,-.82,;6.57,.52,;8.11,.52,;8.88,-.82,;8.48,-2.3,;9.97,-2.7,;10.37,-1.21,;5.8,1.85,;4.26,1.85,;3.49,.52,;1.95,.52,;1.18,1.85,;-.36,1.85,;-1.13,.52,;-2.67,.52,;-3.44,-.82,;-4.98,-.82,;-5.75,.52,;-4.98,1.85,;-3.44,1.85,;-7.29,.52,;-8.06,1.85,;-9.6,1.85,;-10.37,.52,;-9.6,-.82,;-10.07,-2.28,;-8.83,-3.19,;-7.58,-2.28,;-8.06,-.82,;1.95,3.19,;3.49,3.19,)| InChI=1S/C25H38N4O2/c30-24(18-20-2-1-3-20)27-21-6-4-19(5-7-21)9-12-28-13-15-29(16-14-28)25-22-10-17-31-23(22)8-11-26-25/h8,11,19-21H,1-7,9-10,12-18H2,(H,27,30) HRGLDIJXNKMLQF-UHFFFAOYSA-N 106484 US8586579, 73 5-hydroxytryptamine receptor 2A Homo sapiens 13.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106484&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771291 174008795 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225244 FC1(F)CC1C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(8.51,-1.59,;9.28,-.25,;10.53,-1,;9.28,1.29,;7.95,.52,;6.41,.52,;5.64,-.82,;5.64,1.85,;4.1,1.85,;3.33,.52,;1.79,.52,;1.02,1.85,;-.52,1.85,;-1.29,.52,;-2.83,.52,;-3.6,-.82,;-5.14,-.82,;-5.91,.52,;-5.14,1.85,;-3.6,1.85,;-7.45,.52,;-8.22,1.85,;-9.76,1.85,;-10.53,.52,;-9.76,-.82,;-10.24,-2.28,;-8.99,-3.19,;-7.75,-2.28,;-8.22,-.82,;1.79,3.19,;3.33,3.19,)| InChI=1S/C23H32F2N4O2/c24-23(25)15-19(23)22(30)27-17-3-1-16(2-4-17)6-9-28-10-12-29(13-11-28)21-18-7-14-31-20(18)5-8-26-21/h5,8,16-17,19H,1-4,6-7,9-15H2,(H,27,30) YFHWGBZGWDWNRV-UHFFFAOYSA-N 106485 US8586579, 101 5-hydroxytryptamine receptor 2A Homo sapiens 17.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106485&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771292 174008796 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225245 CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.62,-.82,;8.85,.52,;9.62,1.85,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C23H36N4O2/c1-17(2)23(28)25-19-5-3-18(4-6-19)8-11-26-12-14-27(15-13-26)22-20-9-16-29-21(20)7-10-24-22/h7,10,17-19H,3-6,8-9,11-16H2,1-2H3,(H,25,28) HGDNRYBOAYQHNG-UHFFFAOYSA-N 106486 US8586579, 75 5-hydroxytryptamine receptor 2A Homo sapiens 10.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106486&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771293 174008797 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225246 CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(8.85,3.19,;9.62,1.85,;8.85,.52,;9.62,-.82,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C24H38N4O2/c1-3-18(2)24(29)26-20-6-4-19(5-7-20)9-12-27-13-15-28(16-14-27)23-21-10-17-30-22(21)8-11-25-23/h8,11,18-20H,3-7,9-10,12-17H2,1-2H3,(H,26,29) JPVBGGFMPCPVDU-UHFFFAOYSA-N 106487 US8586579, 103 5-hydroxytryptamine receptor 2A Homo sapiens 13.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106487&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771294 174008798 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225247 O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(5.8,-.82,;6.57,.52,;8.11,.52,;8.88,-.82,;8.48,-2.3,;9.97,-2.7,;10.37,-1.21,;5.8,1.85,;4.26,1.85,;3.49,.52,;1.95,.52,;1.18,1.85,;-.36,1.85,;-1.13,.52,;-2.67,.52,;-3.44,-.82,;-4.98,-.82,;-5.75,.52,;-4.98,1.85,;-3.44,1.85,;-7.29,.52,;-8.06,1.85,;-9.6,1.85,;-10.37,.52,;-9.6,-.82,;-10.07,-2.28,;-8.83,-3.19,;-7.58,-2.28,;-8.06,-.82,;1.95,3.19,;3.49,3.19,)| InChI=1S/C24H36N4O3/c29-23(15-19-16-30-17-19)26-20-3-1-18(2-4-20)6-9-27-10-12-28(13-11-27)24-21-7-14-31-22(21)5-8-25-24/h5,8,18-20H,1-4,6-7,9-17H2,(H,26,29) KPWFNAZMRFBRMI-UHFFFAOYSA-N 106488 US8586579, 77 5-hydroxytryptamine receptor 2A Homo sapiens 11 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106488&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771295 174008799 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225248 CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(9.62,-.82,;8.85,.52,;9.62,1.85,;7.31,.52,;6.54,-.82,;6.54,1.85,;5,1.85,;4.23,.52,;2.69,.52,;1.92,1.85,;.39,1.85,;-.38,.52,;-1.92,.52,;-2.69,-.82,;-4.23,-.82,;-5,.52,;-4.23,1.85,;-2.69,1.85,;-6.54,.52,;-7.31,1.85,;-8.85,1.85,;-9.62,.52,;-8.85,-.82,;-9.33,-2.28,;-8.08,-3.19,;-6.84,-2.28,;-7.31,-.82,;2.69,3.19,;4.23,3.19,)| InChI=1S/C22H35N5O2/c1-25(2)22(28)24-18-5-3-17(4-6-18)8-11-26-12-14-27(15-13-26)21-19-9-16-29-20(19)7-10-23-21/h7,10,17-18H,3-6,8-9,11-16H2,1-2H3,(H,24,28) UVEHFXJWIQCNDD-UHFFFAOYSA-N 106489 US8586579, 105 5-hydroxytryptamine receptor 2A Homo sapiens 28.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106489&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125778 174008800 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225249 FC(F)(F)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(5.6,-.05,;6.93,-.82,;8.26,-1.59,;6.16,-2.15,;7.7,.52,;9.24,.52,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C21H29F3N4O2/c22-21(23,24)20(29)26-16-3-1-15(2-4-16)6-9-27-10-12-28(13-11-27)19-17-7-14-30-18(17)5-8-25-19/h5,8,15-16H,1-4,6-7,9-14H2,(H,26,29) SUGHICCAJLONJR-UHFFFAOYSA-N 106490 US8586579, 106 5-hydroxytryptamine receptor 2A Homo sapiens 19.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106490&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 86660552 174008801 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225250 CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.39,-.82,;8.86,-.82,;8.08,-2.15,;8.08,.52,;6.55,.52,;5.77,-.82,;5.77,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.38,1.85,;-1.15,.52,;-2.69,.52,;-3.46,-.82,;-5,-.82,;-5.77,.52,;-5,1.85,;-3.46,1.85,;-7.31,.52,;-8.08,1.85,;-9.62,1.85,;-10.39,.52,;-9.62,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.08,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C24H36N4O2/c1-18(2)17-23(29)26-20-5-3-19(4-6-20)8-11-27-12-14-28(15-13-27)24-21-9-16-30-22(21)7-10-25-24/h7,10,17,19-20H,3-6,8-9,11-16H2,1-2H3,(H,26,29) NBKJTOGTVMGTOS-UHFFFAOYSA-N 106491 US8586579, 107 5-hydroxytryptamine receptor 2A Homo sapiens 16.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106491&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125807 174008802 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225251 C\C=C\CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H36N4O2/c1-2-3-4-23(29)26-20-7-5-19(6-8-20)10-13-27-14-16-28(17-15-27)24-21-11-18-30-22(21)9-12-25-24/h2-3,9,12,19-20H,4-8,10-11,13-18H2,1H3,(H,26,29) KZWUXBIYAIXWII-UHFFFAOYSA-N 106492 US8586579, 108 5-hydroxytryptamine receptor 2A Homo sapiens 22.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106492&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125826 174008803 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225252 CC#CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.78,.52,;9.24,.52,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C23H32N4O2/c1-2-3-22(28)25-19-6-4-18(5-7-19)9-12-26-13-15-27(16-14-26)23-20-10-17-29-21(20)8-11-24-23/h8,11,18-19H,4-7,9-10,12-17H2,1H3,(H,25,28) XDPTVFIWUAWOLA-UHFFFAOYSA-N 106493 US8586579, 82 5-hydroxytryptamine receptor 2A Homo sapiens 12.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106493&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768829 174008804 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225253 O=CN[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:3.2,wD:6.6,(6.93,-.82,;7.7,.52,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C20H30N4O2/c25-15-22-17-3-1-16(2-4-17)6-9-23-10-12-24(13-11-23)20-18-7-14-26-19(18)5-8-21-20/h5,8,15-17H,1-4,6-7,9-14H2,(H,22,25) ABHVAQKOVOLZPM-UHFFFAOYSA-N 106494 US8586579, 110 5-hydroxytryptamine receptor 2A Homo sapiens 23.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106494&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 86660553 174008805 C06049 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225254 Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)on1 |r,wU:8.7,wD:11.11,(11.3,-3.05,;9.97,-2.28,;9.49,-.82,;7.95,-.82,;7.18,.52,;5.64,.52,;4.87,-.82,;4.87,1.85,;3.33,1.85,;2.56,.52,;1.02,.52,;.25,1.85,;-1.29,1.85,;-2.06,.52,;-3.6,.52,;-4.37,-.82,;-5.91,-.82,;-6.68,.52,;-5.91,1.85,;-4.37,1.85,;-8.22,.52,;-8.99,1.85,;-10.53,1.85,;-11.3,.52,;-10.53,-.82,;-11.01,-2.28,;-9.76,-3.19,;-8.51,-2.28,;-8.99,-.82,;1.02,3.19,;2.56,3.19,;7.47,-2.28,;8.72,-3.19,)| InChI=1S/C25H35N5O3/c1-18-16-21(33-28-18)17-24(31)27-20-4-2-19(3-5-20)7-10-29-11-13-30(14-12-29)25-22-8-15-32-23(22)6-9-26-25/h6,9,16,19-20H,2-5,7-8,10-15,17H2,1H3,(H,27,31) ZPEAQOHSKIPYKV-UHFFFAOYSA-N 106495 US8586579, 84 5-hydroxytryptamine receptor 2A Homo sapiens 15.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106495&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768830 174008806 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225255 Cc1cc(on1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.9,wD:12.13,(11.09,-1.02,;9.76,-.25,;8.29,-.73,;7.39,.52,;8.29,1.76,;9.76,1.29,;5.85,.52,;5.08,-.82,;5.08,1.85,;3.54,1.85,;2.77,.52,;1.23,.52,;.46,1.85,;-1.08,1.85,;-1.85,.52,;-3.39,.52,;-4.16,-.82,;-5.7,-.82,;-6.47,.52,;-5.7,1.85,;-4.16,1.85,;-8.01,.52,;-8.78,1.85,;-10.32,1.85,;-11.09,.52,;-10.32,-.82,;-10.8,-2.28,;-9.55,-3.19,;-8.31,-2.28,;-8.78,-.82,;1.23,3.19,;2.77,3.19,)| InChI=1S/C24H33N5O3/c1-17-16-22(32-27-17)24(30)26-19-4-2-18(3-5-19)7-10-28-11-13-29(14-12-28)23-20-8-15-31-21(20)6-9-25-23/h6,9,16,18-19H,2-5,7-8,10-15H2,1H3,(H,26,30) FUAJGUYRNZZDBH-UHFFFAOYSA-N 106496 US8586579, 112 5-hydroxytryptamine receptor 2A Homo sapiens 15.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106496&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768831 174008807 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225256 CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.9,wD:13.13,(9.24,-3.33,;10.01,-2,;11.55,-2,;9.24,-.67,;10.01,.67,;7.7,-.67,;6.93,.67,;5.39,.67,;4.62,-.67,;4.62,2,;3.08,2,;2.31,.67,;.77,.67,;,2,;-1.54,2,;-2.31,.67,;-3.85,.67,;-4.62,-.67,;-6.16,-.67,;-6.93,.67,;-6.16,2,;-4.62,2,;-8.47,.67,;-9.24,2,;-10.78,2,;-11.55,.67,;-10.78,-.67,;-11.26,-2.13,;-10.01,-3.04,;-8.76,-2.13,;-9.24,-.67,;.77,3.33,;2.31,3.33,)| InChI=1S/C25H39N5O3/c1-28(2)24(32)8-7-23(31)27-20-5-3-19(4-6-20)10-13-29-14-16-30(17-15-29)25-21-11-18-33-22(21)9-12-26-25/h9,12,19-20H,3-8,10-11,13-18H2,1-2H3,(H,27,31) GXVCWWLYAQAZCU-UHFFFAOYSA-N 106497 US8586579, 113 5-hydroxytryptamine receptor 2A Homo sapiens 23.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106497&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768832 174008808 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225257 CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(9.73,-2.15,;8.96,-.82,;7.62,-1.59,;10.29,-.05,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,)| InChI=1S/C24H38N4O3/c1-24(2,30)17-22(29)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)23-20-9-16-31-21(20)7-10-25-23/h7,10,18-19,30H,3-6,8-9,11-17H2,1-2H3,(H,26,29) KLTVYCHNHMTZNG-UHFFFAOYSA-N 106498 US8586579, 114 5-hydroxytryptamine receptor 2A Homo sapiens 25 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106498&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125781 174008809 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225258 O[C@H](CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C(F)(F)F |r,wU:6.5,wD:9.9,1.0,(7.31,-2.15,;8.08,-.82,;7.31,.52,;5.77,.52,;5,-.82,;5,1.85,;3.46,1.85,;2.69,.52,;1.15,.52,;.39,1.85,;-1.15,1.85,;-1.92,.52,;-3.46,.52,;-4.23,-.82,;-5.77,-.82,;-6.54,.52,;-5.77,1.85,;-4.23,1.85,;-8.08,.52,;-8.85,1.85,;-10.39,1.85,;-11.16,.52,;-10.39,-.82,;-10.87,-2.28,;-9.62,-3.19,;-8.38,-2.28,;-8.85,-.82,;1.15,3.19,;2.69,3.19,;9.62,-.82,;9.62,.72,;11.16,-.82,;9.62,-2.36,)| InChI=1S/C23H33F3N4O3/c24-23(25,26)20(31)15-21(32)28-17-3-1-16(2-4-17)6-9-29-10-12-30(13-11-29)22-18-7-14-33-19(18)5-8-27-22/h5,8,16-17,20,31H,1-4,6-7,9-15H2,(H,28,32) CTMBSXSNFDPMFG-UHFFFAOYSA-N 106499 US8586579, 115 5-hydroxytryptamine receptor 2A Homo sapiens 33.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106499&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125851 174008810 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225259 CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,2.2,(10.78,.52,;10.01,-.82,;8.47,-.82,;7.7,-2.15,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-2-20(29)17-23(30)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-21-9-16-31-22(21)7-10-25-24/h7,10,18-20,29H,2-6,8-9,11-17H2,1H3,(H,26,30) JBVSQYZVCXMFCI-UHFFFAOYSA-N 106500 US8586579, 116 5-hydroxytryptamine receptor 2A Homo sapiens 30 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106500&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125818 174008811 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225260 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(11.69,-2.62,;10.36,-3.39,;9.02,-2.62,;7.56,-3.1,;6.65,-1.85,;7.56,-.61,;6.79,.73,;5.25,.73,;4.48,-.61,;4.48,2.06,;2.94,2.06,;2.17,.73,;.63,.73,;-.14,2.06,;-1.68,2.06,;-2.45,.73,;-3.99,.73,;-4.76,-.61,;-6.3,-.61,;-7.07,.73,;-6.3,2.06,;-4.76,2.06,;-8.61,.73,;-9.38,2.06,;-10.92,2.06,;-11.69,.73,;-10.92,-.61,;-11.4,-2.07,;-10.15,-2.98,;-8.9,-2.07,;-9.38,-.61,;.63,3.39,;2.17,3.39,;9.02,-1.08,)| InChI=1S/C27H42N4O3/c1-33-23-7-4-21(18-23)19-26(32)29-22-5-2-20(3-6-22)9-12-30-13-15-31(16-14-30)27-24-10-17-34-25(24)8-11-28-27/h8,11,20-23H,2-7,9-10,12-19H2,1H3,(H,29,32) DQTBCNRIVXHDQE-UHFFFAOYSA-N 106501 US8586579, 117 5-hydroxytryptamine receptor 2A Homo sapiens 22.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106501&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 70653201 174008812 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225261 O[C@@H]1COC(CC(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)C1 |r,wU:9.8,wD:12.12,1.0,(11.02,-3.39,;9.69,-2.62,;8.23,-3.1,;7.32,-1.85,;8.23,-.61,;7.46,.73,;5.92,.73,;5.15,-.61,;5.15,2.06,;3.61,2.06,;2.84,.73,;1.3,.73,;.53,2.06,;-1.01,2.06,;-1.78,.73,;-3.32,.73,;-4.09,-.61,;-5.63,-.61,;-6.4,.73,;-5.63,2.06,;-4.09,2.06,;-7.94,.73,;-8.71,2.06,;-10.25,2.06,;-11.02,.73,;-10.25,-.61,;-10.73,-2.07,;-9.48,-2.98,;-8.24,-2.07,;-8.71,-.61,;1.3,3.39,;2.84,3.39,;9.69,-1.08,)| InChI=1S/C25H38N4O4/c30-20-15-21(33-17-20)16-24(31)27-19-3-1-18(2-4-19)6-9-28-10-12-29(13-11-28)25-22-7-14-32-23(22)5-8-26-25/h5,8,18-21,30H,1-4,6-7,9-17H2,(H,27,31) XIVALFSMOKTRNY-UHFFFAOYSA-N 106502 US8586579, 118 5-hydroxytryptamine receptor 2A Homo sapiens 22.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106502&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125839 174008813 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225262 CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:6.5,wD:9.9,(10.4,-.82,;8.86,-.82,;8.09,.52,;6.55,.52,;5.78,-.82,;5.78,1.85,;4.24,1.85,;3.46,.52,;1.93,.52,;1.15,1.85,;-.39,1.85,;-1.15,.52,;-2.7,.52,;-3.46,-.82,;-5,-.82,;-5.78,.52,;-5,1.85,;-3.46,1.85,;-7.32,.52,;-8.09,1.85,;-9.63,1.85,;-10.4,.52,;-9.63,-.82,;-10.1,-2.28,;-8.86,-3.19,;-7.61,-2.28,;-8.09,-.82,;1.93,3.19,;3.46,3.19,)| InChI=1S/C23H36N4O2/c1-2-3-22(28)25-19-6-4-18(5-7-19)9-12-26-13-15-27(16-14-26)23-20-10-17-29-21(20)8-11-24-23/h8,11,18-19H,2-7,9-10,12-17H2,1H3,(H,25,28) ABKVEMFUXMVUSG-UHFFFAOYSA-N 106503 US8586579, 119 5-hydroxytryptamine receptor 2A Homo sapiens 23.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106503&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125780 174008814 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225263 CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.7,wD:11.11,(10.78,.52,;10.01,-.82,;10.78,-2.15,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C25H40N4O2/c1-19(2)3-8-24(30)27-21-6-4-20(5-7-21)10-13-28-14-16-29(17-15-28)25-22-11-18-31-23(22)9-12-26-25/h9,12,19-21H,3-8,10-11,13-18H2,1-2H3,(H,27,30) VMDGNXGFFZHOON-UHFFFAOYSA-N 106504 US8586579, 120 5-hydroxytryptamine receptor 2A Homo sapiens 24.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106504&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125802 174008815 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225264 CCCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O2/c1-2-3-4-23(29)26-20-7-5-19(6-8-20)10-13-27-14-16-28(17-15-27)24-21-11-18-30-22(21)9-12-25-24/h9,12,19-20H,2-8,10-11,13-18H2,1H3,(H,26,29) QVISYVCUOQJANU-UHFFFAOYSA-N 106505 US8586579, 121 5-hydroxytryptamine receptor 2A Homo sapiens 24.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106505&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 70652534 174008816 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225265 FC(F)(F)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:9.8,wD:12.12,(9.63,.72,;9.63,-.82,;11.17,-.82,;9.63,-2.36,;8.09,-.82,;7.32,.52,;5.78,.52,;5,-.82,;5,1.85,;3.46,1.85,;2.7,.52,;1.16,.52,;.38,1.85,;-1.16,1.85,;-1.92,.52,;-3.46,.52,;-4.24,-.82,;-5.78,-.82,;-6.55,.52,;-5.78,1.85,;-4.24,1.85,;-8.09,.52,;-8.86,1.85,;-10.4,1.85,;-11.17,.52,;-10.4,-.82,;-10.87,-2.28,;-9.63,-3.19,;-8.38,-2.28,;-8.86,-.82,;1.16,3.19,;2.7,3.19,)| InChI=1S/C23H33F3N4O2/c24-23(25,26)9-5-21(31)28-18-3-1-17(2-4-18)7-11-29-12-14-30(15-13-29)22-19-8-16-32-20(19)6-10-27-22/h6,10,17-18H,1-5,7-9,11-16H2,(H,28,31) QDQDDWWAKHSCSK-UHFFFAOYSA-N 106506 US8586579, 122 5-hydroxytryptamine receptor 2A Homo sapiens 29.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106506&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125799 174008817 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225266 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,3.19,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C22H32N4O2/c1-16-15-21-20(8-14-28-21)22(23-16)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h8,14-15,18-19H,3-7,9-13H2,1-2H3,(H,24,27) QGKIQQCQAJMJNK-UHFFFAOYSA-N 106507 US8586579, 96 5-hydroxytryptamine receptor 2A Homo sapiens 75.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106507&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125808 174008818 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225267 Cc1cc2occc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.19,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;-7.7,.52,;-8.47,1.85,;-6.16,.52,;-5.39,-.82,;-3.85,-.82,;-3.08,.52,;-1.54,.52,;-.77,1.85,;.77,1.85,;1.54,.52,;3.08,.52,;3.85,1.85,;3.08,3.19,;1.54,3.19,;5.39,1.85,;6.16,.52,;5.39,-.82,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,;-3.85,1.85,;-5.39,1.85,)| InChI=1S/C26H38N4O3/c1-19-18-24-23(9-17-33-24)25(27-19)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h9,17-18,20-22H,2-8,10-16H2,1H3,(H,28,31) GRSPAVQNQLAIED-UHFFFAOYSA-N 106508 US8586579, 124 5-hydroxytryptamine receptor 2A Homo sapiens 25.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106508&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125803 174008819 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225268 Cc1cc2occc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.33,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;-7.7,.67,;-8.47,2,;-6.16,.67,;-5.39,-.67,;-3.85,-.67,;-3.08,.67,;-1.54,.67,;-.77,2,;.77,2,;1.54,.67,;3.08,.67,;3.85,2,;3.08,3.33,;1.54,3.33,;5.39,2,;6.16,.67,;5.39,-.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;-3.85,2,;-5.39,2,)| InChI=1S/C27H40N4O3/c1-20-18-25-24(9-17-34-25)27(28-20)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-26(32)19-22-7-15-33-16-8-22/h9,17-18,21-23H,2-8,10-16,19H2,1H3,(H,29,32) KGHICJQDLKRYCB-UHFFFAOYSA-N 106509 US8586579, 98 5-hydroxytryptamine receptor 2A Homo sapiens 75.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106509&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125771 174008820 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225269 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3occc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,3.19,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H36N4O3/c1-18-17-22-21(8-16-31-22)24(25-18)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-23(29)9-15-30-2/h8,16-17,19-20H,3-7,9-15H2,1-2H3,(H,26,29) PVAIEWDYRNQJFR-UHFFFAOYSA-N 106510 US8586579, 99 5-hydroxytryptamine receptor 2A Homo sapiens 86.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106510&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125797 174008821 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225270 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3OCCc23)CC1 |r,wU:4.3,wD:7.7,(9.24,.52,;7.7,.52,;6.93,-.82,;6.93,1.85,;5.39,1.85,;4.62,.52,;3.08,.52,;2.31,1.85,;.77,1.85,;,.52,;-1.54,.52,;-2.31,-.82,;-3.85,-.82,;-4.62,.52,;-3.85,1.85,;-2.31,1.85,;-6.16,.52,;-6.93,1.85,;-8.47,1.85,;-9.24,3.19,;-9.24,.52,;-8.47,-.82,;-8.95,-2.28,;-7.7,-3.19,;-6.45,-2.28,;-6.93,-.82,;3.08,3.19,;4.62,3.19,)| InChI=1S/C22H34N4O2/c1-16-15-21-20(8-14-28-21)22(23-16)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h15,18-19H,3-14H2,1-2H3,(H,24,27) VLMVFBMJXRVZOG-UHFFFAOYSA-N 106511 US8586579, 100 5-hydroxytryptamine receptor 2A Homo sapiens 215 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106511&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125856 174008822 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225271 Cc1cc2OCCc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.19,;-10.01,1.85,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;-7.7,.52,;-8.47,1.85,;-6.16,.52,;-5.39,-.82,;-3.85,-.82,;-3.08,.52,;-1.54,.52,;-.77,1.85,;.77,1.85,;1.54,.52,;3.08,.52,;3.85,1.85,;3.08,3.19,;1.54,3.19,;5.39,1.85,;6.16,.52,;5.39,-.82,;7.7,.52,;8.47,-.82,;10.01,-.82,;10.78,.52,;10.01,1.85,;8.47,1.85,;-3.85,1.85,;-5.39,1.85,)| InChI=1S/C26H40N4O3/c1-19-18-24-23(9-17-33-24)25(27-19)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h18,20-22H,2-17H2,1H3,(H,28,31) ITNGDGJSTGEEEQ-UHFFFAOYSA-N 106512 US8586579, 128 5-hydroxytryptamine receptor 2A Homo sapiens 58.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106512&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125785 174008823 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225272 Cc1cc2OCCc2c(n1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-10.78,3.33,;-10.01,2,;-10.78,.67,;-10.01,-.67,;-10.49,-2.13,;-9.24,-3.04,;-7.99,-2.13,;-8.47,-.67,;-7.7,.67,;-8.47,2,;-6.16,.67,;-5.39,-.67,;-3.85,-.67,;-3.08,.67,;-1.54,.67,;-.77,2,;.77,2,;1.54,.67,;3.08,.67,;3.85,2,;3.08,3.33,;1.54,3.33,;5.39,2,;6.16,.67,;5.39,-.67,;7.7,.67,;8.47,-.67,;7.7,-2,;8.47,-3.33,;10.01,-3.33,;10.78,-2,;10.01,-.67,;-3.85,2,;-5.39,2,)| InChI=1S/C27H42N4O3/c1-20-18-25-24(9-17-34-25)27(28-20)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-26(32)19-22-7-15-33-16-8-22/h18,21-23H,2-17,19H2,1H3,(H,29,32) QGUAUKGVRXXHQV-UHFFFAOYSA-N 106513 US8586579, 129 5-hydroxytryptamine receptor 2A Homo sapiens 193.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106513&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768833 174008824 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225273 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nc(C)cc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.78,-2.15,;10.01,-.82,;8.47,-.82,;7.7,.52,;6.16,.52,;5.39,-.82,;5.39,1.85,;3.85,1.85,;3.08,.52,;1.54,.52,;.77,1.85,;-.77,1.85,;-1.54,.52,;-3.08,.52,;-3.85,-.82,;-5.39,-.82,;-6.16,.52,;-5.39,1.85,;-3.85,1.85,;-7.7,.52,;-8.47,1.85,;-10.01,1.85,;-10.78,3.19,;-10.78,.52,;-10.01,-.82,;-10.49,-2.28,;-9.24,-3.19,;-7.99,-2.28,;-8.47,-.82,;1.54,3.19,;3.08,3.19,)| InChI=1S/C24H38N4O3/c1-18-17-22-21(8-16-31-22)24(25-18)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-23(29)9-15-30-2/h17,19-20H,3-16H2,1-2H3,(H,26,29) RCSLPJAWSBFTLD-UHFFFAOYSA-N 106514 US8586579, 103 5-hydroxytryptamine receptor 2A Homo sapiens 255 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106514&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125782 174008825 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225274 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3occc23)CC1 |r,wU:4.3,wD:7.7,(10.01,.52,;8.47,.52,;7.7,-.82,;7.7,1.85,;6.16,1.85,;5.39,.52,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,-.82,;-3.08,-.82,;-3.85,.52,;-3.08,1.85,;-1.54,1.85,;-5.39,.52,;-6.16,1.85,;-7.7,1.85,;-8.47,.52,;-10.01,.52,;-7.7,-.82,;-8.18,-2.28,;-6.93,-3.19,;-5.68,-2.28,;-6.16,-.82,;3.85,3.19,;5.39,3.19,)| InChI=1S/C22H32N4O2/c1-16-15-23-22(20-8-14-28-21(16)20)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h8,14-15,18-19H,3-7,9-13H2,1-2H3,(H,24,27) ALJNGMYHXPZTTG-UHFFFAOYSA-N 106515 US8586579, 131 5-hydroxytryptamine receptor 2A Homo sapiens 13.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106515&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771296 174008826 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225275 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)C3CCOCC3)CC2)c2ccoc12 |r,wU:14.17,wD:11.10,(-11.55,.52,;-10.01,.52,;-9.24,1.85,;-7.7,1.85,;-6.93,.52,;-5.39,.52,;-4.62,-.82,;-3.08,-.82,;-2.31,.52,;-.77,.52,;,1.85,;1.54,1.85,;2.31,.52,;3.85,.52,;4.62,1.85,;3.85,3.19,;2.31,3.19,;6.16,1.85,;6.93,.52,;6.16,-.82,;8.47,.52,;9.24,-.82,;10.78,-.82,;11.55,.52,;10.78,1.85,;9.24,1.85,;-3.08,1.85,;-4.62,1.85,;-7.7,-.82,;-7.22,-2.28,;-8.47,-3.19,;-9.72,-2.28,;-9.24,-.82,)| InChI=1S/C26H38N4O3/c1-19-18-27-25(23-9-17-33-24(19)23)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h9,17-18,20-22H,2-8,10-16H2,1H3,(H,28,31) XZKJWFNUAUOHAC-UHFFFAOYSA-N 106516 US8586579, 105 5-hydroxytryptamine receptor 2A Homo sapiens 5.67 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106516&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771508 174008827 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225276 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)CC3CCOCC3)CC2)c2ccoc12 |r,wU:14.17,wD:11.10,(-11.55,.67,;-10.01,.67,;-9.24,2,;-7.7,2,;-6.93,.67,;-5.39,.67,;-4.62,-.67,;-3.08,-.67,;-2.31,.67,;-.77,.67,;,2,;1.54,2,;2.31,.67,;3.85,.67,;4.62,2,;3.85,3.33,;2.31,3.33,;6.16,2,;6.93,.67,;6.16,-.67,;8.47,.67,;9.24,-.67,;8.47,-2,;9.24,-3.33,;10.78,-3.33,;11.55,-2,;10.78,-.67,;-3.08,2,;-4.62,2,;-7.7,-.67,;-7.22,-2.13,;-8.47,-3.04,;-9.72,-2.13,;-9.24,-.67,)| InChI=1S/C27H40N4O3/c1-20-19-28-27(24-9-17-34-26(20)24)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-25(32)18-22-7-15-33-16-8-22/h9,17,19,21-23H,2-8,10-16,18H2,1H3,(H,29,32) JTMYPGNBDACXLP-UHFFFAOYSA-N 106517 US8586579, 106 5-hydroxytryptamine receptor 2A Homo sapiens 11.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106517&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771509 174008828 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225277 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3occc23)CC1 |r,wU:7.6,wD:10.10,(11.6,-2.32,;10.73,-.82,;9.19,-.82,;8.42,.52,;6.88,.52,;6.11,-.82,;6.11,1.85,;4.57,1.85,;3.8,.52,;2.26,.52,;1.49,1.85,;-.05,1.85,;-.82,.52,;-2.36,.52,;-3.13,-.82,;-4.67,-.82,;-5.44,.52,;-4.67,1.85,;-3.13,1.85,;-6.98,.52,;-7.75,1.85,;-9.29,1.85,;-10.06,.52,;-11.6,.52,;-9.29,-.82,;-9.77,-2.28,;-8.52,-3.19,;-7.27,-2.28,;-7.75,-.82,;2.26,3.19,;3.8,3.19,)| InChI=1S/C24H36N4O3/c1-18-17-25-24(21-8-16-31-23(18)21)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-22(29)9-15-30-2/h8,16-17,19-20H,3-7,9-15H2,1-2H3,(H,26,29) XPRRZXPFKHAHFH-UHFFFAOYSA-N 106518 US8586579, 107 5-hydroxytryptamine receptor 2A Homo sapiens 12 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106518&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771510 174008829 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225278 CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3OCCc23)CC1 |r,wU:4.3,wD:7.7,(10.01,.52,;8.47,.52,;7.7,-.82,;7.7,1.85,;6.16,1.85,;5.39,.52,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,-.82,;-3.08,-.82,;-3.85,.52,;-3.08,1.85,;-1.54,1.85,;-5.39,.52,;-6.16,1.85,;-7.7,1.85,;-8.47,.52,;-10.01,.52,;-7.7,-.82,;-8.18,-2.28,;-6.93,-3.19,;-5.68,-2.28,;-6.16,-.82,;3.85,3.19,;5.39,3.19,)| InChI=1S/C22H34N4O2/c1-16-15-23-22(20-8-14-28-21(16)20)26-12-10-25(11-13-26)9-7-18-3-5-19(6-4-18)24-17(2)27/h15,18-19H,3-14H2,1-2H3,(H,24,27) ACEAZRLEPRIAMD-UHFFFAOYSA-N 106519 US8586579, 135 5-hydroxytryptamine receptor 2A Homo sapiens 67.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106519&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125815 174008830 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225279 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)C3CCOCC3)CC2)c2CCOc12 |r,wU:14.17,wD:11.10,(-11.55,.52,;-10.01,.52,;-9.24,1.85,;-7.7,1.85,;-6.93,.52,;-5.39,.52,;-4.62,-.82,;-3.08,-.82,;-2.31,.52,;-.77,.52,;,1.85,;1.54,1.85,;2.31,.52,;3.85,.52,;4.62,1.85,;3.85,3.19,;2.31,3.19,;6.16,1.85,;6.93,.52,;6.16,-.82,;8.47,.52,;9.24,-.82,;10.78,-.82,;11.55,.52,;10.78,1.85,;9.24,1.85,;-3.08,1.85,;-4.62,1.85,;-7.7,-.82,;-7.22,-2.28,;-8.47,-3.19,;-9.72,-2.28,;-9.24,-.82,)| InChI=1S/C26H40N4O3/c1-19-18-27-25(23-9-17-33-24(19)23)30-13-11-29(12-14-30)10-6-20-2-4-22(5-3-20)28-26(31)21-7-15-32-16-8-21/h18,20-22H,2-17H2,1H3,(H,28,31) KMPUTTSRRTYIRY-UHFFFAOYSA-N 106520 US8586579, 136 5-hydroxytryptamine receptor 2A Homo sapiens 19.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106520&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125809 174008831 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225280 Cc1cnc(N2CCN(CC[C@H]3CC[C@@H](CC3)NC(=O)CC3CCOCC3)CC2)c2CCOc12 |r,wU:14.17,wD:11.10,(-11.55,.67,;-10.01,.67,;-9.24,2,;-7.7,2,;-6.93,.67,;-5.39,.67,;-4.62,-.67,;-3.08,-.67,;-2.31,.67,;-.77,.67,;,2,;1.54,2,;2.31,.67,;3.85,.67,;4.62,2,;3.85,3.33,;2.31,3.33,;6.16,2,;6.93,.67,;6.16,-.67,;8.47,.67,;9.24,-.67,;8.47,-2,;9.24,-3.33,;10.78,-3.33,;11.55,-2,;10.78,-.67,;-3.08,2,;-4.62,2,;-7.7,-.67,;-7.22,-2.13,;-8.47,-3.04,;-9.72,-2.13,;-9.24,-.67,)| InChI=1S/C27H42N4O3/c1-20-19-28-27(24-9-17-34-26(20)24)31-13-11-30(12-14-31)10-6-21-2-4-23(5-3-21)29-25(32)18-22-7-15-33-16-8-22/h19,21-23H,2-18H2,1H3,(H,29,32) ADDORVGWJJXKFK-UHFFFAOYSA-N 106521 US8586579, 137 5-hydroxytryptamine receptor 2A Homo sapiens 44 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106521&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125884 174008832 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225281 COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2ncc(C)c3OCCc23)CC1 |r,wU:7.6,wD:10.10,(11.6,-2.32,;10.73,-.82,;9.19,-.82,;8.42,.52,;6.88,.52,;6.11,-.82,;6.11,1.85,;4.57,1.85,;3.8,.52,;2.26,.52,;1.49,1.85,;-.05,1.85,;-.82,.52,;-2.36,.52,;-3.13,-.82,;-4.67,-.82,;-5.44,.52,;-4.67,1.85,;-3.13,1.85,;-6.98,.52,;-7.75,1.85,;-9.29,1.85,;-10.06,.52,;-11.6,.52,;-9.29,-.82,;-9.77,-2.28,;-8.52,-3.19,;-7.27,-2.28,;-7.75,-.82,;2.26,3.19,;3.8,3.19,)| InChI=1S/C24H38N4O3/c1-18-17-25-24(21-8-16-31-23(18)21)28-13-11-27(12-14-28)10-7-19-3-5-20(6-4-19)26-22(29)9-15-30-2/h17,19-20H,3-16H2,1-2H3,(H,26,29) OZUAEHNGHNUWOV-UHFFFAOYSA-N 106522 US8586579, 138 5-hydroxytryptamine receptor 2A Homo sapiens 37 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106522&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771511 174008833 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225282 OC(C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)C(F)(F)F |r,wU:5.4,wD:8.8,(8.96,-.82,;8.19,.52,;6.65,.52,;5.88,-.82,;5.88,1.85,;4.34,1.85,;3.57,.52,;2.03,.52,;1.26,1.85,;-.28,1.85,;-1.05,.52,;-2.59,.52,;-3.36,-.82,;-4.9,-.82,;-5.67,.52,;-4.9,1.85,;-3.36,1.85,;-7.21,.52,;-7.98,1.85,;-9.52,1.85,;-10.29,.52,;-9.52,-.82,;-10,-2.28,;-8.75,-3.19,;-7.51,-2.28,;-7.98,-.82,;2.03,3.19,;3.57,3.19,;8.96,1.85,;9.73,3.19,;7.62,2.62,;10.29,1.08,)| InChI=1S/C22H31F3N4O3/c23-22(24,25)19(30)21(31)27-16-3-1-15(2-4-16)6-9-28-10-12-29(13-11-28)20-17-7-14-32-18(17)5-8-26-20/h5,8,15-16,19,30H,1-4,6-7,9-14H2,(H,27,31) PMYFBYDQSGEVHT-UHFFFAOYSA-N 106523 US8586579, 112 5-hydroxytryptamine receptor 2A Homo sapiens 11.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106523&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771512 174008834 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225283 COC(CC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)OC |r,wU:7.6,wD:10.10,(8.48,-3.33,;7.71,-2,;8.48,-.67,;7.71,.67,;6.17,.67,;5.4,-.67,;5.4,2,;3.86,2,;3.09,.67,;1.55,.67,;.78,2,;-.76,2,;-1.53,.67,;-3.07,.67,;-3.84,-.67,;-5.38,-.67,;-6.17,.67,;-5.38,2,;-3.84,2,;-7.71,.67,;-8.48,2,;-10.02,2,;-10.79,.67,;-10.02,-.67,;-10.49,-2.13,;-9.25,-3.04,;-8,-2.13,;-8.48,-.67,;1.55,3.33,;3.09,3.33,;10.02,-.67,;10.79,.67,)| InChI=1S/C24H38N4O4/c1-30-23(31-2)17-22(29)26-19-5-3-18(4-6-19)8-11-27-12-14-28(15-13-27)24-20-9-16-32-21(20)7-10-25-24/h7,10,18-19,23H,3-6,8-9,11-17H2,1-2H3,(H,26,29) AVYIORKUKBQLOA-UHFFFAOYSA-N 106524 US8586579, 140 5-hydroxytryptamine receptor 2A Homo sapiens 15.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106524&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125824 174008835 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225284 COC(CCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)OC |r,wU:8.7,wD:11.11,(11.56,.67,;10.02,.67,;9.25,-.67,;7.71,-.67,;6.94,.67,;5.4,.67,;4.63,-.67,;4.63,2,;3.09,2,;2.32,.67,;.78,.67,;.01,2,;-1.53,2,;-2.3,.67,;-3.84,.67,;-4.61,-.67,;-6.15,-.67,;-6.94,.67,;-6.15,2,;-4.61,2,;-8.48,.67,;-9.25,2,;-10.79,2,;-11.56,.67,;-10.79,-.67,;-11.26,-2.13,;-10.02,-3.04,;-8.77,-2.13,;-9.25,-.67,;.78,3.33,;2.32,3.33,;10.02,-2,;9.25,-3.33,)| InChI=1S/C25H40N4O4/c1-31-24(32-2)8-7-23(30)27-20-5-3-19(4-6-20)10-13-28-14-16-29(17-15-28)25-21-11-18-33-22(21)9-12-26-25/h9,12,19-20,24H,3-8,10-11,13-18H2,1-2H3,(H,27,30) LIWZXUWAEHOPHY-UHFFFAOYSA-N 106525 US8586579, 141 5-hydroxytryptamine receptor 2A Homo sapiens 18.1 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106525&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125791 174008836 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225285 CS(=O)(=O)c1ccc(s1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:12.12,wD:15.16,(11.77,-1.79,;10.43,-1.02,;9.66,-2.36,;11.2,.31,;9.1,-.25,;9.1,1.29,;7.64,1.76,;6.73,.52,;7.64,-.73,;5.19,.52,;4.42,-.82,;4.42,1.85,;2.88,1.85,;2.11,.52,;.57,.52,;-.2,1.85,;-1.74,1.85,;-2.51,.52,;-4.05,.52,;-4.82,-.82,;-6.36,-.82,;-7.15,.52,;-6.36,1.85,;-4.82,1.85,;-8.69,.52,;-9.46,1.85,;-11,1.85,;-11.77,.52,;-11,-.82,;-11.47,-2.28,;-10.23,-3.19,;-8.98,-2.28,;-9.46,-.82,;.57,3.19,;2.11,3.19,)| InChI=1S/C25H34N4O4S2/c1-35(31,32)23-7-6-22(34-23)25(30)27-19-4-2-18(3-5-19)9-12-28-13-15-29(16-14-28)24-20-10-17-33-21(20)8-11-26-24/h6-8,11,18-19H,2-5,9-10,12-17H2,1H3,(H,27,30) HWZBTMUYGJHELF-UHFFFAOYSA-N 106526 US8586579, 115 5-hydroxytryptamine receptor 2A Homo sapiens 9.46 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106526&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125814 174008837 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225286 Cc1ccc(cn1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:10.10,wD:13.14,(11.46,.52,;10.11,.52,;9.34,1.85,;7.8,1.85,;7.03,.52,;7.8,-.82,;9.34,-.82,;5.49,.52,;4.72,-.82,;4.72,1.85,;3.18,1.85,;2.41,.52,;.87,.52,;.1,1.85,;-1.44,1.85,;-2.21,.52,;-3.75,.52,;-4.52,-.82,;-6.06,-.82,;-6.84,.52,;-6.06,1.85,;-4.52,1.85,;-8.38,.52,;-9.15,1.85,;-10.69,1.85,;-11.46,.52,;-10.69,-.82,;-11.17,-2.28,;-9.92,-3.19,;-8.68,-2.28,;-9.15,-.82,;.87,3.19,;2.41,3.19,)| InChI=1S/C26H35N5O2/c1-19-2-5-21(18-28-19)26(32)29-22-6-3-20(4-7-22)9-12-30-13-15-31(16-14-30)25-23-10-17-33-24(23)8-11-27-25/h2,5,8,11,18,20,22H,3-4,6-7,9-10,12-17H2,1H3,(H,29,32) UNPARBQWWULNRE-UHFFFAOYSA-N 106527 US8586579, 143 5-hydroxytryptamine receptor 2A Homo sapiens 15.5 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106527&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54769063 174008838 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225287 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)C#N |r,wU:3.2,wD:6.6,(3.95,-.82,;4.72,.52,;3.95,1.85,;2.41,1.85,;1.64,.52,;.1,.52,;-.67,1.85,;-2.21,1.85,;-2.98,.52,;-4.52,.52,;-5.29,-.82,;-6.83,-.82,;-7.61,.52,;-6.83,1.85,;-5.29,1.85,;-9.15,.52,;-9.92,1.85,;-11.46,1.85,;-12.23,.52,;-11.46,-.82,;-11.94,-2.28,;-10.69,-3.19,;-9.45,-2.28,;-9.92,-.82,;.1,3.19,;1.64,3.19,;6.26,.52,;7.03,-.82,;8.57,-.82,;9.34,.52,;8.57,1.85,;7.03,1.85,;10.69,.52,;12.23,.52,)| InChI=1S/C27H33N5O2/c28-19-21-1-5-22(6-2-21)27(33)30-23-7-3-20(4-8-23)10-13-31-14-16-32(17-15-31)26-24-11-18-34-25(24)9-12-29-26/h1-2,5-6,9,12,20,23H,3-4,7-8,10-11,13-18H2,(H,30,33) MHYHDPMWTXPZLG-UHFFFAOYSA-N 106528 US8586579, 144 5-hydroxytryptamine receptor 2A Homo sapiens 13 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106528&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54768834 174008839 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225288 CN1CCN(CC1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:16.17,wD:19.21,(13.77,.52,;12.23,.52,;11.46,-.82,;9.92,-.82,;9.15,.52,;9.92,1.85,;11.46,1.85,;7.8,.52,;7.03,-.82,;5.49,-.82,;4.72,.52,;5.49,1.85,;7.03,1.85,;3.18,.52,;2.41,-.82,;2.41,1.85,;.87,1.85,;.1,.52,;-1.44,.52,;-2.21,1.85,;-3.75,1.85,;-4.52,.52,;-6.06,.52,;-6.83,-.82,;-8.37,-.82,;-9.15,.52,;-8.37,1.85,;-6.83,1.85,;-10.69,.52,;-11.46,1.85,;-13,1.85,;-13.77,.52,;-13,-.82,;-13.48,-2.28,;-12.23,-3.19,;-10.99,-2.28,;-11.46,-.82,;-1.44,3.19,;.1,3.19,)| InChI=1S/C31H44N6O2/c1-34-15-19-36(20-16-34)27-8-4-25(5-9-27)31(38)33-26-6-2-24(3-7-26)11-14-35-17-21-37(22-18-35)30-28-12-23-39-29(28)10-13-32-30/h4-5,8-10,13,24,26H,2-3,6-7,11-12,14-23H2,1H3,(H,33,38) FNDLZQGZKLRGIU-UHFFFAOYSA-N 106529 US8586579, 118 5-hydroxytryptamine receptor 2A Homo sapiens 4.51 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106529&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771736 174008840 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225289 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(nc1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.18,-.82,;3.95,.52,;3.18,1.85,;1.64,1.85,;.87,.52,;-.67,.52,;-1.44,1.85,;-2.98,1.85,;-3.75,.52,;-5.29,.52,;-6.06,-.82,;-7.6,-.82,;-8.38,.52,;-7.6,1.85,;-6.06,1.85,;-9.92,.52,;-10.69,1.85,;-12.23,1.85,;-13,.52,;-12.23,-.82,;-12.71,-2.28,;-11.46,-3.19,;-10.22,-2.28,;-10.69,-.82,;-.67,3.19,;.87,3.19,;5.49,.52,;6.26,1.85,;7.8,1.85,;8.57,.52,;7.8,-.82,;6.26,-.82,;9.92,.52,;10.69,-.82,;12.23,-.82,;13,.52,;12.23,1.85,;10.69,1.85,)| InChI=1S/C29H40N6O3/c36-29(23-3-6-27(31-21-23)34-16-19-37-20-17-34)32-24-4-1-22(2-5-24)8-11-33-12-14-35(15-13-33)28-25-9-18-38-26(25)7-10-30-28/h3,6-7,10,21-22,24H,1-2,4-5,8-9,11-20H2,(H,32,36) SWYRWYLIJXJVNV-UHFFFAOYSA-N 106530 US8586579, 146 5-hydroxytryptamine receptor 2A Homo sapiens 15.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106530&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771737 174008841 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225290 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-c1cccnc1 |r,wU:3.2,wD:6.6,(3.18,-.82,;3.95,.52,;3.18,1.85,;1.64,1.85,;.87,.52,;-.67,.52,;-1.44,1.85,;-2.98,1.85,;-3.75,.52,;-5.29,.52,;-6.06,-.82,;-7.6,-.82,;-8.38,.52,;-7.6,1.85,;-6.06,1.85,;-9.92,.52,;-10.69,1.85,;-12.23,1.85,;-13,.52,;-12.23,-.82,;-12.71,-2.28,;-11.46,-3.19,;-10.22,-2.28,;-10.69,-.82,;-.67,3.19,;.87,3.19,;5.49,.52,;6.26,-.82,;7.8,-.82,;8.57,.52,;7.8,1.85,;6.26,1.85,;9.92,.52,;10.69,1.85,;12.23,1.85,;13,.52,;12.23,-.82,;10.69,-.82,)| InChI=1S/C31H37N5O2/c37-31(25-7-5-24(6-8-25)26-2-1-14-32-22-26)34-27-9-3-23(4-10-27)12-16-35-17-19-36(20-18-35)30-28-13-21-38-29(28)11-15-33-30/h1-2,5-8,11,14-15,22-23,27H,3-4,9-10,12-13,16-21H2,(H,34,37) SBHJIEDINHIMAF-UHFFFAOYSA-N 106531 US8586579, 120 5-hydroxytryptamine receptor 2A Homo sapiens 12.3 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106531&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125836 174008842 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225291 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc2OCOc2c1 |r,wU:3.2,wD:6.6,(4.56,-.82,;5.33,.52,;4.56,1.85,;3.02,1.85,;2.25,.52,;.71,.52,;-.06,1.85,;-1.6,1.85,;-2.37,.52,;-3.91,.52,;-4.68,-.82,;-6.22,-.82,;-7,.52,;-6.22,1.85,;-4.68,1.85,;-8.54,.52,;-9.31,1.85,;-10.85,1.85,;-11.62,.52,;-10.85,-.82,;-11.33,-2.28,;-10.08,-3.19,;-8.84,-2.28,;-9.31,-.82,;.71,3.19,;2.25,3.19,;6.87,.52,;7.64,-.82,;9.18,-.82,;9.95,.52,;11.46,.84,;11.62,2.37,;10.22,3,;9.18,1.85,;7.64,1.85,)| InChI=1S/C27H34N4O4/c32-27(20-3-6-24-25(17-20)35-18-34-24)29-21-4-1-19(2-5-21)8-11-30-12-14-31(15-13-30)26-22-9-16-33-23(22)7-10-28-26/h3,6-7,10,17,19,21H,1-2,4-5,8-9,11-16,18H2,(H,29,32) CEMWPWPBXGCHCV-UHFFFAOYSA-N 106532 US8586579, 148 5-hydroxytryptamine receptor 2A Homo sapiens 17.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106532&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771738 174008843 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225292 O=C(Cc1ccc2OCOc2c1)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.14,wD:16.18,(4.56,3.85,;5.33,2.52,;6.88,2.52,;7.65,1.18,;6.88,-.15,;7.65,-1.48,;9.19,-1.48,;10.22,-2.63,;11.62,-2,;11.46,-.47,;9.96,-.15,;9.19,1.18,;4.56,1.18,;3.02,1.18,;2.25,-.15,;.71,-.15,;-.06,1.18,;-1.6,1.18,;-2.37,-.15,;-3.91,-.15,;-4.68,-1.48,;-6.22,-1.48,;-7,-.15,;-6.22,1.18,;-4.68,1.18,;-8.54,-.15,;-9.31,1.18,;-10.85,1.18,;-11.62,-.15,;-10.85,-1.48,;-11.33,-2.95,;-10.08,-3.85,;-8.84,-2.95,;-9.31,-1.48,;.71,2.52,;2.25,2.52,)| InChI=1S/C28H36N4O4/c33-27(18-21-3-6-25-26(17-21)36-19-35-25)30-22-4-1-20(2-5-22)8-11-31-12-14-32(15-13-31)28-23-9-16-34-24(23)7-10-29-28/h3,6-7,10,17,20,22H,1-2,4-5,8-9,11-16,18-19H2,(H,30,33) ONAUJHKYHSJWDK-UHFFFAOYSA-N 106533 US8586579, 149 5-hydroxytryptamine receptor 2A Homo sapiens 33.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106533&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771739 174008844 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225293 OC1(CCC1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:8.8,wD:11.12,(8.48,-1.02,;8.48,.52,;10.02,.52,;10.02,2.06,;8.48,2.06,;6.94,.52,;6.17,-.82,;6.17,1.85,;4.63,1.85,;3.86,.52,;2.32,.52,;1.55,1.85,;.01,1.85,;-.76,.52,;-2.3,.52,;-3.07,-.82,;-4.61,-.82,;-5.4,.52,;-4.61,1.85,;-3.07,1.85,;-6.94,.52,;-7.71,1.85,;-9.25,1.85,;-10.02,.52,;-9.25,-.82,;-9.72,-2.28,;-8.48,-3.19,;-7.23,-2.28,;-7.71,-.82,;2.32,3.19,;3.86,3.19,)| InChI=1S/C24H36N4O3/c29-23(24(30)9-1-10-24)26-19-4-2-18(3-5-19)7-12-27-13-15-28(16-14-27)22-20-8-17-31-21(20)6-11-25-22/h6,11,18-19,30H,1-5,7-10,12-17H2,(H,26,29) WPDISOIHGGRFRZ-UHFFFAOYSA-N 106534 US8586579, 123 5-hydroxytryptamine receptor 2A Homo sapiens 9.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106534&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771740 174008845 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225294 CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:7.6,wD:10.10,(10.02,.52,;8.48,.52,;8.48,-1.02,;8.48,2.06,;6.94,.52,;6.17,-.82,;6.17,1.85,;4.63,1.85,;3.86,.52,;2.32,.52,;1.55,1.85,;.01,1.85,;-.76,.52,;-2.3,.52,;-3.07,-.82,;-4.61,-.82,;-5.4,.52,;-4.61,1.85,;-3.07,1.85,;-6.94,.52,;-7.71,1.85,;-9.25,1.85,;-10.02,.52,;-9.25,-.82,;-9.72,-2.28,;-8.48,-3.19,;-7.23,-2.28,;-7.71,-.82,;2.32,3.19,;3.86,3.19,)| InChI=1S/C23H36N4O3/c1-23(2,29)22(28)25-18-5-3-17(4-6-18)8-11-26-12-14-27(15-13-26)21-19-9-16-30-20(19)7-10-24-21/h7,10,17-18,29H,3-6,8-9,11-16H2,1-2H3,(H,25,28) ZATCCWHVTMAUCE-UHFFFAOYSA-N 106535 US8586579, 124 5-hydroxytryptamine receptor 2A Homo sapiens 7.82 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106535&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125837 174008846 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225295 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)N1CCS(=O)(=O)CC1 |r,wU:3.2,wD:6.6,(2.67,-.82,;3.44,.52,;2.67,1.85,;1.13,1.85,;.36,.52,;-1.18,.52,;-1.95,1.85,;-3.49,1.85,;-4.26,.52,;-5.8,.52,;-6.57,-.82,;-8.11,-.82,;-8.89,.52,;-8.11,1.85,;-6.57,1.85,;-10.43,.52,;-11.2,1.85,;-12.74,1.85,;-13.51,.52,;-12.74,-.82,;-13.22,-2.28,;-11.97,-3.19,;-10.73,-2.28,;-11.2,-.82,;-1.18,3.19,;.36,3.19,;4.67,.52,;5.44,-.82,;6.98,-.82,;7.75,.52,;6.98,1.85,;5.44,1.85,;9.1,.52,;9.87,-.82,;11.41,-.82,;12.18,.52,;13.51,1.29,;13.51,-.25,;11.41,1.85,;9.87,1.85,)| InChI=1S/C30H41N5O4S/c36-30(24-3-7-26(8-4-24)34-18-21-40(37,38)22-19-34)32-25-5-1-23(2-6-25)10-13-33-14-16-35(17-15-33)29-27-11-20-39-28(27)9-12-31-29/h3-4,7-9,12,23,25H,1-2,5-6,10-11,13-22H2,(H,32,36) JUAVLXRBQKTSPW-UHFFFAOYSA-N 106536 US8586579, 152 5-hydroxytryptamine receptor 2A Homo sapiens 16.6 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106536&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125857 174008847 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225296 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-n1cccn1 |r,wU:3.2,wD:6.6,(3.54,-.82,;4.31,.52,;3.54,1.85,;2,1.85,;1.23,.52,;-.31,.52,;-1.08,1.85,;-2.62,1.85,;-3.39,.52,;-4.93,.52,;-5.7,-.82,;-7.24,-.82,;-8.03,.52,;-7.24,1.85,;-5.7,1.85,;-9.57,.52,;-10.34,1.85,;-11.88,1.85,;-12.65,.52,;-11.88,-.82,;-12.35,-2.28,;-11.11,-3.19,;-9.86,-2.28,;-10.34,-.82,;-.31,3.19,;1.23,3.19,;5.85,.52,;6.62,-.82,;8.16,-.82,;8.93,.52,;8.16,1.85,;6.62,1.85,;10.28,.52,;11.18,-.73,;12.65,-.25,;12.65,1.29,;11.18,1.76,)| InChI=1S/C29H36N6O2/c36-29(23-4-8-25(9-5-23)35-15-1-13-31-35)32-24-6-2-22(3-7-24)11-16-33-17-19-34(20-18-33)28-26-12-21-37-27(26)10-14-30-28/h1,4-5,8-10,13-15,22,24H,2-3,6-7,11-12,16-21H2,(H,32,36) BNGQWOSQOPVKCC-UHFFFAOYSA-N 106537 US8586579, 153 5-hydroxytryptamine receptor 2A Homo sapiens 35.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106537&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125848 174008848 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225297 Cc1nc(no1)-c1cccc(c1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:15.16,wD:18.20,(12.46,4.24,;11.13,3.47,;10.65,2,;9.11,2,;8.64,3.47,;9.88,4.37,;8.34,.67,;9.11,-.67,;8.34,-2,;6.8,-2,;6.03,-.67,;6.8,.67,;4.49,-.67,;3.72,-2,;3.72,.67,;2.18,.67,;1.41,-.67,;-.13,-.67,;-.9,.67,;-2.44,.67,;-3.21,-.67,;-4.75,-.67,;-5.52,-2,;-7.06,-2,;-7.84,-.67,;-7.06,.67,;-5.52,.67,;-9.38,-.67,;-10.15,.67,;-11.69,.67,;-12.46,-.67,;-11.69,-2,;-12.17,-3.47,;-10.92,-4.37,;-9.68,-3.47,;-10.15,-2,;-.13,2,;1.41,2,)| InChI=1S/C29H36N6O3/c1-20-31-27(33-38-20)22-3-2-4-23(19-22)29(36)32-24-7-5-21(6-8-24)10-13-34-14-16-35(17-15-34)28-25-11-18-37-26(25)9-12-30-28/h2-4,9,12,19,21,24H,5-8,10-11,13-18H2,1H3,(H,32,36) DZYJECJNISMMEC-UHFFFAOYSA-N 106538 US8586579, 154 5-hydroxytryptamine receptor 2A Homo sapiens 48.9 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106538&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771971 174008849 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225298 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc2ncccc2c1 |r,wU:3.2,wD:6.6,(4.23,-.82,;5,.52,;4.23,1.85,;2.7,1.85,;1.93,.52,;.39,.52,;-.39,1.85,;-1.93,1.85,;-2.7,.52,;-4.23,.52,;-5,-.82,;-6.54,-.82,;-7.31,.52,;-6.54,1.85,;-5,1.85,;-8.85,.52,;-9.62,1.85,;-11.16,1.85,;-11.93,.52,;-11.16,-.82,;-11.64,-2.28,;-10.39,-3.19,;-9.15,-2.28,;-9.62,-.82,;.39,3.19,;1.93,3.19,;6.54,.52,;7.31,1.85,;8.85,1.85,;9.62,.52,;11.16,.52,;11.93,-.82,;11.16,-2.15,;9.62,-2.15,;8.85,-.82,;7.31,-.82,)| InChI=1S/C29H35N5O2/c35-29(23-5-8-26-22(20-23)2-1-12-30-26)32-24-6-3-21(4-7-24)10-14-33-15-17-34(18-16-33)28-25-11-19-36-27(25)9-13-31-28/h1-2,5,8-9,12-13,20-21,24H,3-4,6-7,10-11,14-19H2,(H,32,35) ATHCQCSSVYPJIN-UHFFFAOYSA-N 106539 US8586579, 155 5-hydroxytryptamine receptor 2A Homo sapiens 23.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106539&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771972 174008850 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225299 O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.14,wD:16.18,(4.27,-.82,;5.04,.52,;6.58,.52,;7.35,-.82,;6.87,-2.28,;8.12,-3.19,;9.36,-2.28,;10.87,-2.6,;11.9,-1.46,;11.43,.01,;9.92,.33,;8.89,-.82,;4.27,1.85,;2.73,1.85,;1.96,.52,;.42,.52,;-.35,1.85,;-1.89,1.85,;-2.66,.52,;-4.2,.52,;-4.97,-.82,;-6.51,-.82,;-7.28,.52,;-6.51,1.85,;-4.97,1.85,;-8.82,.52,;-9.59,1.85,;-11.13,1.85,;-11.9,.52,;-11.13,-.82,;-11.61,-2.28,;-10.36,-3.19,;-9.12,-2.28,;-9.59,-.82,;.42,3.19,;1.96,3.19,)| InChI=1S/C28H35N5O3/c34-27(19-24-22-3-1-2-4-26(22)36-31-24)30-21-7-5-20(6-8-21)10-13-32-14-16-33(17-15-32)28-23-11-18-35-25(23)9-12-29-28/h1-4,9,12,20-21H,5-8,10-11,13-19H2,(H,30,34) MWMCOQFLGVOAHE-UHFFFAOYSA-N 106540 US8586579, 156 5-hydroxytryptamine receptor 2A Homo sapiens 27.8 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106540&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771973 174008851 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225300 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1cnc(cn1)N1CCOCC1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,1.85,;7.7,1.85,;8.47,.52,;7.7,-.82,;6.16,-.82,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C28H39N7O3/c36-28(24-19-31-26(20-30-24)34-14-17-37-18-15-34)32-22-3-1-21(2-4-22)6-9-33-10-12-35(13-11-33)27-23-7-16-38-25(23)5-8-29-27/h5,8,19-22H,1-4,6-7,9-18H2,(H,32,36) MTJDLXLLSRKTMU-UHFFFAOYSA-N 106541 US8586579, 157 5-hydroxytryptamine receptor 2A Homo sapiens 18.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106541&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 67125784 174008852 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225301 CC(C)(C)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1 |r,wU:13.13,wD:16.17,(10.78,2.06,;10.78,.52,;10.78,-1.02,;12.32,.52,;9.24,.52,;8.47,-.82,;6.93,-.82,;6.16,.52,;6.93,1.85,;8.47,1.85,;4.62,.52,;3.85,-.82,;3.85,1.85,;2.31,1.85,;1.54,.52,;,.52,;-.77,1.85,;-2.31,1.85,;-3.08,.52,;-4.62,.52,;-5.39,-.82,;-6.93,-.82,;-7.7,.52,;-6.93,1.85,;-5.39,1.85,;-9.24,.52,;-10.01,1.85,;-11.55,1.85,;-12.32,.52,;-11.55,-.82,;-12.03,-2.28,;-10.78,-3.19,;-9.53,-2.28,;-10.01,-.82,;,3.19,;1.54,3.19,)| InChI=1S/C30H42N4O2/c1-30(2,3)24-8-6-23(7-9-24)29(35)32-25-10-4-22(5-11-25)13-16-33-17-19-34(20-18-33)28-26-14-21-36-27(26)12-15-31-28/h6-9,12,15,22,25H,4-5,10-11,13-14,16-21H2,1-3H3,(H,32,35) ZZJDFRAENYUPMH-UHFFFAOYSA-N 106542 US8586579, 158 5-hydroxytryptamine receptor 2A Homo sapiens 66.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106542&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771974 174008853 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225302 Clc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(CC3)c3nccc4OCCc34)CC2)c(Cl)c1 |r,wU:8.7,wD:11.11,(11.55,.52,;10.01,.52,;9.24,1.85,;7.7,1.85,;6.93,.52,;5.39,.52,;4.62,-.82,;4.62,1.85,;3.08,1.85,;2.31,.52,;.77,.52,;,1.85,;-1.54,1.85,;-2.31,.52,;-3.85,.52,;-4.62,-.82,;-6.16,-.82,;-6.93,.52,;-6.16,1.85,;-4.62,1.85,;-8.47,.52,;-9.24,1.85,;-10.78,1.85,;-11.55,.52,;-10.78,-.82,;-11.26,-2.28,;-10.01,-3.19,;-8.76,-2.28,;-9.24,-.82,;.77,3.19,;2.31,3.19,;7.7,-.82,;6.93,-2.15,;9.24,-.82,)| InChI=1S/C26H32Cl2N4O2/c27-19-3-6-21(23(28)17-19)26(33)30-20-4-1-18(2-5-20)8-11-31-12-14-32(15-13-31)25-22-9-16-34-24(22)7-10-29-25/h3,6-7,10,17-18,20H,1-2,4-5,8-9,11-16H2,(H,30,33) KVMPVICKYUXJEP-UHFFFAOYSA-N 106543 US8586579, 159 5-hydroxytryptamine receptor 2A Homo sapiens 21.7 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106543&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54771975 174008854 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225303 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-n1cccc1 |r,wU:3.2,wD:6.6,(3.44,-.82,;4.21,.52,;3.44,1.85,;1.9,1.85,;1.13,.52,;-.41,.52,;-1.18,1.85,;-2.72,1.85,;-3.49,.52,;-5.04,.52,;-5.81,-.82,;-7.35,-.82,;-8.12,.52,;-7.35,1.85,;-5.81,1.85,;-9.66,.52,;-10.43,1.85,;-11.97,1.85,;-12.74,.52,;-11.97,-.82,;-12.44,-2.28,;-11.2,-3.19,;-9.95,-2.28,;-10.43,-.82,;-.41,3.19,;1.13,3.19,;5.75,.52,;6.52,-.82,;8.06,-.82,;8.83,.52,;8.06,1.85,;6.52,1.85,;10.37,.52,;11.27,-.73,;12.74,-.25,;12.74,1.29,;11.27,1.76,)| InChI=1S/C30H37N5O2/c36-30(24-5-9-26(10-6-24)34-15-1-2-16-34)32-25-7-3-23(4-8-25)12-17-33-18-20-35(21-19-33)29-27-13-22-37-28(27)11-14-31-29/h1-2,5-6,9-11,14-16,23,25H,3-4,7-8,12-13,17-22H2,(H,32,36) HIUMOAWWYUAXFP-UHFFFAOYSA-N 106544 US8586579, 160 5-hydroxytryptamine receptor 2A Homo sapiens 24.2 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106544&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54772198 174008855 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 225304 O=C(N[C@H]1CC[C@H](CCN2CCN(CC2)c2nccc3OCCc23)CC1)c1ccc(cc1)-c1ccccc1 |r,wU:3.2,wD:6.6,(3.08,-.82,;3.85,.52,;3.08,1.85,;1.54,1.85,;.77,.52,;-.77,.52,;-1.54,1.85,;-3.08,1.85,;-3.85,.52,;-5.39,.52,;-6.16,-.82,;-7.7,-.82,;-8.47,.52,;-7.7,1.85,;-6.16,1.85,;-10.01,.52,;-10.78,1.85,;-12.32,1.85,;-13.09,.52,;-12.32,-.82,;-12.8,-2.28,;-11.55,-3.19,;-10.3,-2.28,;-10.78,-.82,;-.77,3.19,;.77,3.19,;5.39,.52,;6.16,-.82,;7.7,-.82,;8.47,.52,;7.7,1.85,;6.16,1.85,;10.01,.52,;10.78,-.82,;12.32,-.82,;13.09,.52,;12.32,1.85,;10.78,1.85,)| InChI=1S/C32H38N4O2/c37-32(27-10-8-26(9-11-27)25-4-2-1-3-5-25)34-28-12-6-24(7-13-28)15-18-35-19-21-36(22-20-35)31-29-16-23-38-30(29)14-17-33-31/h1-5,8-11,14,17,24,28H,6-7,12-13,15-16,18-23H2,(H,34,37) ZQZUTJSBLPRYPL-UHFFFAOYSA-N 106545 US8586579, 161 5-hydroxytryptamine receptor 2A Homo sapiens 23.4 US Patent 10.7270/Q2QV3K55 aid1800145 US8586579 Gobbi, L; Rodriguez Sarmiento, RM; Wichmann, J 11/19/2013 3/12/2014 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=106545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=106545&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 54772199 174008856 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0